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 Natural products have played a major role in the history of medicine.  Despite this 
history, many view the area of natural products discovery to be tapped dry, thus the focus 
of drug development companies has shifted towards other avenues to discover new drug 
leads (i.e. combinatorial chemistry).  In recent years, there has been an expansion of 
antimicrobial-resistant organisms accompanied by a lack of new drug entities coming to 
market.  These trends illustrate a need to find new approaches other than the current 
status quo. 
 Analyses of microbial genomes show that there are many more secondary 
metabolite biosynthetic pathways than known secondary metabolites.  These silent 
biosynthetic pathways (SBPs) offer the opportunity to discover new chemistry and the 
hope of new drug-like entities.  Current methodologies to access SBPs fall into one of 
two categories:  culture-dependent methods or molecular-based techniques, which are 
highlighted in chapter 1.  While both approaches have been utilized to access SBPs, there 
are many deficiencies which inhibit the overall effectiveness of both methods.  We offer 
another approach to bypass these difficulties.  Studies of fungal genomes have 
demonstrated that many secondary metabolite biosynthetic genes are under epigenetic 
regulation.  It is thought that treating fungi with small molecule epigenetic modifiers will 
upregulate the transcription of SBPs and allow the isolation of new secondary 
metabolites.  This dissertation describes the work done using small molecules pig netic 
modifiers to access SBPs and isolate new secondary metabolites.  The third chapter 
involves pilot studies of cultures which were treated with epigenetic modifiers and the 




chapter follows up this work by demonstrating that the use of epigenetic modifiers results 
in the transcriptional upregulation of secondary biosynthetic pathways for a well-studied 
strain of Aspergillus niger.  This is followed by the isolation of nygerone A from 
Aspergillus niger in the fifth chapter, which also presents a structural revision and 
bioactivity analysis of a set of γ-pyrones and γ-pyridones.  The final chapter diverges 
from the topic of small molecule epigenetic modifiers and investigates the icht yotoxicity 
of Prymnesium parvum, an invasive algal species which has transitioned from coastal 




Chapter 1. Oveview of Natural Products and Methods to Access Silent 
Biosynthetic Pathways 
This chapter has been is adapted from portions of a previously published book chapter.1  
1.1  Natural Products and the Pharmaceutical Industry 
  
Natural products have had a long, rich history with respect to their importance in 
the treatment of disease.  Since 1980, greater than 60% of drugs developed were deriv d 
from natural sources.2-4  Despite the overwhelming number of drugs and drug leads from 
natural product sources, pharmaceutical companies appear to believe that new discoveries 
from natural products have been tapped dry.  Thus, companies have moved towards other 
methods to develop drug leads (i.e. combinatorial chemistry).2, 3 
The completion of the human genome project allowed for new disease targets to 
be identified for high-throughput bioassays.  The development of these bioassays has led 
to a shift in the approach with which pharmaceutical companies identify new bioactive 
compounds.  Combinatorial chemistry was envisioned as the means to develop large 
compound libraries to screen for bioactive compounds; however, this approach has not 
met expectations.2, 3  In 2004, new active substances from the pharmaceutical companies 
hit a 24-year low,2 even with changes in the rationale for creating combinatorial   
libraries.5-7  The lack of new drug-like entities has come at a time when there has been 
dramatic increase in the presence of antimicrobial resistant organisms, which indicates 







1.2 Analysis of Microbial Genomes 
The proliferation of fully sequenced microbial genomes during the past decade 
demonstrated that only a fraction of nature's chemical bounty has been explored.  This 
discovery has sparked significant interest in probing silent biosynthetic pathways (SBPs) 
for new and bioactive natural products and has led to the rapid development of several 
innovative technologies for investigating these compounds.  Given the substantial 
scientific interest in this field, several articles about microbial SBPs have been published 
within the past few years.  These publications have provided deeper understanding of the 
topic.8-21  The remainder of this chapter focuses on the methodological approaches used 
to access the products of SBPs.   
Further investigations into SBPs illustrate that many microorganisms express only 
a fraction of their secondary-metabolite-encoding pathways under typical laboratory 
culture conditions (Table 1.1).  In each of these cases, the numbers of secondary 
metabolites observed from laboratory-grown cultures fall short of their genetically 
encoded biosynthetic potential.  Several terms have arisen in the natural products 
literature as descriptors of this phenomenon.  By definition, “silent” biosynthetic 
pathways include the broad range of suppressive transcriptional, translational, nd 
biosynthetic mechanisms responsible for inhibiting secondary metabolite formation.  It is 
interesting to consider that some secondary-metabolite-encoding pathways at appear 
functionally silent might actually be transcribed at low levels, resulting in the generation 
of relatively minor concentrations of their respective biosynthetic products.  




gene's or gene cluster's associated natural products.22  In other cases, SBPs have 
demonstrated complete transcriptional suppression under laboratory culture.22, 23 
Regardless of the cause, SBPs occupy the vast gulf that exists between our knowledge of 
what microorganisms are genetically able to produce and the natural products that 
researchers are capable of chemically detecting.   
Generally, approaches utilized for exploring SBPs fall into two categories:  
manipulation of culture-dependent methods or molecular-based techniques.  The 
following sections will take a glimpse into the present state of these two areas. 
Table 1.1  Number of polyketide synthase (PKS), non-ribosomal peptide synthetase (NRPS), and hybrid 
polyketide synthase/non-ribosomal peptide synthetase (HPN) gene clusters in selected bacteria and fungi.1 
1.3 Manipulation of Culture Conditions 
The ability to activate SBPs by altering microbial culture conditions was well 
known long before researchers were knowledgeable of the functional roles that DNA, 
Organism Genome 
size (Mb) 
Number of gene clusters Reference 
PKS NRPS HPN 
Aspergillus fumigatus Af293 29.4 14 13 1 24 
Aspergillus nidulans FGSC A4 30.0 27 13 1 25 
Aspergillus niger ATCC 1015 37.2 31 15 9 13 
Aspergillus niger CBS 513.88 33.7 34 17 7 26 
Aspergillus oryzae RIB40 37.0 30 18 0 27 
Frankia sp. Ccl3 5.4 6 3 1 28 
Magnaporthe grisea 70-15 37.9 23 6 8 25 
Mycobacterium tuberculosis H5N1 4.4 11 2 0 28 
Neurospora crassa N150 38.6 7 2 1 29 
Nocardia farcinica IFM 10152 6.0 6 7 1 28 
Penicillium chrysogenum Wisconsin54-1255 32.2 20 10 2 30 
Salinispora tropica CNB-440 5.2 6 3 4 28 
Streptomyces avermitilis 9.0 12 4 0 31, 32 
Streptomyces coelicolor A3(2) 8.7 7 3 0 33 




RNA, and proteins played in their production.  Early accounts that described altered 
chemical profiles of microorganisms following culture condition manipulation 
demonstrated this point.  At  the turn of the twentieth century, there was significant 
debate as to the roles that various nutrients and chemical "stimulants" contributed to the 
phenotypic traits of microbes.36, 37  While most of these studies focused heavily on 
features such as cell mass accumulation and spore formation, it was also observed that 
culture manipulation resulted in significant qualitative and quantitative changes in an 
organism's chemical composition.38  For example, the addition of 0.01% ZnSO4 to 
Aspergillus niger was shown to result in a 41% increase in the production of 1, along 
with the appearance and greater yields of many other unidentified small organic 
substances.  Similarly, the effects of varying media/culture conditions were observed to 
appreciably alter the production of pigments and antibiotics including 2 (Aspergillus 
fumigatus),39 3 (Aspergillus clavatus),39 4 and 5 (Fusarium culmorum),40 6 (Penicillium 
phoeniceum),41 and 7 (Penicillium spp.).42-47  While this list of examples is by no means  
exhaustive, it does provide important evidence for understanding the conceptual basis on 
which modern culture manipulation strategies have been designed.  
In the last decade, culture condition manipulation to access SBPs was reviewed 
and presented as the OSMAC (One Strain Many Compounds) method.48  While previous 
discussions demonstrate that this concept had been used for decades, the review 
presented by Bode t. al. gives a  nice summary of culture alteration methods for the 
elicitation of new natural products from fungi and other microbial sources.48  Recently, 
several new compounds have been characterized from fungi using this methodology.  For 





marine derived fungus Spicaria elegans when the media conditions were changed.49  
Additionally, compounds 14-16 from Phomopsis asparagi,50 17-19 from Daldinia 
concentric,51 and 20 and 21 from Ascochyta salicornia52 represent a set of  examples  
which demonstrated the value of culture manipulations strategies.  A significant h ghlight 
of the OSMAC method was shown in a study involving Sphaeropsidales p. F-24'707.  
Varying culture conditions, which included  differing culture vessel type, fermentation 
technique, media formula, and presence or absence of enzyme inhibitors, led to the 
isolation of 8 new and 6 known spirobisnapthalenes.53  While these results demonstrate 
that one can alter growth conditions to trigger the production of SBPs that produce new 
or hidden natural products, the endless conditions which could be used to access these 
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Aspochalasin P (12) R1 = H, R2 = OH





conditions which may be favorable for accessing SBPs of one organism are not 
guaranteed to be conducive to a different organism.   
Another culturing method which has been explored in the attempt to access SBPs 
is based on the fact that fungi natrually live in complex communities which involve a 
wide range of chemical interactions.  It has been proposed that cohabitating 
microorganisms might serve as a signal for the production of natural products.54  
Consequently, it was thought that agents capable of triggering SBP production might 
include a variety of undefined signaling molecules making co-culture a highly promising 
approach for natural product discovery.55  Since 1978, the literature is scattered with 
instances in which mixed fermentation resulted in the increased production of known 
secondary metabolites.56-60  What is more interesting are the  published accounts which 
have described new chemistry under co-culture conditions ranging from the mixing of 
multiple live organisms to the addition of microbial-derived components into         
cultures.61-65 
The microbial metabolite pestalone (22) was reported in 2001 from a marine-
derived Pestalotia sp.61   It is noteworthy that pestalone was not detected from 
monocultures of the Pestalotia sp.  However, addition of an unidentified marine 
bacterium resulted in the production of this metabolite, which was found to possess 
antimicrobial activity.  Other examples in which co-culture conditions produced new 
secondary metabolites include 23 in a combined culture of a fungal and bacterial strain 
which were isolated from an abandoned mine;63 28 and 29 from a combination of a 
fungus, Emericella sp.,62 and a bacteria, Salinispora arenicola,62 and 30 and 31 from a 




that in all of these instances, the newly isolated secondary metabolites demonstrated 
antimicrobial bioactivity. 
A final example to address is the isolation of libertellenones A-D (24-27).  In this 
instance, Oh et. al. were able to isolate this series of secondary metabolites when 
culturing a marine fungus, Libertella sp., with a marine α-proteobacterium.65  These 
compounds demonstrated modest bioactivity, with 27 being the most bioactive in the 
group, which again supports the concepts of co-culturing to access SBPs.  However, the 
authors were also forthright in the work that went into the isolation of these four 
compounds.  During the process, more than 50 fungal strains were co-cultured with a 
marine bacterium, and only the Libertella sp. challenged with marine bacterium showed 
significant changes in secondary metabolite production by LC-MS when compared to 
control conditions.65   These results definitively support the power which co-culturing 
conditions can provide when accessing SBPs.  The small sampling of results 
demonstrates that often times these isolates have interesting chemistry (i.e. presence of 
halogen (22) or nitro-group (23)) and bioactivity.  As with adjusting media conditions, 
co-culturing has the potential for accessing SBPs, yet the libertellenone story 
demonstrates that there are similar drawbacks.  The secondary metabolite production of 
one strain may respond to a certain organism(s), but the next could require completely 
different organism(s) to be added in order to elicit changes in secondary metbolit  
production.  Ultimately, there is a need for understanding the genome of an organism in 
order to rationally approach culture dependent methods to access SBPs.  Otherwise, the 
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1.4 Heterologous Expression as an Approach to Investigating SBPs 
With the access that genome sequencing has granted, additional genomic 
methodologies have been utilized to explore SPBs.  Heterologous expression techniqu s 
provide the opportunity to selectively transfer a SBP into a new host possessing a  
non-transcriptionally suppressed regulatory environment to produce the enzymatic 
machinery for silent natural product biosynthesis.  While this technology has been widely 
used for investigating non-secondary-metabolite-encoding genes, its application to the 
study of natural products and SBPs has evolved dramatically in recent years.  In 2006, 
genome scanning by Muller and colleagues led to the discovery of a type III PKS in the 
myxobacterium Sorangium cellulosum for which no corresponding secondary metabolite 
could be identified.66  Cloning and subsequent transfection of the type III PKS into 
Escherichia coli and Pseudomonas p. demonstrated that the pseudomonad was able to 
function as an appropriate host for expression.  The transfected Pseudomonas p. culture 
turned visibly red and HPLC profiling confirmed the presence of a new metabolite.  The 
structure of the compound was determined to be a naphthoquinone, flaviolin (34), that is 
readily generated from the oxidation of the actual biosynthetic precursor product, 1,3,6,8-
tetrahydroxynaphthalene.   
An important advantage of heterologously expressing SBPs is the opportunity it 
affords to manipulate biosynthetic genes and enzymes, as well as study secondary 
metabolite production in a cell-free environment.  For example, the Canes group noted a 
terpene synthase of unknown function in S. coelicolor A367 and transfected the cloned 
gene into E. coli.  Using gene manipulation, the researchers were able to produce a 





chromatography.68  In vitro incubation of the recombinant protein with farnesyl 
diphosphate in the presence of Mg2+ yielded 31.  The importance of this approach is that 
utilization of the recombinant protein allowed the group to carefully analyze the r action 
mechanisms and kinetics of the new terpene synthase, which is generally not possible in a 
cellular host. 
Palmu et al. have taken the idea of SBP manipulation one step further, leading to 
the production of new angucycline analogs.69  This group observed that both 
Streptomyces p. PGA64 and Streptomyces p. H021 possessed PKS gene clusters, 
exhibiting significant homology to each other.  Heterologous expression of varying 
portions of the gene clusters in Streptomyces lividans TK24 resulted in the generation of 
natural products 32 and 33.  These and other examples demonstrate the promise of using 
heterologous expression systems to manipulate SBPs.  The ability to generate u ique 
pools of natural and "unnatural" secondary metabolites presents an exceptional 
opportunity to identify new drugs and engineer novel chemical scaffolds.  Despite it  
promising features, the routine use of heterologous expression systems for activating 
SBPs faces a number of significant difficulties.  These challenges include the training and 
development of the necessary skill sets researchers need in heterologous expression, 
along with new and widely applicable tools (e.g., universal heterologous hosts, novel 
vectors for routinely handling large gene clusters, etc.) in order to probe the 





1.6  Conclusions and Perspectives on Methods for Accessing SBPs 
The investigation of SBPs has advanced significantly in the past 5 years, and it is 
expected that further advances in genome-based technologies will continue to fuel this 
trend.  Culture-dependent and genomics-driven methods each have unique advantages 
and disadvantages for studying SBPs.  There is the potential that traditional culture-based 
approaches will have significantly diminished value as part of the repertoire of 
contemporary SBP research methods.  Replacing these approaches will be a variety of 
new tools, including some of the work discussed in this dissertation, that offer increased 
speed and efficiency for evaluating SBPs in a high-throughput fashion.  Consequently, 





Chapter 2 Hypothesis and Chapter Overviews 
2.1 Hypothesis 
 Natural products have played a crucial role in the drug development process, yet 
many of the leaders in the pharmaceutical industry have abandoned their natural product 
research programs.  While compelling evidence exists that there are still significant 
numbers of secondary metabolites left to discover in even well-studied bacterial and 
fungal strains; the overall methodology to best access these biosynthetic pathways, with 
respect to time and cost, is still out of reach.  Therefore, if we could find a wayto directly 
access these pathways, then a whole new world could be open for discovery in 
pharmaceuticals as well as other industries. 
The work of Keller and colleagues provided enticing evidence for an epigenetic 
component to the transcriptional regulation of secondary-metabolite-encoding genes and 
gene clusters.70-72  Based on this work, the following hypothesis has been proposed for 
this dissertation:  the use of small molecule epigenetic modifying agents which inhibit 
histone deacetylase and DNA methyltranferase/histone methyltransferase functions 
will lead to the transcriptional upregulation of SBPs resulting in the production 
novel secondary metabolites.  Chapters 3-5 summarize my research and results from the 
use of epigenetic modifiers, along with further investigations into the propensity of a 
class of γ-pyrones and γ-pyridinones in black aspergilli are explored through the use of 
LC-MS.  Finally, Chapter 6 diverges into an investigation of ichthyotoxic secondary 
metabolites produced by an invasive aquatic species, Prymnesium parvum.  While this 




scientific merits of understanding the toxins and the effects on freshwater ecosystems 
make it significant and a part of my doctoral research. 
2.2 Chapter 3.   Epigenetic remodeling of the fungal secondary metabolome. 
 Genome sequencing has shown that only a small portion of secondary metabolites 
have ever been observed in laboratory settings.  While methods have been developed to 
access different pathways, major weaknesses in these methods inhibit the overall 
effectiveness.  Molecular based techniques have great potential, but require specialized 
skills and understanding of the gene sequences.  Culture dependent methods are simple 
and available to everyone, but finding a condition which results in the isolation of a new 
compound is not straightforward, and is costly and time-consuming. 
 Ideally, a means to access all the biosynthetic pathways of an organism while in a 
laboratory is greatly desired.  Using inspiration from Keller and colleagu s, 12 different 
strains of filamentous fungi were screened against a panel of small molecule epigenetic 
modifiers in the culture medium.  Extracts of these cultures were subjected to 
chromatography to determine if there were new and/or enhanced levels of secondary 
metabolites.  The effect a methyltransferase inhibitor, 5-azacytidine, had on a Diatrype. 
sp. was explored in a large scale culture condition, resulting in the isolation of two new 
secondary metabolites.  
2.3 Chapter 4 Chemical induction of silent biosynthetic pathway transcription in 
Aspergillus niger 
  The results described in Chapter 3 revealed that the addition of small molecule 
epigenetic modifiers to 11 of 12 fungal strains resulted in the production of new and/or 




to our hypothesis, it was still uncertain if the effects of these epigenetic modifiers were 
actually causing the upregulation of genes in the fungi.  To further investigate the extent 
to which epigenetic modifying agents were able to alter the transcription of secondary-
metabolite-encoding pathways,  Aspergillus niger was treated with suberoylanilide 
hydroxamic acid or 5-azacytidine, and changes in the transcription of its 31 polyketide 
synthases (PKS), 15 nonribosomal peptide synthetases (NRPS), and 9 hybrid polyketide 
synthase-nonribosomal peptide synthetase (HPN) gene clusters were examined.   
2.4 Chapter 5  Analysis of a class of γ-pyrones and γ-pyridones isolated from 
Aspergillus niger  
Based on the results in the changes in transcription of the PKS, NRPS and HPN 
gene clusters of A. niger under epigenetic modifier conditions, the task of characterizing 
the new SBP-derived metabolites was undertaken.  This led to the identification of the 
new N-phenylpyridine metabolite nygerone A following addition of suberoylanilide 
hydroxamic acid to the culture medium, which is discussed in this chapter.   
During the isolation of nygeone A, a set of compounds were isolated, which when 
dereplicated, based on NMR and MS data, led to two different classes of compounds.  A 
portion of this chapter focuses on solving the true class of structures to which these 
metabolites belong in using DFT calculations and total synthesis.  In addition, we report 
the prevalence of this class of compounds in black aspergilli, along with a follow up 
analysis regarding the nygerone structure and bioassay data for some compounds 




2.6 Chapter 6  Reassessing the Ichthyotoxin Profile of Cultured Prymnesium 
parvum (Golden Algae) and Comparing it to Samples Collected from Recent 
Freshwater Bloom and Fish Kill Events in North America. 
In the United States, there has been a sharp rise in the number of harmful algal 
blooms occurring in freshwater systems.  Unfortunately, the toxins produced by these 
algal species are often times poorly characterized or unknown and this presents a 
significant impediment to the development of effective risk management strategies aimed 
at protecting humans.  One of the most menacing of the freshwater algae, Prymnesium 
parvum, has recently made a surprising transition from coastal waters to inland lakes, 
rivers, and reservoirs throughout the southern United States.  The spread of P. parvum 
and similar algal species into recreational and municipal water supplies is anticipated to 
have devastating effects on a wide range of ecological and economic systems, as well as 
human health.  Using a bioassay guided fractionation methodology, a series of toxins 
produced by P. parvum grown under both laboratory culture conditions and from recent 
algal blooms occurring during 2008 and early 2009 were isolated and characterized in 




Chapter 3.  Epigenetic Remodeling of the Fungal Secondary 
Metabolome. 
This chapter is adapted from a publication in Organic and Biomolecular Chemistry.73 
3.1. Introduction 
Fungi are biosynthetically talented organisms capable of producing a wide rang  
of chemically diverse and biologically intriguing small molecules. The majority of 
scientific interests in fungal natural products have centered on their pharmaceutic l 
applications, roles as mycotoxins, and multifarious ecological functions. Unfortunately, 
typical fungal fermentation methods such as axenic shake or static cultures on artificially 
defined media are poor surrogates for mimicking an organism's native habitat. The 
consequence of these practices is that only a subset of the biosynthetic pathways wich 
encode for secondary metabolite production in fungi are ever expressed, thus limiting
prospects for realizing the complete drug discovery potential of these organisms. 
Moreover, without securing the full range of ‘silent’74 secondary metabolites, 
opportunities for testing hypothesis-based inquiries regarding their native functions 
(antibiosis, intra- and inter-species communication, and modulation of diverse biotic 
responses) remain unattainable. The magnitude of this problem has become markedly 
apparent with the advent of modern genomic technologies. With the exception of yeast, 
the number of putative natural product biosynthetic pathways in fungi exceeds the sum 
total of natural products observed under laboratory culture conditions. Pertinent examples 
highlighting this phenomenon are found among Aspergillus spp.,75 Neurospora crassa,29 




Methods developed for exploring the products of silent secondary metabolic 
pathways in microorganisms fall into two broad categories:14 molecular-based techniques 
and cultivation-dependent approaches. Despite their incredible promise for providing 
outstanding access to and control over silent biosynthetic pathways, molecular-based 
methods utilizing heterologous expression systems are limited by problems such as 
locating and cloning genes, difficulties with gene transformation and inactivation, and 
host incompatibilities. Alternatively, a variety of cultivation-dependent procedures in 
which biotic and abiotic culture parameters are manipulated have likewise been proposed. 
While this methodology has been a mainstay of microbial natural products for decades, 
the concept was more recently formalized by Zeeck and colleagues48 and has since been 
applied by several groups.76  Unfortunately, this protractive strategy is labor intensive, 
lacks predictable outcomes, and inflates the workload of natural products screening 
programs. These difficulties are further compounded by strain-specific variation in the 
quantity of metabolite production as well as the seemingly capricious behavior of fungi to 
alter metabolite profiles when re-cultured. Consequently, an alternative methodology that 
is universally applicable for rationally inducing the expression of silent natural product 
biosynthetic pathways in fungi is needed. 
The discovery of the putative nuclear transcriptional regulator LaeA, which 
controls secondary metabolite production in Aspergillus,72 has inspired our group to 
examine global mechanisms by which fungi restrictively manage the production of 
natural products under laboratory culture conditions. Published fungal genomes 
demonstrate a propensity for the positioning of many putative natural product 




portions of fungal genomes are noted to exist in a heterochromatin state whose 
constitutive genes are often transcriptionally controlled by epigenetic regulation such as 
histone deacetylation and DNA methylation. Recently, Keller and colleagues have 
demonstrated that disruption of histone deacetylase activity (∆hda) in Aspergillus 
nidulans led to the transcriptional activation of gene clusters for the production of 
sterigmatocystin and penicillin.77  Moreover, extension of these observations to growing 
cultures of Alternaria alternate and Penicillium expansum suggested that inhibition of 
histone deacetylase activity could positively modulate secondary metabolite pr duction. 
Based on these observations, we hypothesized that small-molecule epigenetic modifiers 
could be rationally employed for accessing silent natural product pathways and 
enhancing the native production of fungal secondary metabolites. The development of 
such an approach would present significant advantages to the natural products research
community for controlling the expression of latent biosynthetic pathways and creating 
new opportunities for novel small-molecule discoveries. 
3.3. Results and Discussions 
Our initial experiments testing this approach consisted of subjecting a diverse 
panel of twelve fungi to treatment with a focused library of DNA methyltransferase and 
histone deacetylase inhibitors in dose dilution series (0.1 µM to 10 mM).  Comparative 
profiling by HPLC, MS, 1H-NMR and TLC demonstrated eleven of the fungi were 
responsive to one or more epigenetic treatments based on the production of new natural 
products and/or enhanced accumulation of constitutive secondary metabolites. 
Furthermore, exposure of selected Aspergillus, Cladosporium, Clonostachys, Diatrype, 




new natural products were exclusively obtained following the use of epigenetic 
modifying treatments. Cultures treated with amphotericin B, cycloheximide, and 5-
fluorouracil did not produce new or enhanced secondary metabolite profiles indicating 
that epigenetic modifiers impacted fungi in a manner that was functionally distinct from 
that of a general cytotoxic response. Interestingly, a combination treatment, composed of 
a DNA methyltransferase inhibitor and histone deacetylase inhibitor, was tested and 
determined to be only modestly effective due to significant growth restriction and/or 
generation of metabolite profiles dominated by the effects of a single component in the 
mixture (e.g., effects of individual compound treatments were not additive as a mixture). 
In order to probe the nature of metabolic remodeling induced by epigenetic modifier 
treatment, a fungal isolate from our lab was selected for scale-up studies.  
This fungal isolate was obtained from the foregut of a fifth instar luna moth 
(Actias luna; Saturniidae) larva that was cultured on an exclusive diet of sweet gum 
(Liquidambar styraciflua L.; Hamamelidaceae) leaves. Initial characterization of the 
fungus by analysis of the 26S rRNA gene gave a 93% sequence homology to Diatrype 
disciformis. While control cultures of this Diatrype sp. were relatively void of any 
secondary metabolites, addition of 5-azacytidine triggered a significant chge in the 
organism's metabolic profile (Figure 3.1A) based on the HPLC UV chromatographic 




Diatrype sp. Treated with 5
polyketides, lunalides A and B, were produced following treatment 
with the DNA methyltransferase inhibitor.  Compounds were 
characterized by NMR and HRESIMS.
Using the initial analysis as a guide, two metabolites were isolated from the 5
azacytidine treated cultures and were further characte ized.  Compound 
as amorphous solids via HPLC fractionation.  
m/z 595.3494 [M + Na]+ indicating the molecular formula of 
C30H52O10Na, 595.3458). The 
methyls, two methylenes, and fifteen methines. In addition, four quaternary carbons were 
observed, one of which was a carbonyl based on its chemical shift and the other three 
were incorporated into double bonds. HMBC, HSQC, and COSY correlations were used 
to piece together a polyketide backbone, with a sugar moiety attached at C
distinct anomeric proton (
The sugar moiety was determined to be 
and susceptibility to enzymatic hydrolysis with 
remove the sugar residue with 
21 
  Difference chromatogram (UV trace at 210 nm) for 





Data from HRESIMS exhibited a peak of 
35 to be C30
1H and 13C-NMR spectra suggested the presence of nine 
1H δ 4.37 ppm) and carbon (13C δ 97.5 ppm) chemical shifts. 
β-mannopyranose based on 1D-NOE correlations 
β-mannosidase whereas attempts to 
α-mannosidase were unsuccessful.  
35 R1 = H; R2 = β-D-mannopyranoside 
36 R1 = R2 = β-D-mannopyranoside  
-
was obtained 





 Compound 36 was also obtained as an amorphous solid from HPLC fractionation.  
Data from HRESIMS exhibited a peak of m/z 757.3971 [M + Na]+ indicating the 
molecular formula of 36 to be C36H62O15 (calc. for C36H62O15Na, 757.3986). Observing 
the 1H-NMR spectrum indicated the presence of two anomeric proton signatures (1H δ 
4.35 and 4.58 ppm). The proton spectrum, along with the difference in  
mass data between compounds 35 and 36, supported that compound 36 had the same  
polyketide backbone, with an additional β-mannopyranose moiety being present. A 
combination of 2-D HMBC, HSQC, and COSY data confirmed these suspicions, with the 
new β-mannopyranose substituted at the at the C-8 hydroxyl.  Again, the sugar moieties 
were determined to be β-mannopyranose based on enzymatic hydrolysis. Further support 
as to the identity of the β-mannopyranose was obtained by careful comparison of our 1H 
and 13C-NMR data to that of authentic D-mannose.  It is interesting to note that one other 
non-epigenetic culture treatment, elicitation with E. coli, resulted in the biosynthesis of 
35 and 36 which were otherwise repressed under axenic culture conditions. The results 
suggest that their production is under specific control of a unique environmental cue. 
The success of inducing the production of new natural products from fungi by 
administering small-molecule epigenetic modifiers indicates that this technique is a very 
promising and rational approach for the native expression of silent biosynthetic pathways. 
This method has several significant benefits compared to currently available molecular or 
culture-dependent techniques. First and foremost, it provides a needed tool for rapidly 
accessing potential pools of cryptic fungal natural products in their native hosts. Second, 
this methodology can be readily implemented in most labs without extensive retooling, 




and effort of acquiring the products of silent secondary metabolic pathways since fungi 
do not need to be pre-screened using a multitude of culture conditions. 
3.2. Materials and Methods 
3.2.1 General Chemical Methods. Initial HPLC separation of secondary 
metabolite mixtures was performed on a Shimadzu preparative HPLC using a SCL-10A 
VP system controller, SPD-10AV VP UV-VIS detector, LC-6AD pumps, DGU-14A 
solvent degasser, and FRC-10A programmable fraction collector. Samples were 
separated over a Phenomenex C18 Gemini column (5 µm, 110 Å, 250 × 21.2 mm) with 
fractions collected at a rate of one per minute. Semi-preparative HPLC was performed on 
a similar system using LC-10AT VP pumps and a Phenomenex C18 Gemini column (5 
µm, 110 Å, 250 × 10 mm). Mass data from electrospray ionization were acquired on a 
LCT Premier (Waters Corp.) time of flight mass spectrometer. Corrections for exact mass 
determinations were made automatically with the lock mass feature in the MassLynx data 
system.  A reference compound in an auxiliary sprayer was sampled every third cycle by 
toggling a ‘shutter’ between the analysis and reference needles. Samples for mass 
determination were dissolved in MeOH-H2O (9:1) and introduced for ionization with a 20 
µL loop on an auto injector system. NMR data were obtained on a Varian VNMR 
spectrometer at 500 MHz (1H) and 125 MHz (13C). All solvents were of ACS grade or 
better. 
3.3.2 Fungal Test Strains. Fungal test strains for initial screening were obtained 
from the Agricultural Research Services (ARS) Culture Collection (formerly NRRL) and 
The University of Oklahoma Natural Products Discovery Group (OU NPDG) collecti ns. 




marine sediments collected from across the United States including Alaska and its coastal 
waters, Arizona, California and its coastal waters, Indiana, Maine and its coastal waters, 
Oklahoma, Washington, and Wyoming. All strains were grown on appropriate media and 
cryopreserved in 15% glycerol at -80 ºC. Fungi selected for this study included the 
following: Aspergillus flavus (ARS), Aspergillus westerdijkiae (ARS), Cladosporium 
cladosporioides (OU NPDG), Clonostachys p. (OU NPDG), Diatrype sp. (OU 
NPDG), Penicillium chrysogenum (ARS), Penicillium citrinum (ARS), Rhizopus sp. (OU 
NPDG), and Verticillium sp. (OU NPDG), and three additional marine-derived isolates 
that have not yet been identified. 
3.3.3 Small Molecule Epigenetic Modifiers. Small molecule epigenetic 
modifiers were selected to include both DNA methyltransferase and histone deacetylase 
inhibitors. The DNA methyltransferase inhibitors consisted of 5-azacytidine, 5-aza-2′-
deoxycytidine, hydralazine, procaine, and procainamide which were all purchase from 
Sigma. Histone deacetylase inhibitors included sodium butyrate, suberohydroxamic acid, 
and valproic acid from Sigma and suberoylanilide hydroxamic acid from TRC 
Biomedical Research. Compounds were prepared in deionized H2O and filter sterilized 
(0.22 µM) before being added to fungal cultures. 
3.3.4 Screening Epigenetic Modifiers. For MIC determinations, stock cultures 
were prepared by lawning fungi onto Petri plates and the resulting mycelial mats were 
submerged in sterile water and mechanically disrupted so as to uniformly disperse 
cells/spores. Microplates (96-well sterile polystyrene plates, 300 µL well volume, with 
low-evaporation covers, Corning, Inc.) were loaded with 200 µL of media/well and 1 µL 




Pure compounds were tested in a series of six, ten-fold dilutions ranging in concentration 
from 0.1 µM to 10 mM. Aliquots of 20 µL fungal cell/spore suspension were used to 
inoculate each well of the plates. Plates were covered and incubated in a humidified 
chamber in the dark at 25 ºC. After 3-7 days (dependant upon growth characteristics of 
each fungal strain), the MIC values of the compounds were determined visually based on 
turbidity. 
The MIC value was assigned as the lowest compound concentration capable of 
inhibiting fungal growth.  Epigenetic modifying agents were tested for their capacity to 
induce secondary metabolite production by culturing organisms in 25 mL of media, and 
after 24 h, compounds were added at concentrations 10-fold less than their respective 
MIC values. The cultures were incubated an additional 6 days at which point 12 mL of 
MeOH was added to each culture before being partitioned twice against 30 mL of 
dichloromethane. The combined organic extracts were dried under vacuum and stored at  
-20 ºC prior to analysis. 
3.3.5 Isolation and Identification of Fungi. Diatrype sp. was isolated in a three 
phase process. It was first isolated from the fore gut of a fifth instar Ac ias luna 
(Saturniidae) larva that was cultured on an exclusive diet of Liquidambar styraciflua L. 
(Hamamelidaceae) leaves. Substrates containing fungi (~500 mg) were mixed with 15 
mL sterile water, vortexed vigorously, and two, ten-fold dilutions made. Aliquots (200 
µL) of the three suspensions were lawned onto primary isolation plates containing potato-
dextrose agar with chloramphenicol to inhibit bacterial growth and cycloheximide to 
restrict expansion of rapidly growing fungi. Dilution plates were prepared in triplicate 




formation and monitored every other day for three weeks. Emerging colonies exhibiting 
filamentous character were excised from the primary plate using a sterile probe and 
transferred to a secondary Petri plate containing potato dextrose agar with 
chloramphenicol (cycloheximide was omitted). Colonies were selected from primary 
plates for sub-culturing on secondary plates based on their differential morphologies and 
time of appearance. Rapidly spreading colonies and those having morphological features 
identical to isolates already sub-cultured were ‘pruned’ from the primary pl tes in order 
to allow the slower growing and less abundant strains to mature. Secondary plates were 
maintained upright at 20 ºC and the hyphae of the growing organisms allowed to radia e
outward from the point of inoculation. After 1-2 weeks, sterile probes were used to 
remove small samples from the leading edges of the spreading fungal colonies and 
transferred to tertiary Petri plates containing potato-dextrose agar (chlo amphenicol and 
cycloheximide were omitted). Plates were incubated upright at 20 ºC for an additional 1-2 
weeks after which the fungal cultures were prepared for cryostorage. Sterile probes were 
used to remove pieces of mycelia and deposited into sterile cryostorage vials contining 
15% glycerol in water. The samples were then stored at -80 ºC. 
Diatrype sp. was tentatively identified based on analysis of the 300 base pair 
sequence of the D2 region of the large ribosomal subunit (26S rRNA gene). Analysis of 
samples was performed under the expert review of Michael G. Sinclair, Ph.D., 
Mycologist and Laboratory Director, Microcheck, Inc. Briefly, portins of the mycelia 
mats were scraped from the surface of an agar plate and placed in a sample tube with 
Prepman reagent (Applied Biosystems) to lyse the cells and liberate DNA. The mixture 




transferred to a fresh tube and PCR reagents added (buffers, primers, and dNTPs) and the 
26S rRNA gene amplified in a thermal-cycler. Next, ExoSAP-IT was added to 
remove unreacted primers and dNTPs. Finally sequencing reagent was added containing 
fluorescently-tagged ddNTPs yielding 3′ end labeled product and purified. After clean-
up, the samples were loaded into a 3130xl Genetic Analyzer (Applied Biosystems) for 
sequencing. The final consensus sequence was compared to a library of 1,113 fungal 
standards using MicroSeq ID software. The software allowed for comparisons of sample 
sequences to those stored in the library by weighting mismatches (i.e. purine to purine 
substitutions are weighted lower than purine to pyrimidine substitutions) thereby 
providing a percent match score against known fungi.  Most fungi that we encounter can 
be readily identified to the genus level (match score of >95% to known species); 
however, identification to species is less typical. Most general assignments ar  then 
confirmed by morphological/microscopic evaluation according to standard mycologi al 
methods. 
3.3.6 Fungal Culture Conditions and Initial Screening. Seed cultures of fungi 
were prepared by inoculating five 25 mL portions of media with agar plugs from Petri 
plates containing hypae of Diatrype sp. The cultures were allowed grow with shaking for 
seven days at 20 ºC. Scale-up fermentations consisted of sets of ten 1 L Erlenmeyer 
flasks containing 250 mL of sterile potato-dextrose media that were inoculated with 2 mL 
of their respective seed cultures. The newly prepared cultures were allowed to incubate 
with rotary shaking (100 rpm) for 24 h at 25 ºC. Each set of 10 cultures was treated with 
epigenetic modifying compounds or water blank (control) and returned to further 




100 mL of MeOH to each flask before being partitioned twice against 300 mL of 
dichloromethane. The combined organic extracts from replicate flasks were dried under 
vacuum and stored at -20 ºC prior to analysis. All treatments and controls for each fungus 
were performed in tandem with test and control cultures randomly interspersed on the 
shaker. 
3.3.7 Culture Comparison and Compound Isolation. For each experiment, sets 
composed of ten culture flasks (each with 250 mL of potato-dextrose media each 
inoculated 24 h prior with 1 mL of fungal seed culture) were treated with 5-azacytidine 
(DNA methyltransferase inhibitor), suberoylanilide hydroxamic acid (histone deacetylase 
inhibitor), or sterile water blank. Parallel experiments also examined the effects of ten 
different media conditions on secondary metabolite production (Table A1). Cultures of 
Diatrype sp. were incubated with shaking for 14 days and the contents within each 
treatment group pooled. An additional experiment was performed on the Diatrype sp. by 
treating growing cultures of the fungus with 1 mL aliquots of autoclaved Escherichia coli 
culture instead of epigenetic modifiers. A 1 L portion of methanol was added to the 
media-cells mixture and then extracted three times with equal volumes of 
dichloromethane. The total organic extract from each treatment was injected onto C18 
preparative HPLC (20-100% acetonitrile-water over 50 minutes) and monitored by dual 
wavelength UV detection at 210 nm and 254 nm. Difference chromatograms were 
generated for the 210 nm trace by subtracting the untreated control chromatogram fr m 
the treatment groups (Lab Solutions). Peaks phasing upward represent metabolites that 




Compounds Diatrype sp. were isolated by semi-preparative HPLC with repeated re-
injection and separation across C18 using acetonitrile-water gradient conditions. 
3.3.8 Lunalide A (35). 1H-NMR (500 MHz, CD3OD) δ 0.77 (3H, d, J=7.0 Hz, H-
20), 0.82 (3H, d, J=7.5 Hz, H-22), 0.87 (3H, t, J=7.5 Hz, H-17), 0.94 (3H, d, J=7.5 Hz, 
H-18), 0.99 (3H, d, J=6.5 Hz, H-24), 1.24 (1H, m, H-16a), 1.40 (1H, m, H-16b), 1.59 
(3H, d, 1.0 Hz, H-23), 1.64(3H, d, 1.0 Hz, H-19), 1.66 (3H, d, 1.0 Hz, H-21), 2.39 (1H, 
m, H-15), 2.61 (1H, m, H-3), 2.64 (1H, m, H-7), 2.70 (1H, m, H-11), 3.07 (1H, m, H-5′), 
3.36 (1H, m, H-3′), 3.52 (1H, dd, J=9.5Hz, 9.5 Hz, H-4′), 3.70 (3H, s, H-1), 3.70 (1H, d, 
J=9.5 Hz, H-8), 3.71 (1H, m, H-6a′), 3.73 (1H, m, H-2′), 3.86 (1H, dd, J= 2.5 Hz, 11.5 
Hz, H-6b′), 3.95 (1H, d, J=10 Hz, H-12), 4.06 (1H, d, J=10 Hz, H-4), 4.37 (1H, bs, H-1′), 
5.26 (1H, d, J=9 Hz, H-14), 5.33 (1H, d, J=10 Hz, H-6), 5.38 (1H, d, J=9.5 Hz, H-10); 
13C-NMR (125 MHz, CD3OD) δ 10.8 (C-19), 11.2 (C-21 and C-23), 12.7 (C-17), 14.9 
(C-18), 17.9 (C-20 and C-22), 21.7 (C-24), 31.5 (C-16), 35.4 (C-11), 35.5 (C-15), 36.8 
(C-7), 44.8 (C-3), 52.3 (C-1), 63.0 (C-6′), 68.9 (C-4′), 73.2 (C-2′), 75.8 (C-3′), 78.6 (C-
5′), 82.0 (C-4), 84.5 (C-8), 88.9 (C-12), 97.5 (C-1′), 31.8 (C-13), 134.9 (C-10), 35.5 (C-
6), 136.2 (C-5 and C-9), 140.8 (C-14), 179.2 (C-2); HRESIMS m/z [M + Na]+ 595.3494 
(calcd for C30H52NaO10 595.3458). 
3.3.9 Lunalide B (36).  1H-NMR (500 MHz, CD3OD) δ 0.77 (3H, d, J=7.0 Hz, H-
20), 0.81 (3H, d, J=7.0 Hz, H-22), 0.87 (3H, t, J=7.5 Hz, H-17), 0.93 (3H, d, J=6.5 Hz, 
H-18), 1.00 (3H, d, J=6.5 Hz, H-24), 1.24 (1H, m, H-16a), 1.40 (1H, m, H-16b), 1.58 
(3H, d, J=1.5 Hz, H-19), 1.61(6H, bs, H-21, H-23), 2.40 (1H, m, H-7), 2.60 (1H, m, H-3), 
2.68 (1H, m, H-15), 2.74 (1H, m, H-11), 3.03 (1H, m, H-5′), 3.33 (1H, m, H-3′), 3.41 




3.70 (3H, s, H-1), 3.72 (2H, m, H2′ and H2′′), 3.78 (1H,dd, J=7 Hz, 12 Hz, H-6a′′), 3.85 
(1H, dd, J=2.5 Hz, 12 Hz, H-6b′), 3.89 (1H, dd, J=2.5 Hz, 12 Hz, H-6b′′), 3.98 (1H, d, 
J=10 Hz, H-8), 4.02 (1H, d, J=10 Hz, H-12), 4.08 (1H, d, J=10 Hz, H-4),4.35 (1H, bs, H-
1′), 4.58 (1H, bs, H-1′′), 5.27 (1H, d, J=9.5 Hz, H-14), 5.42 (1H, d, J=8 Hz, H-6), 5.45 
(1H, d, J=8.5 Hz, H-10); 13C-NMR (125 MHz, CD3OD) δ 10.7 (C-19), 11.1 (C-21 and C-
23), 12.7 (C-17), 15.0 (C-18), 17.9 (C-20), 18.0 (C-22), 21.7 (C-24), 31.5 (C-16), 35.4 
(C-7), 35.5 (C-11 and C-15), 44.8 (C-3), 52.3 (C-1), 63.3 (C-6′ and C-6′′), 69.3 (C-4′), 
69.5 (C-4′′), 73.0 (C-2′), 73.4 (C-2′′), 75.0 (C-3′′), 75.9 (C-3′), 77.6 (C-5′′), 78.9 (C-5′), 
82.0 (C-4), 88.4 (C-8), 88.5 (C-12), 97.1 (C-1′′), 97.5 (C-1′), 131.8 (C-13), 132.7 (C-9), 
134.9 (C-5), 136.4 (C-6), 138.6 (C-10), 141.1 (C-14), 178.3 (C-2); HRESIMS m/z [M + 





Chapter 4. Chemical Induction of Silent Biosynthetic Pathway 
Transcription in Aspergillus niger 
This chapter is adapted from a publication in The Journal of Industrial Microbiology 23.  
The project involved many collaborators in diverse areas such as genomics and 
evolutionary genetics.  The materials and methods along with corresponding results 
presented in this chapter are my contribution to the research.   
4.1 Introduction 
Among the many remarkable discoveries emerging from the genomics era is the 
revelation that most microorganisms, and in particular, filamentous fungi, possess far 
greater numbers of gene clusters encoding for the production of secondary metabolites 
than the numbers of natural products that have been isolated from these same    
organisms.15, 20, 21  It is not uncommon for fungi to have dozens of unique gene clusters 
encoding for previously uncharacterized polyketide (PKS), non-ribosomal peptide 
(NRPS), and hybrid PKS-NRPS (HPN) natural products.78-85  These transcriptionally 
suppressed gene clusters, which are collectively referred to as silent biosynthetic 
pathways (SBPs), generally remain unexpressed or under-expressed under a variety of 
laboratory culture conditions.  SBPs are anticipated to be a rich source of chemically 
diverse compounds (e.g., novel organic moieties, multifaceted stereochemical features, 
unique heteroatom incorporation, etc.) with outstanding potential for generating novel 
therapeutic leads.  Obtaining the products from transcriptionally suppressed gen  clusters 





In an effort to obtain new drug leads from silent biosynthetic pathways, epigenetic 
modifying substances have been identified as promising tools for manipulating the 
secondary metabolism of fungi.  It has been proposed that epigenome-level changes are 
extensively involved in controlling the transcriptional accessibility of gene clusters 
encoding for biosynthetic enzymes.73, 77, 86  Several proteins are required to facilitate 
chromatin remodeling in fungi and their collective influence on gene expression i  quite 
remarkable.87-94  Chief among the chromatin interacting proteins are histones.  These 
proteins undergo a wide-range of post-translational modifications92, 94 with acetylation 
and methylation being two of the most frequently encountered and well-studied of the 
histone alterations.  While histone deacetylation is generally associated with gene 
silencing, the effects of methylation vary depending on which histone subtypes and 
specific amino acid residues are modified within nucleosomal complexes.87, 95, 96 
A variety of highly specific small-molecule probes are known to selectively 
inhibit the functions of histone modifying proteins and these compounds have found 
important roles as molecular tools for studying the epigenome.96  Several families of 
histone acetyltransferases are responsible for catalyzing the covalent addition of acetyl 
groups to histones, while the reverse reaction is carried out by histone deacetylases 
(HDAC) and sirtuins.92, 94  The hydroxamate-bearing natural product trichostatin A and 
its synthetic derivative, suberoylanilide hydroxamic acid (SAHA), are two noteworthy 
examples of potent HDAC inhibitors that have been successfully used as chemical 
epigenetic probes in a variety of eukaryotic systems including filamentous fungi.96 
Another epigenetic modifying agent, 5-azacytidine (5-AZA), was originally 




dysfunctions related to production of tRNAs, rRNAs, and proteins.97  Further studies 
have shown that 5-AZA has strong epigenetic modifying properties due to its inhibitory 
interactions with DNA methyltransferases resulting in hypomethylation of DNA and 
chromatin restructuring.96, 98  Interestingly, the epigenetic role of DNA methylation in 
fungi is still poorly understood and in some cases, the very existence of DNA 
methylation in these organisms has been questioned.93, 99  Two proposed explanations for 
how 5-AZA induces chromatin remodeling in fungi involve 1) inhibition of DNA 
methylation, which may occur at very low levels or transiently in fungi or 2) inhibition of 
histone methyltransferase (HMT) function.100, 101  A HMT inhibitory role for 5-AZA is 
highly plausible given its structural similarity to other confirmed methyltransferase 
inhibitors such as methylthioadenosine, sinefungin, and S-a enosylhomocysteine.96  
Nevertheless, the ability of 5-AZA to cause distinctive chromatin remodeling ffects, 
even in the absence of detectable changes in DNA methylation, makes this and similar 
chemical epigenetic probes valuable molecular tools for inducing chromatin remodeling 
in fungi. 
In this study, we screened a suite of epigenome-modifying agents as chemical 
tools for eliciting the expression of fungal silent biosynthetic pathways.  Aspergillus 
niger was selected for this work since three separate genome sequencing initiatives h ve 
been completed in recent years102-104 allowing confirmation of the presence of numerous 
PKS, NRPS, and HPN gene clusters in this fungus.  The genome-wide impacts of the 
epigenetic modifiers SAHA and 5-AZA on the transcription of PKS, NRPS, and HPN 
biosynthetic gene clusters in A. niger were determined using real-time quantitative 




to results from two expressed sequence tag (EST) libraries generated with A. niger that 
was grown under a wide variety of culture conditions.  In conjunction with this work, we 
have also addressed the remarkable diversity of PKS and HPN gene clusters in A. niger 
through a phylogenetic analysis of their respective ketosynthase domains.  Results
emerging from this study strongly support the use of epigenetic modifying agents as an 
effective methodological approach for upregulating the transcription of secondary-
metabolite-encoding biosynthetic gene clusters in fungi. 
4.2 Results and Discussions 
Comprehensive examination of these and other suspected biosynthetic genes led 
to the identification of 33 PKS, 15 NRPS, and 9 HPN gene clusters distributed 
throughout the genome of A. niger ATCC 1015.23  Previously, two expressed sequence 
tag (EST) libraries have been generated for A. niger that was cultured under a wide 
variety of conditions.  The first of these studies utilized wild-type A. niger N402 (4732 
from the Fungal Genetics Stock Center) resulting in the generation of 12,820 ESTs 
accounting for a total of 5,108 of the fungus’s genes.105  For this experiment, A. niger was 
grown on seven different carbon sources (glucose, bran, maltose, xylan, xylose, sorbitol, 
and lactose).  Nucleotide BLASTN and protein-nucleotide TBLASTN searches of the 
EST database provided only a handful of sequences corresponding to homologs for five 
PKS-, six NRPS-, and zero HPN-containing biosynthetic pathways.23, 105   
The second library of ESTs was prepared using A. niger ATCC 1015 on an even 
more extensive assortment of media conditions including arabinose, cellulose, corn fiber, 
glucose, hemicelluloses-protein, lactose, lignins, rapeseed meal, starch-maltose, wheat 




Examination of the ESTs using nucleotide BLASTN and protein-nucleotide TBLASTN 
searches identified transcripts from 16 PKS- and NRPS-related biosynthetic pathways.104   
Eleven of the 16 ESTs were identical to those observed in the A. niger N402 strain.  ESTs 
for the other five secondary-metabolite-encoding genes corresponded to two PKS-, two 
NRPS-, and one HPN-containing biosynthetic pathway.  Interestingly, results of A. niger 
ATCC 1015 grown under a broad range of nutrient conditions revealed that 
approximately 29% of PKS, NRPS, and HPN gene clusters were expressed.23  
The results of the EST library studies supported that axenic cultures of A. niger 
generated only a modest portion of its genomically-encoded natural products under in 
vitro culture conditions.23, 104, 105  Screening of 18 epigenetic modifying agents (five DNA 
methyltransferase inhibitors (DNMT), seven histone deacetylase inhibitors (HDAC), four 
SIR2 deacetylase inhibitors, and two histone methyltransferase inhibitors) (Table 4.1) 
was initiated to determine which inhibitors were capable of increasing the number of 
secondary metabolites that were biosynthesized by fungus.  Initially, cultures of A. niger 
ATCC 1015 were treated during early log-phase growth (24 h post-inoculation) with 
compounds (10-fold steps from 1 nM to 1 mM) in order to determine the effects of 
treatments and treatment concentrations by visual observation (i.e. cell growth, 
alterations in phenotype, color changes) when compared controls.  Five of the treatmnt 
conditions had little to no impact on cell growth at the highest dose, so these were 
eliminated from further analysis in secondary metabolite diversity.  Out of the remaining 
conditions explored, alterations in the culture morphology were visually observed in five 
treatments (courmarin, dihydrocourmarin, 7,8 dihydroxycourmarin, hydralazine 








Table 4.1 List of epigenetic modifiers and their effects on mycelial growth and secondary metabolite 
production in A. niger ATCC 1015.  
Compound 
(mode of action) 
Effect on cell growth 





-3 -4 -5 -6 -7 
Acetohydroxamic acid 
(presumed HDAC inhibitor) 
++ +++ +++ +++ +++ ND No significant changes in growth 
5-Azacytidine (5-AZA) 
(DNMT inhibitor) 
+ ++ +++ +++ +++ 10 
Culture turned pale yellow; new metabolites 
confirmed by HPLC 
5-Aza-2'-deoxycytidine 
(DNMT inhibitor) 
++ ++ +++ +++ +++ 8 Results similar to 5-azacytidine 
Benzohydroxamic acid 
(presumed HDAC inhibitor) 
- + ++ +++ +++ 8 Strong color change (yellow) at 10 µM 
Coumarin 
(SIR2 deacetylase inhibitor) 
- ++ ++ +++ +++ ND Culture phenotype altered (small pellets) 
Dihydrocoumarin 
(SIR2 deacetylase inhibitor) 
- + ++ ++ +++ 11 Culture phenotype altered (small pellets) 
7,8-Dihydroxycoumarin 
(SIR2 deacetylase inhibitor) 
++ ++ +++ +++ +++ ND 





- + ++ ++ +++ 9 
Cells exhibited strong discoloration from 
dye 
Eosin Y disodium salt 
(histone methyltransferase 
inhibitor) 
- + + ++ +++ 10 




+ ++ ++ +++ +++ 11 
Culture phenotype altered (small pellets); 
strong color change (yellow) at 10 µM 
Nicotinamide 
(SIR2 deacetylase inhibitor) 
+ ++ ++ +++ +++ 10 Strong color change (yellow) at 100 µM
Nicotinic acid hydroxamate 
(presumed SIR2 
deacetylase/HDAC inhibitor) 
+ ++ ++ +++ +++ 8 Strong color change (yellow) at 100 µM
Procainamide hydrochloride 
(DNMT inhibitor) 
++ ++ +++ +++ +++ ND No significant changes in growth 
Procaine hydrochloride 
(DNMT inhibitor) 
++ ++ +++ +++ +++ ND No significant changes in growth 
Sodium butyrate 
(HDAC inhibitor) + ++ ++ +++ +++ 8 No significant changes in growth 
Splitomicin 
(HDAC/sirtuin inhibitor) 
- + ++ +++ +++ 7 








+ ++ ++ +++ +++ 9 
Culture phenotype altered; strong color 
change at 100 µM; new metabolites 
confirmed by HPLC 
a Growth of A. niger was qualitatively assessed by visual inspection of replicate cultures.  Fungal growth 
was scored as “+++” (growth equivalent to control cultures), “++” (<50% reduction in growth), “+” (≥50% 
reduction in growth), or “-” (no growth observed).  Growth scores indicated in bold and underlined 
represent the concentration of epigenetic modifier used for assessing secondary metabolite chemical 
diversity 
 
b Chemical diversity was determined as the number of new spots observed from crude culture extracts by 
silica gel TLC.  Plates were developed with toluene- thyl acetate-acetic acid (50:50:1 by volume).  A 





yellow color appeared in eight of the treatments (5-azacytidine, 5-aza-2'-deoxycytidine, 
benzohydroxamic acid, hydralazine hydrochloride, nicotinamide, nicotinic acid 
hydroxamate, syberohydroxamic acid, and suberoylanilide hydroxamic acid).   
The extracts of the thirteen (out of 18) remaining treatments were defatte and 
prepared for TLC and HPLC, giving a simple, yet accurate means for qualitative y 
comparing the relative secondary metabolite diversity in treatment versus untreated 
control groups.  In most instances, a range of 8 to 11 “new” secondary metabolites could 
be visualized on TLC plates under UV irradiation at 254 and 365 nm and/or development 
by sulfuric acid spray reagent.  A significant difference in number of new spots on the
TLC plate was observed when suberohydroxamic acid treated cultures (4 new TLC spots) 
were compared to SAHA treated cultures (9 new TLC spots).  This was interesti g, since 
the only difference between these two compounds is that SAHA has a phenyl group 
substituted for one of the terminal hydroxyl groups in suberohydroxamic acid.  Further 
analysis of the extracts was then performed by HPLC, and during this analysis,  
dramatic difference in the profile chromatogram of the SAHA treated culture was 
observed when compared with the control (Figure 4.1).  While differences in the HPLC 
chromatograms of other treated cultures were not as dramatic as SAHA, there were still 
observed changes.  In the end of the analysis, both SAHA and 5-AZA showed good 
activities resulting in the production of several new secondary metabolites (Table 4.1) 
and they were selected for further investigation through real-time qRT-PCR given their 
prior successful use in our lab for generating new natural products.73  The resulting 




by real-time qRT-PCR) were more pronounced in SAHA treated cultures over 5-AZA 
treated cultures.23  Under the effects of SAHA, expression levels of 23 of 33 PKS, 14 of 
15 NRPS and 6 of 9 HPN gene clusters were upregulated.23  Overall, under SAHA 
chemical epigenetic conditions with one media source, upregulation of greater than 85% 
of the PKS, NRPS, and HPN gene clusters was observed, which is a significant increase 
to the 29% previously reported under a broad range of nutrient conditions.23   
Whole-genome sequencing data obtained from a variety of fungi demonstrate that 
these microorganisms harbor large numbers of PKS, NRPS, HPN, and other natural 
product biosynthetic gene clusters.  Most of these pathways remain suppressed under in 
vitro culture conditions meaning that only a fraction of a fungi’s biosynthetic potential is 
generally accessible for drug screening applications.  Based on our observations, we 
conservatively estimate that fungi express less than half of their natural-product-encoding 
biosynthetic pathways under standard shake-flask and static culture conditions. 
Figure 4.1  HPLC difference chromatogram of SAHA treated versus control cultures observed at a 
wavelength of 254 nm.  Any chromatographic peak above the zero value represents an increased 
production the  in SAHA treated cultures.  Any chromatographic peak below the zero value represents a 
decreased production in the SAHA treated culture.  All injections were made at 2 mg of crude extract in 
200 µL of MeOH (range of crude extracts were between 9-11 mg). 














Even Neurospora crassa, which has been intensively studied since the 1920s and 
was considered devoid of any secondary metabolites, has now been shown to possess no 
less than seven PKS, four NRPS, and several terpene biosynthetic gene clusters that are 
believed to fulfill a variety of important functions.80  With the exceptions of fungi from 
the sub-phyla Saccharomycotina and Taphrinomycotina,106 most fungi that have been 
sequenced to date carry a variety of biosynthetic gene clusters encoding for the 
production of uncharacterized natural products.  These compounds are expected to 
possess a wide range of unique biological activities and therefore have significant value 
as drug discovery leads.21, 107, 108  The strict transcriptional suppression of secondary 
metabolites is conjectured to protect fungi from the potentially deleterious (autotoxic) 
effects of natural products and their biosynthesis is only elicited when an appropriate 
environmental trigger is encountered.  Based on emerging molecular evidence,77 we had 
predicted that the expression of many secondary metabolite pathways is transcriptionally 
controlled through epigenetic mechanisms.109, 110  Consequently, we consider the 
chemical epigenetic manipulation of silent gene clusters to be a highly promising 
approach for procuring novel drug leads from fungi.  This methodology has many 
significant advantages over currently available molecular-based techniques and 
cultivation-dependent approaches.107, 108  Namely, our chemical epigenetic approach 
offers significantly greater simplicity, broad-spectrum applicability, and an ability to be 
readily incorporated into modern microbial screening programs. 
The precise molecular mechanisms involved in upregulating the expression of 
silent secondary-metabolite-encoding pathways are likely more complex than what is 




epigenetic modifying agents.  For example in Saccharomyces cerevisiae, the HDAC 
inhibitor trichostatin A and several HDAC deletion mutants demonstrated a wide varety 
of transcriptional effects 88.  These included both the upregulation and downregulation of 
genes involved in cell cycle progression, as well as amino acid and carbohydrate 
metabolism.  Curiously, they noted that the effects of trichostatin A on a subset of S. 
cerevisiae genes were detectable within 15 min of exposure to the inhibitor.  This 
suggests that trichostatin A has other, yet undefined, effects on modifying gene 
transcription (e.g., direct transcriptional activation).   
Similar to our observations, others also have noted that the impact of HDAC 
inhibitors and HDAC mutants were most pronounced on genes located within the distal 
regions of fungal chromosomes.  For example, Bernstein e  al.88 reported that deletion of 
the yeast HDAC, RPD3, preferentially altered the transcription of genes positioned near 
the termini of chromosomes.  Moreover, deletion of the transcriptional regulator laeA, 
whose methyltransferase product was suggested to alter chromatin structure 111, has been 
shown to decrease the expression of many telomere proximal NRPS gene clusters in 
Aspergillus fumigatus.72  The dynamics of histone-mediated heterochromatin formation 
and gene quelling in fungi is proposed to function in a generally linear fashion, exerting 
an initial silencing influence on the most distally located genes, which progresses 
proximally over multiple cell division cycles.112  In view of the complex processes 
involved in the continual shifting of DNA between euchromatin and heterochromatin 
states, our data suggest the need for considering the roles of other potential signaling 
pathways linking outwardly unrelated nuclear and cytoplasmic events to the 




For nearly a century, natural products have served as an unrivaled resource in the 
quest for new drug entities.  However, recent concerns and misconceptions in the 
pharmaceutical industry about the long-term value of natural products as a discovery 
platform have all but eliminated secondary metabolites from most research and 
development programs.113-116  It is likely that the folly of this collective decision will 
further impair an already flagging drug-discovery pipeline.2  Fortunately, emerging 
techniques in the field of natural products discovery, like the genomic and epigenetic 
methods described in this study, offer an opportunity to reinvigorate the fundamental role 
of secondary metabolites as a drug discovery tool.   
4.3 Materials and Methods 
4.3.1. Fungal strain and growth conditions.  Aspergillus niger ATCC 1015 was 
obtained from the American Type Culture Collection.  Suspensions of mycelia and spores 
were stored in 15% aqueous glycerol at -80 °C.  For experiments, 100 µL samples of the 
cryopreserved A. niger stock cultures were lawned onto potato-dextrose plates (10 g dried 
potatoes, 5 g dextrose, 1,000 mL DI water, and 20 g agar) and the plates incubated at 25 
°C (12 h light/12 dark).  Liquid cultures of A. niger were prepared by inoculating potato-
dextrose broth (10 g dried potatoes, 5 g dextrose, 1,000 mL DI water) with uniform 
suspensions of spores and mycelia harvested from the potato-dextrose plates.  Cultures
for compound screening were prepared by adding 100 µL of A. niger suspensions to test 
tubes containing 3 mL of potato-dextrose broth and the tubes were incubated at 25 °C on 
a rotary shaker (170 rpm).  Tube cultures received chemical epigenetic modifier 
treatments after 24 h and the fungi were incubated an additional six days before being 




suspensions to 1 L Erlenmeyer flasks containing 250 mL of potato-dextrose broth.  
Cultures were treated with epigenetic modifiers after incubating for 24 h (25 °C on a 
rotary shaker at150 rpm) and they were allowed to continue growing for an additional 
four days before extracting RNA. 
4.3.2  Epigenetic modifier screening.  Test tube cultures of A. niger (pre-
incubated for 24 h) were treated with epigenetic modifiers dissolved in H2O or dimethyl 
sulfoxide.  The solutions of test compounds were filter-sterilized (0.22 µM) before being 
added to the cultures.  After incubating for six days, mycelia growth in each tube was 
qualitatively scored relative to the vehicle-only controls.  Fungal growth was scored as 
“+++” (growth equivalent to control cultures), “++” (<50% reduction in growth), “+” 
(≥50% reduction in growth), or “-” (no growth observed). 
After scoring all cultures, 3 mL of dichloromethane was added to each tube to 
extract secondary metabolites.  The dichloromethane was removed by aspiration and the
organic solvent evaporated in vacuo.  Prior to analysis, all samples were defatted by 
partitioning the extracts between aqueous methanol (9:1 MeOH-H2O) and hexane.  After 
removal of the hexane, the aqueous methanol layers were evaporated in vacuo yielding 
the crude mixtures of secondary metabolites that were used for chemical analyses.  Thin 
layer chromatography (TLC) was performed on the samples by spotting them onto silica 
gel plates that were developed in toluene-ethyl acetate-acetic acid (50:50:1 by volume).  
Secondary metabolites were visualized under UV irradiation at 254 and 365 nm and by 
sulfuric acid spray reagent.  Additional visualization of secondary metabolite mix ures 
was performed on selected extracts by HPLC (C18 column using a 10-100% Acetonitrile-





analyses (extracts were dissolved in 650 µL of CD3O  and spectra generated by 
averaging 128 scans using a standard 1H pulse sequence).  A list of all the epigenetic 
modifiers that were screened along with their effects on cell growth and secondary 






Chapter 5.  Analysis of a Class of γ-pyrones and γ-pyridones Isolated 
from Aspergillus niger 
This chapter is adapted from 1) a publication in Organic and Bimolecular Chemistry86 
and 2) a publication that is currently under preparation.    
5.1  Introduction 
The black aspergilli possess an extraordinarily diverse set of secondary metabolite 
biosynthetic pathways.  In a previous analysis, Nielsen et. al. listed 145 metabolites that 
had been isolated and structurally elucidated from this assemblage of fungi.117   Further 
investigation of the genome of one strain from this group, As ergillus niger ATCC 1015, 
demonstrates the presence of 31 polyketide synthase (PKS), 15 non-ribosomal peptide 
synthetase (NRPS), and 9 hybrid PKS-NRPS (HPN) gene clusters; yet onl  30% of those 
genes were transcribed under various in vitro culture conditions.23, 104, 105   This 
demonstrated that there are still many more secondary metabolites to access, isolate, and 
characterize from A. niger.   
To address the problem of gene cluster under-expression in laboratory conditions, 
we demonstrated that treating A. niger ATCC 1015 with a small-molecule epigenetic 
modifier, suberoylanilide hydroxamic acid (SAHA), resulted in a transcriptional 
upregulation of over 85% of the PKS, NRPS, and HPN gene clusters under a single 
culture condition.23  With the ability to access new secondary metabolites, we turned our 
focus to identifying these compounds.  This chapter addresses 1) the elucidation of a new 
metabolite which was isolated under SAHA-treated epigentic conditions and follow-up 




compounds, and 3) antimicrobial bioactivity of secondary metabolites and semi-synthetic 
derivatives from A. niger ATCC 1015.  
5.2 Results and Discussions 
Aspergillus niger cultures grown under SAHA epigenetic conditions resulted in 
the isolation of a unique secondary metabolite, nygerone A (37).  HRESIMS analysis 
provided two pseudo-molecular ions at m/z 419.1542 and 441.1402 corresponding to 
molecular formulae of C24H23N2O5 ([M + H]
+, calcd 419.1607, −6.5 mmu error) and 
C24H22N2NaO5 ([M + Na]
+, calcd 441.1426, −2.4 mmu error), respectively. Using these 
data, a chemical formula of C24H22N2O5 was proposed for 37 indicating that the fungal 
metabolite contained a total of 15 double-bond equivalents. Some minor discrepancies 
between the 1H- and 13C-NMR data for 37 (Table 5.1) and the MS -derived formula still 
required reconciliation. For example, integration of the 1H-NMR data collected in 
methanol-d4 revealed only 20 hydrogens, but this was rationalized as evidence for the 
presence of two exchangeable protons in 37. In addition, the 13C-NMR data provided 
evidence for 20 unique spins; however, two of these carbons (δC 128.9 and 129.0) 
exhibited significantly greater relative intensities compared to surrunding spins.  
Therefore, it was surmised that each of these 13C-NMR resonances represented two 
superimposed carbons. Together, these data offered strong support for C24H22N2O5 as the 
chemical formula of 37 which permitted us to proceed with elucidating the metabolite's 
structure. 
Further examination of the 1-D NMR results in combination with data generated 
from a series of 2-D NMR experiments (1H-1H COSY , 1H-1H NOESY , 1H-13C HSQC , 




A-D) for 37 (Figure 5.1). Fragment A was determined to contain five aromatic protons 
[δH 6.77 (2H), 7.18 (3H)] belonging to a monosubstituted benzyl group. This was 
confirmed by 1H-13C HMBC experiment which also gave a strong correlation extending 
from the aromatic spin at δH 6.55 to the benzylic methylene (δC 39.4).  Similarly, 
fragment B (Figure 5.1) contained five protons in an AA′BB′C system [δH 7.06 (2H),  
Table 5.1 1H and 13C-NMR data for nygerone A (43) in CDCl3 at 400 MHz (
1H) and 100 MHz (13C) 
Position δC δH (mult., J in Hz) HMBC 
1H →13C 
a Significant overlap occurred between these two sets of resonances. 
C-2 148.2 8.43, 1H (s) 1′, 4, 6, 14 
C-3 117.2   
C-4 177.6   
C-5 122.3 6.55, 1H (s) 3, 4, 6, 7, 14 (weak) 
C-6 152.0   
C-7 39.4 3.67, 2H (s) 5, 6, 8, 9/13 
C-8 134.8   
C-9/13 128.9 6.77, 2H (m) 7, 11 
C-10/12 129.0 7.18, 2H (m)a 8 
C-11 127.7 7.18, 1H (m)a 8, 9/13 
C-14 163.2   
N-15  12.83, 1H (br s) 17 
C-16 173.2   
C-17 42.0 2.86, 1H (dd, 5.1, 17.2); 3.20, 1H (dd, 8.2 17.2) 16, 18, 19, 20 
C-18 35.1 3.05, 1H (m) 16, 17, 19, 20 
C-19 178.9   
C-20 17.2 1.27, 3H (d, 7.0) 17, 18, 20 
C-1′ 140.4   
C-2′/6′ 127.0 7.06, 2H (d, 7.6) 1′, 4′ 
C-3′/5′ 130.2 7.42, 2H (t, 7.6) 1′ 
C-4′ 130.5 7.49, 1H (t, 7.6) 2′/6′ 
7.42 (2H), and 7.49 (1H)] representative of a monosubstituted phenyl group. 
Unfortunately, 1H-13C HMBC couplings from the aromatic protons provided no 
additional evidence as to the identity of the aryl substituent of this fragment. 
Analysis of the protons in fragment C by 1H-1H COSY indicated the presence of 
an A2MX3 spin system which was confirmed by 




Additional 2-3JH-C correlations extending to two carbonyl resonances (δC 173.2 and 178.9) 
that were positioned at opposing ends of fragment C were also noted.  Based on their 
chemical shifts, both carbonyl groups were presumed to be attached to heteroatoms (Q1 
and Q2 = N and/or O, Figure 5.1); however, the identities of these atoms were not 
determined at this juncture. Next, we turned our attention to assembling the remaining 
atoms that comprised fragment D which included six carbons (δC 117.2, 122.3, 148.2, 
152.0, 163.2, and 177.6) and three heteroatoms (N and/or O). A 1H-13C  

















Figure 5.1.  NMR spectroscopic data (1H-1H COSY : bold bonds and 1H-13C 
HMBC : solid curved arrows) used to establish the four partial structures, 
fragments A-D, for 11. Heteroatoms Q1, Q2, and Q3 were subsequently  
assigned as N, O, and N, respectively, based on the chemical shifts of adjacent 
carbon atoms and 1H-15N HMBC correlations as illustrated in Figure 5.2. 
 
attached protons (δH 8.43 and 6.55, respectively) that appeared as sharp singlet 
resonances. Two of the other carbons (δC 163.2 and 177.6) were determined to be 
carbonyls based on their downfield shifts.  This accounted for two of the five double-




chemical shifts for the carbon atoms at δC 148.2 and 152.0 suggested that they were both 
sp2 hybridized and attached to the remaining heteroatom, Q3, due to their respective 
downfield shifts. The identity of Q3 was determined to be a nitrogen since an oxygen at 
this position would have resulted in even greater deshielding of the adjacent carbon 
resonances (i.e. δC >160). Our assignment for Q3 was further confirmed by a 
1H-15N 
HMBC experiment in which the protons in fragment D (δH 6.55 and 8.43) exhibited 
2-3JH-
N correlations to a nitrogen resonating at δN 158.0 (Figure 5.2). The assignments of the 
carbon atoms at δC 117.2 and 122.3 were now simplified since the methine carbons could 
not be adjacent to one another due to a lack of vicinal coupling between their attached 
protons. The upfield shifts of these carbons were rationalized to be due to their positions 
α to a carbonyl, thus fragment D was comprised of a substituted γ-pyridone system. 
With working structures proposed for fragments A-D, it was now possible to 
address the connectivities between these partial structures, as well as clarify the identities 
of Q1 and Q2. Fragment A was joined to the γ-pyridone based on long-range 
2-3JH-C 
correlations from the benzylic methylene protons (δH 6.55, H-7) to carbons at δC 122.3 
(C-5) and 152.0 (C-6) in fragment D (Figure 5.1). Fragment B was also determined to be 
attached to fragment D as a result of a 3JH-C correlation from δH 8.43 (H-2) to δC 140.4 
(C-1′). The connection established from the phenyl group through the nitrogen atom 
yielding a 1-phenylpyridin-4(1H)-one system was rather intriguing to us since this 
unusual substructure has not been previously reported from a natural source. With only 
two isolated bonds remaining to be joined, it was readily apparent that fragment D was 
also connected to fragment C through Q1 or Q2; however, no long-range coupling could 




identity of Q1 based on a 
1JH-N correlation observed in CDCl3 between the proton at δH 
12.83 (1H, s) and a nitrogen at δN 154.8 and an additional 
3JH-C correlation from this 
proton to the methylene carbon at δC 42.0 (C-17). With all of the other heteroatoms 
accounted for in the molecular formula of 37, Q2 was deduced to be the last remaining 
oxygen atom. We proposed that the connectivity between fragments C and D occurred 
through the nitrogen atom, rather than the oxygen, since this mono-hydrogenated 
nitrogen still required one additional covalent bond in order to complete its valence shell. 
During the course of our efforts to further optimize 1H-13C and 1H-15N HMBC 
experimental parameters for additional verification of the proposed imide bond in 37, a 
doubling of the proton resonances appeared suggesting that the metabolite had begun to 
degrade. Purification by HPLC yielded two products, nygerone B (38) and 2-
methylsuccinate (39) (Figure 5.2).   The fortuitous appearance of 38 as a hydrolysis 
product was key to confirming the presence of the imide bond in 37 since the N-15  
 
Figure 5.2.  Key long-range hetero-nuclear correlation (1H-13C HMBC : solid curved arrows and 1H-15N 
HMBC : broken curved arrows) and other NMR spectrosopic data used to assemble fragments A-D into 
11. The 1H-NMR data of 11 showed a single proton (δH 12.83) attached to the imide nitrogen (N-15), while 
hydrolysis of the N-15 to C-16 bond yielded 12 which displayed two hydrogens attached to the resulting 
amide nitrogen (δH 5.70 and 9.90). The other hydrolysis product, 3, was identified as (S)-2-methylsuccinate 
based on comparisons of its ESIMS , 1H-NMR , and optical rotation data to authentic samples of the R and 




nitrogen atom now exhibited two attached amide protons at δH 5.70 (1H, br s) and 9.90 
(1H, br s). Interestingly, a similar regio-specific imide hydrolysis process was previously 
observed as part of the degradation pathway for 
the quinolactacins from Penicillium citrinum.118  
Thus, we were able to rule out an anhydride 
linkage between fragments C and D and confirm 
the presence of the imide linkage as illustrated 
for 37. With the planar structure of 37 
determined, only the absolute configuration of 
the C-18 asymmetric center remained to be 
addressed. Polarimetry performed on the 
purified degradation product 39 gave an optical 
rotation of [α]D
21 −13.3 that was identical to an 
authentic sample of (S)-2-methylsuccinate. 
During the isolation of nygerone A, we 
detected additional secondary metabolites which 
displayed similar resonances.86  The analysis of 
the 1H- and 13C-NMR data for one of these 
secondary metabolites demonstrated the 
presence of a monosubstituted phenyl group (δH 
7.20-7.38), along with 2 methine protons (δH
6.23(s) and δH 8.71(s)), and one methylene proton (δH 3.87(s)).  Key 
1H-13C HMBC 
correlations were observed for the methine protons at δH 6.23 and δH 8.71 to carbons at δC 
40: R = H (Tensidol A)









42: R = H (Tensidol B)













45: R = O (Carbonarone A)
38: R = N-Ph (Nygerone B)
44: R = O (Pestalamide A)








119.8, 164.3, 169.3, and 178.6 and the methylene proton δH at 3.87 to carbons at δC 
116.5, 128.3, 134.2, and 169.3.  This NMR data led to two published compounds, 
tensidol A (40)119 and carbonarone A (45),120 which contained the identical 1H- and 13C-
NMR data.  We conjectured that one of the structures may have been incorrectly 
elucidated, making a structural revision and unification of the published compounds 
necessary.   
Recently, Takagi et al. reported the isolation of two new tensidols, JBIR-86 (41) 
and JBIR-87 (43), which contained a methoxy ester in place of a hydroxy in position 3A 
of tensidol A (40) and methoxy group in place of the acid hydroxyl group of tensidol B 
(42).121    Since there were no other structures published in the literature which matched 
the NMR (1H, 13C, J-coupling) and MS data for JBIR-86, we proposed several alternative 
structural candidates which could fit the published MS and NMR data.  Initially, many of 
the proposed structures were eliminated simply by looking for incompatibilities n 
theoretical 1H-NMR resonances and J-couplings, with particular focus on the presence of 
the two methine singlets observed at δH 6.41 and 8.43 in JBIR-86.  After this initial 
screening and elimination of proposed structures, compounds 46-48 (Figure 5.3A) were 
left having the best fit to the methine singlets and rest of the NMR data.  Underfurth r 
scrutiny, compound 46 was eliminated based on the estimated 13C-NMR resonance of 
position 2 derived from previous reports of 13C-NMR resonance of position 2 of γ-
pyridones,  aspernigrin A122 and pestalamide B.123, 124   In this instance, the expected δC 
would be 15 to 20 ppm upfield from the reported value in JBIR-86. Compound 47 was 




the reported resonances for carbon and proton (δC 52.8, δH 3.87).   Inspection of 48 
provided the best overall fit with the published 13C-NMR resonances at position 2 of the  
γ-pyrones, carbonarone A120 and pestalamide A,123 along with predicted values for the 
methoxy carbon and proton chemical shifts.  However, 48 presented a problem in regards 
to the fact that the MS data 
for this compound would be 
approximately 1 amu larger 
than the published data for 
JBIR-86.   Due to the 
difficulties that have been 
presented throughout the 
structure elucidation history 
of these compounds,119, 120, 
122, 123, 125 we hypothesized 
that 1)  JBIR-86 was 
incorrectly elucidated as 
well, 2) there was an error in 
the reported mass for JBIR-86, 
and 3) JBIR-86 actually has 
the structure of 48.  In order to 
confirm these hypotheses, we 
proceeded with computational 
analyses of 41 and 48 and full synthesis of 48. 
Figure 5.3  A)  Compounds (46-48) which demonstrated the best 
initial fit to the NMR data published for 41.  B)  Numbering 
scheme utilized for measurements in computational alysis.  
The mean average error (MAE) was caluculated by Σ(δcalc – 
δexp)/# of carbons.  A smaller MAE value represents a better 
overall agreement between the computational and published data 
for 13C-NMR chemical shifts. C)  Key 1H-13C HMBC 
correlations observed in synthesized compound which matched 




Over the last decade, the use of DFT calculations using Gauge-Including Atomic 
Orbital (GIAO) to theoretically determine 13C-NMR chemical resonances have aided in 
clarification and correction of structural features in natural products.126-128  With the 
success that had been previously reported using density functional theory (DFT) 
calculations, computations using DFT were utilized for JBIR-86 (41) and 48 to test the 
hypothesis that the tensidol core was incorrectly elucidated.  The resulting deviations 
between calculated and measured 13C-NMR chemical shifts of JBIR-86 and 48 is shown 
in Figure 5.4 and demonstrates a dramatic difference in the agreement of the 
computationally predictive values versus the published 13C-NMR data for JBIR-86 (mean 
mean absolute error (MAE) was calculated for 41 and 48 (Figure 5.3B) found to be 
15.95 and 3.76 ppm, respectively).  Further analysis of these results demonstrated that 
both compounds had good calculated 13C-NMR chemical shift agreement where 
structural similarity was present (i.e. the phenyl ring), however, when directly comparing 
the data for the furopyrrol ring of JBIR-86 and the γ-pyrone ring of 48, significant  
deviations were observed.  In JBIR-86 at positions C-2, C-3, C-3a, C-4, C-5, and C-6a, 
labeled in Figure 5.3B, the average deviation of the calculated 13C-NMR chemical shifts 
from published values121 was 30.2 ppm in the furropyrol ring of JBIR-86, while the 
average deviation in the same positions of the γ-pyrone ring of 48 was 4.4 ppm.  These 






incorrectly assigned, and that the true structure is represented by the γ-pyrone structure 
shown in 44, 45, and 48. 
Synthesis of 48 was undertaken using a modified version of a scheme previously 
utilized by McCombie et. al.,129 as shown in Scheme 5.1, to add further support that 48 
was the true structure.  After purification of the synthesized compound, HRESIMS 
 
Scheme 5.1.  Method used to synthesize proposed 48. 
analysis showed a peak with m/z at 245.0815 [M + H]+ indicating the molecular formula 
of C14H12O4 (calc. for C14H13O4, 245.0814). The 
1H- and 13C-NMR analysis of the   
Figure 5.4  Deviations in the calculated versus measured 13C-NMR chemical shifts for 41 
and 48.  Differences close to zero demonstrate better agreement of structurally calculated 
values versus reported 13C-NMR experimental data.  Larger differences signify poor 









synthesized compound showed excellent agreement to the published chemical shifts of 
JBIR-86 (Table 5.2).  Furthermore, the key correlations from the 1H-13C  
Table 5.2  Comparison of experimental 1H- and 13C-NMR of 48 versus the published values of 
JBIR-86. 
 
Synthesized Compound 48 Literature Values for JBIR-86 
(41) 
Position δH
 (J in Hz) δC δH
 (J in Hz) δC 
2 8.41, s 162.0 8.43, s 162.0 
3a  119.3  119.1 
4  175.0  175.0 
5 6.19, s 116.9 6.21, s 117.3 
6a  167.4  167.6 
7 3.81, s 39.7 3.83, s 40.0 
8  133.9  134.1 
9,13 7.22, m 129.1 7.24, m 129.4 
10,12 7.35, m 129.1 7.32, m 129.4 
11  7.32, m 127.8 7.32, m 128.0 
3   163.6  163.9 
3-OCH3  3.85, s 52.7 3.87, s 52.8 
 
HMBC added additional support that 48 was the correct structure (Figure 5.3C).  In 
compound 48, long-range couplings from 2-H (δH 8.41) and 5-H (δH 6.19) were observed 
to C-3, C-3a, C-4, and C-6a, along with a long-range coupling of the methoxy proton (δH 
3.85) to C-3.  This data aligns precisely with the observed correlations that had been 
presented with JBIR-86,121 thus yielding further evidence supporting 48 as the true 
structure.  Extrapolating this data to other tensidol structures, it is apparent that the 
furopyrrol core of tensidols have been incorrectly elucidated, and that the correct 
structures contain a γ-pyrone core, as observed in carbonarone A,120 pestalamide A,123 
and 48.  Even with access to advanced technology and techniques (i.e. two-dimensional 
NMR) which allow for greater structural elucidation power, the importance of thoroughly 
analyzing the data in order to publish correct structures cannot be forgotten.  In this




and B (42),117, 121, 130-136 including the structural elucidation of JBIR-86 and JBIR-87,  
which must now be reevaluated.     
Interestingly, the γ-pyrone or γ-pyridinone core shown in these metabolites is 
relatively new.  In a detailed review of secondary metabolites from black aspergilli, it 
was mentioned that the production of this class of γ-pyrones and γ-pyridones had been 
shown to be limited to A. niger and Aspergillus tubingensis.117  We sought to analyze 
additional strains of aspergilli for the presence of these compounds under normal and 
epigentically modified conditions.  Using retention time and detection by LC-DAD
ESIMS, the data suggests that these compounds are more prevalent in black aspergilli 
than originally stated.  Based on retention time and mass profiles, pestalamide B was 
observed in at least one growth condition for each of the 12 aspergilli which were testd.  
(Table A2).  Analysis of the epigentically modified cultures demonstrated neither an 
increase nor decrease in the number of cultures in which these compounds were present.  
This indicates that the γ-pyrones and γ-pyridones are produced in these strains under 
normal culture conditions, and the biosynthetic genes do not appear to be under 
epigenetic control.  Additionally, two other important pieces of information were
obtained from this analysis.  First, the presence of the methyl succinate moiety of 
compounds such as pestalamide A and B123 appears to be play an important role in the 
biosynthesis of these compounds.  As demonstrated, the presence of pestalamide B was 
always present in the cultures when aspernigrin A was present, however the opposite 
observation could not be made (Table A2).  This data further supports analysis in the 
review article by Nielsen et. al.,117 indicating that compounds such as 45 and aspernigrin 




isolation and purification process, which also matches what was observed during the 
purification of nygerone A.  Interestingly, it is thought that organisms may use the 
succinate moiety as a means of self-protection from the secondary metabolit s eing  
produced.137  Second, nygerone A (37) was only definitively observed in the A. niger 
ATCC 1015 suberoylanilide hydroxamic acid (SAHA) treated cultures.  It seemed 
unusual that only one strain was able to produce nygerone A, so this compound was 
further explored. 
Under further scrutiny of nygerone A, The N-phenyl ring of nygerone A was 
reminiscent of a structural portion of SAHA.  Therefore, it was hypothesized that in the 
course of treating A. niger with SAHA to turn on silent 
pathways,23 the excess SAHA was catabolized by A. niger 
and incorporated into biosynthesis of nygerone A.  To test 
this, a para-flouro SAHA derivative (p-F-SAHA) was 
synthesized (See Appendix) and a 50 µM concentration 
was added to shake-flask cultures of A. niger in potato dextrose media.  From the crude 
culture extract of A. niger treated with p-F-SAHA, LC-ESIMS data showed a molecular 
ion with an m/z of 437.1 [M + H] +, suggesting the presence of nygerone A with fluorine 
substitution on the N-Phenyl ring veryifying the proposed hypothesis.  Rapid degradation 
of this molecular ion occurred during isolation through chromatography which resulted in 
the loss of the methyl succinate moiety, leaving the fluorinated version of nygerone B.  
After purification, this new isolate, p-fluoro-nygerone B (49), was fully characterized.  
HRESIMS provided a pseudo-molecular ion at m/z 323.1192 [M + H]+ (calc. for 




proposed for 49, which corresponded to the loss of one proton and gain of one fluorine, 
when compared with nygerone B.  Similar 1H-NMR, 13C-NMR, 1H-13C HSQC and 1H-
13C HMBC correlations were observed when compared to published values of nygerone 
B, with the exception of one fewer aromatic proton.  This was explained by the 
observation of a 19F-NMR revealed at δF  =  -112.6 ppm.  While this demonstrated that A. 
niger was capable of catabolizing excess SAHA and utilizing these components in 
biosynthetic processes, it still left open the question of whether the epigenetic action of 
SAHA was necessary for the production of any of the nygerones.  To follow up these 
results, A. niger cultures were grown under multiple treatment conditions (Table 5.3) to 
determine if it was possible to observe fluoro-derived nygerones without the presence of 
p-F-SAHA.  While both conditions in which the presence of  p-fluoro aniline (Table 5.3, 
Conditions 3 and 4) showed a lack of fluoro-nygerones by ESIMS, the presence of p-
fluoro acetanilide (Table 5.3, Conditions 5 and 6) yielded the detection of  
Table 5.3  Cultures were grown under varying conditions to determine: 1) if suberoyanilide hydroxamic 
acid was necessary for the production of nygerone-like compounds under amide and free amine conditions 
and 2) if the amide or free amine alone could produce nygerone-like compounds.  A ‘+’ means that this 
compounds was added to that culture condition, while a ‘—‘ means that this compound was not added to 













1 — — — — + No 
2 + — — — + Yes 
3 — — + — + No 
4 — — + + + No 
5 — + — — + Yes 
6 — + — + + Yes 
fluoro-nygerones by ESIMS and 19F-NMR.  Further inspection through a BLAST search 
of A. niger 1015 showed the presence of gene clusters for an acetamidase and a 
formamidase which did not have homologs in any of the other Aspergilli sp. which were 




what allows this strain of A. niger the ability to catabolize excess SAHA and use the 
components in biosynthetic processes or it could simply be coincidental. 
We tested nygerones A and C, pestalamide A,  and synthesized γ-pyrones for 
bioactivity.  Initially, compounds 37, 44, 48, 49, and 50 (Table 5.4)129, 138 were screened 
against a suite of bacterial and fungal strains.  All compounds showed a lack of 
significant toxicity when tested against the bacterial strains, and only 48 and 50 
demonstrated any significant activity against fungal strains between 10 µg/mL to 100 
µg/mL.  Compound 50 had a slightly better profile of activity, when compared to 48, sinc 
activity against Aspergillus fumigatus, Aspergillus flavus, and Candida crusei was 
observed at 10 µg/mL. The primary differences between the two compounds were that 50 
contained an ethoxy and lacked a methylene between the pyrone and phenyl ring, while 
48 contained a methoxy and a methylene linker between the pyrone and phenyl ring .  A 
 Compounds 
Microbial Strain 37 44 48 49 50 51 52 
Acinetobacter baumannii — — — — — NT NT 
Acinetobacter baumannii BAA — — — — — NT NT 
Burkholderia cepacia — — — — — NT NT 
Enterobacter cloacae — — — — — NT NT 
Escherichia coli 10798 — — — — — NT NT 
Escherchia coli 11775 — — — — — NT NT 
Pseudomonas aeruginosa  — — — — — NT NT 
Klebsiella pneumoniae 33495 — — — — — NT NT 
Klebsiella pneumonia 51503 — — — — — NT NT 
Staphylococcus epidermidis — — — — — NT NT 
Staphylococcus aureus 25293 — — — — — NT NT 
Staphylococcus aureus 700787 — — — — — NT NT 
Candida albicans — — + — + + — 
Candida glabrata — — + — + + — 
Candida krusei — — + — ++ ++ — 
Candida parapsilosis — — + — + + — 
Candida tropicalis — — + — + + — 
Aspergillus fumigatus — — + — ++ ++ — 
Aspergillus flavus — — ++ — ++ ++ — 
Table 5.4  Inhibitory properties of γ-pyrone and γ-pyridone compounds when tested against various bacteri l 
and fungal strains based on change in OD600. ‘—’ represents that the compounds were not active at the 
highest concentration tested (100µg/mL).  ‘+’ represents activity observed at 100µg/mL.  ‘++’ represents that 




brief exploration into the structure-activity relationship of the compounds was undertaken 
by creating derivatives of 50 (described in materials and methods). The results of this 
assay demonstrated that 51 had a similar range of activity as 50, however, the acid moiety 
on 52 resulted in a loss of activity in the compound.  This suggests that the activity is 
dependent on the presence of the carboxylate moiety in 48, 50, and 51, while the presence 
of a carboxamide (pestalamide A and B and nygerone A) or a carboxylic acid (52) results 
in the loss of bioactivity.  In addition, the improved activity of 50 and 51 over 48 
suggests that the loss of the methylene between the pyrone and the aromatic rings aids in 
the potency of the molecules.  
This chapter demonstrates the need for exploration and detective work to obtain a 
deep understanding of scientific data since explanations may be more complex than they 
first appear. For example, difficulties in the characterization of compounds from this 
class of γ-pyrones and γ-pyridnones have been observed since they were first   
isolated.122, 125, 139  The significant number of correlations in the ring understandably led 
researchers to incorrectly elucidate the tensidol structures, and would have benefit d from 
other means of support (i.e. DFT calculations) to deeply explore all potential structural 
leads during the elucidation process.  The data collected through computations and 
synthetic methods shows that tensidol’s furopyrrol core has been incorrectly assigned, 
and that the true structure is that of a γ-pyrone core.  Since tensidol A and B were isolated 




suggests that the name of tensidol A and B 
remain, but the structure is revised to 45 and 
44.  In addition, the revisions of JBIR-86 and 
JBIR-87 are shown in 48 and 53, respectively.  Another example is nygerone A, which 
was isolated and first thought to be biosynthesized due to the use of small molecule 
epigenetic modifiers accessing epigenetically controlled gene pathways.  However, 
further evaluations of our initial hypothesis led to a revision in this thought with the 
realization that A. niger is a very biosynthetically talented organism.  In turn, nygerone A 
turned out to be produced due to the ability of A. niger to catabolize SAHA and 
incorporate these molecular components into biosynthetic pathways.  This does not 
diminsh from previous results which illustrate that SAHA upregulates biosynthetic gene 
pathways under epigenetic control,23 but demonstrates that additional thought needs to go 
into the process of isolating the new compounds.   
5.3 Materials and Methods 
5.3.1 General Chemical Methods. Initial separation of secondary metabolite 
mixtures was performed by MPLC using HP-20SS resin using a step gradient of 20:80 
MeOH-H2O to 100:0 MeOH-H2O.  Further isolation and purification was performed 
using preparative and semi-preparative HPLC using Phenomenex C18 Gemini columns. 
ESI-LC-MS data was collected using a Thermo-Finnigan Survery LC system and a 
Finnigan LCQ Deca mass analyzer.  HRESIMS data was obtained from electrospray 
ionization acquired on a time of flight mass spectrometer. Samples for mass 
determination were dissolved in MeOH and introduced for ionization with a 20 µL loop 




400 MHz (1H) and 100 MHz (13C) or at 500 MHz (1H) and 125 MHz (13C) and processed 
using VNMRj software. All solvents were of ACS grade or better. 
5.3.2 Fermentaion, Extraction, and Isolation of Nygerone A (37).  
Cryopreserved sample of Aspergillus niger ATCC 1015 was removed and plated on 
potato-dextrose agar and grown for 14 days.  Hyphae were suspended in sterile wat  and 
used in a in the inoculation of 28 Fernbach-style flasks, each containing 150 mL of a 
semi-solid vermiculite-based medium (0.2 grams cornmeal, 0.2 grams steel-roll d oats, 
0.2 grams white rice, LB broth (20 g/L)) and treated with 50 µM of SAHA.  Cultures 
were maintained under static conditions (12 h light/12 h dark, 25 °C) for two weeks. 
Cultures were harvested by adding 500 mL of ethyl acetate to each flask and after 12 h of 
extraction, the ethyl acetate and aqueous layers were decanted and filtere , th  organic 
layer was removed by partitioning, and the solvent was evaporated yielding 195 mg of 
ethyl acetate soluble organic matter. The total organic extract was subjected to repeated 
reversed-phase preparative and semi-preparative HPLC under MeOH-H2  and 
Acetonitrile-H2O gradient conditions providing 1.9 mg of nygerone A (37) as an off-
white to slightly yellowish amorphous solid.  Nygerone A (37): slightly yellow 
amorphous solid; HRESIMS m/z 419.1542 [M + H]+ (calc. for C24H24N2O5, 419.1607  
[M + H]+.  See Table 5.1 for 1H- and 13C-NMR data.  
          5.3.3 Nygerone B (38): 1H-NMR (400 MHz, CDCl3) δH 3.66 (2H, s, H-7), 5.70 
(1H, br s, N-Ha-15), 6.48 (1H, s, H-5), 6.80 (2H, m, H-9/13), 7.05 (2H, d, J = 7.6 Hz, H-
2′/6′), 7.17 (2H, m, H-10/12), 7.18 (1H, m, H-11), 7.40 (2H, t, J = 7.6 Hz, H-3′/5′), 7.47 
(1H, d, J = 7.6 Hz, H-4′), 8.42 (1H, s, H-2), 9.90 (1H, br s, N-Hb-15); 
13C-NMR (100 




128.7 (C-9/13), 128.7 (C-10/12), 129.7 (C-3′/5′), 130.0 (C-4′), 134.7(C-8), 140.4 (C-1′), 
146.9 (C-2), 150.9 (C-6), 166.0 (C-14), 177.8 (C-4); HRESIMS m/z 305.1292 [M + H]+ 
(calc. for C19H17N2O2 305.1290). 
5.3.4 Density Functional Theory Calculations (DFT).  Full geometry 
optimization and carbon chemical shift calculations for the proposed 48 and JBIR-86 (41) 
were performed on 8 nodes of the Pentium-4 Xeon54 Quad Core Linux Cluter (running 
Red Hat Linux) using Gaussian03.  Geometry optimization with frequency check and 
GIAO methods for determining carbon chemical shifts were performed using the basis 
set, b3lyp/6-31+g(d,p).  DFT calculations of tetramethylsilane (TMS) were also 
performed to determine the carbon chemical shift to be used as a reference.  Carbon 
chemical shifts were referenced by subtracting the calculated δC of each carbon from the  
calculated δC of TMS.  Analysis of results was performed by comparing the calculated 
chemical shifts with the published chemical shifts of JBIR-86.121 
5.3.5 Synthesis of 3-Carbmethoxy-6-benzyl-4-pyrone (48).  The general 
scheme for synthesis of the proposed pyrone followed the previous methodology 
developed by McCombie t al.129   The enaminone, methyl 2-[(dimethylamino) 
methylene]-3-oxobutanonte, was synthesized as described in the paper with the 
modification of using methyl acetoacetate as a starting material instead of ethyl 
acetoacetate.  Methyl acetoacetate (5.4 mL, 0.05 mol) was added to the DMF-Me2SO4 
adduct in CH2Cl2 (75 mL) at 0° C and triethylamine (10 mL) was added over slowly 
over 3 minutes.  The mixture was stirred for 2 hours at room temperature and then 
washed with aqueous tartaric acid (10% w/v, 100 mL) and water (100 mL × 2) then 




and the filtrate was dried under vacuum.  The crude material was subjected to silica gel 
flash chromoatography (Biotage Isolera) using a CHCl3-ethyl acetate gradient (100:0 to 
0:100).  The enaminone was then dried under vacuum and further purified by additional 
flash chromatography using a hexanes-ethyl acetate gradient (90:10 to 0:100).  The 
solvent was dried to give the white solid product methyl 2-(dimethylamino)methylene]-
3-oxobutanonte (6.2 g, 72.5%). 
 To construct the pyrone ring, a solution of hexamethldisilazine in THF was 
stirred at -78° C and n-BuLi in hexanes was added slowly over 2 minutes.  After the 
mixture was cooled, a solution of enaminone (methyl 2-[(dimethylamino)methylene]-3-
oxobutanonte) and phenyl acetyl chloride in THF was added over 1 minute.  The dry 
ice-acetone bath was removed and the solution was allowed to warm for 5 minutes.  
Diethyl ether was added to the reaction, followed by 3N HCl.  The solution was 
allowed to stir rapidly overnight.  The following day, the organic phase was washed 
with saturated sodium bicarbonate (100 mL) and water (100 mL × 2) then dried 
(anhydrous MgSO4).  The sample was gravity filtered (Whatman #1 filter paper) and 
the filtrate was dried under vacuum.  The residue was subjected to silica gel fl sh 
chromatography using a CH2Cl2-ethyl acetate gradient (100:0 to 0:100).  Purification of 
the γ-pyrone was performed on preparative HPLC (Phenomenex Gemini 5 µm C-18 
250 × 20 mm column) using a MeOH-H2O gradient (50:50 to 100:0) over 60 minutes at 
a flow rate of 10 mL/minute.   The resulting purification resulted in the isolation of a 
reddish amorphous solid (16 mg, 6%).  1H-NMR (400 MHz, MeOH-d4):  δ 3.84 (2H, s), 
3.88 (3H, s), 6.22 (1H, s), 7.23 (2H, m), 7.34 (3H, m), 8.45 (1H, s).  13C-NMR (100 




11), 129.29 (C-10 and 12), 129.35 (C-9 and 13), 134.00 (C-8), 161.77 (C-2), 163.94 (C-
14), 167.67 (C-6), 175.15 (C-4).  HRESIMS m/z 245.0815 [M + H]+ (calc. for 
C14H13O4, 245.0814). 
5.3.6 LC-ESIMS analysis of black aspergilli sp under chemical epigenetic 
conditions.  Freeze-dried spores from thirteen strains of black aspergilli (Aspergillus 
aculeatus NRRL 5094,  Aspergillus japonicus NRRL 2053, Aspergillus basiliensis 
NRRL 35542, Aspergillus heteromorphus NRRL 4747, Aspergillus carbonarius NRRL 
346, Aspergillus ibericus NRRL 35644, Aspergillus tubingensis NRRL 4875, 
Aspergillus carbonarius NRRL 369, Aspergillus parasiticus NRRL, Aspergillus 
ellipticus NRRL 5120, Aspergillus niger NRRL 1956, Aspergillus niger NRRL 326, 
Aspergillus niger NRRL 1015) were obtained from the NRRL mycology collection.  
All strains were grown on appropriate media and cryopreserved in a 15% (v/v) glycerol 
solution at -80° C.  Cryopreserved samples were removed and plated on potato-
dextrose agar and grown for 14 days.  Hyphae from each aspergilli were suspended in 
sterile water and used to inoculate 3 1-L Erlenmeyer flasks containing 250-mL of 
sterile potato-dextrose broth.  To each flask for a fungal strain, either 50 µM 
suberoylanilide hydroxamic acid (dissolved in 50:50 DMSO:H2 ), 50 µM 5-
azacytidine (dissolved in 50:50 DMSO: H2O), or bolus of 50:50 DMSO: H2O was 
added.  Cultures were grown for 21-days at room temperature under shake flask 
conditions at 250 rpm.  After 21-days, 2% (wt/v) Diaion HP-20 resin was added to each 
flask and continued to be shaken for 4 hours followed by filtration of the cell mass and 
resin.  The cell mass and resin were collected and then extracted in 2 250-mL aliquots 




down by rotary evaporation. 
 Dried extracts were prepared for LC-ESIMS analysis by suspending the ex ract 
in a minimal amount of MeOH and then drying to loose C18 stationary phase.  The 
dried C18 stationary phase, with sample, was then placed in SPE cartridges and rinsed 
with 5 mL of distilled water followed by 5 mL of methanol, each collected separately, 
on a vacuum manifold.  The separate water and methanol samples were dried in 
weighed 2 dram vials overnight.  The vials containing the dried methanol rinse were 
weighed and then suspended in a 90:10 MeOH: H2O solution to give a concentration of 
approximately 20 mg/mL.  A portion of each sample was then pipetted into a 2-mL 
Ependorff tube and centrifuged at 14,000 RPM for 5 minutes.  The crude supernatant in 
the Ependorff tube was placed in vials and then sampled by LC/MS (Phenomenex Luna 
3µm C18 50 x 2 mm column) using a MeOH-H2O gradient (25:75 isocratic for 3 
mintues, 25:75 to 100:0 for 28 minutes, 100:0 for 6 minutes, then re-equilibrated to 
25:75 for 3 minutes) at a flow rate of 400 µL/min.  The mass spec detector was set to 
scan a range of m/z from 120-1500 mass units.  The photodiode array (PDA) detector 
scanned wavelengths from 200-600 nm, with 3 channels set at 210 nm, 254 nm, and 
280 nm.  Collected spectra from each sample were analyzed for the presence of known 
γ-pyrones and γ-pyridinones.  
5.3.7 Isolation and Purification of p-fluoro-nygerone B (49).  Cryopreserved 
sample of Aspergillus niger ATCC 1015 was removed and plated on potato-dextrose 
agar and grown for 14 days.  Hyphae were suspended in sterile water and used in 
inoculating 20 1-L Erlenmeyer flasks containing 250 mL of sterile potato-dextrose 




suberoylanilide hydroxamic acid (p-F-SAHA) (dissolved in 50:50 DMSO:H2O) 
[Synthesis described in appendix material].  Controls were created by inoculating  4    
1-L Erlenmeyer flasks containing 250-mL of sterile PDB and 0.5% (vol/vol) of 50:50 
DMSO:H2O.  Cultures were grown on a rotary shaker (150 rpm) for 14 days at room 
temperature then partitioned three times with an equivalent volume of dichloromethane.  
The organic phase was collected and dried down by vacuum.  The treated and control 
extracts were generated and processed for LC-ESIMS analysis by methods previously 
described in 5.3.6.   Further fractionation was performed on the p-F-SAHA culture 
extract by preparative HPLC (Phenomenex Gemini 5 µm C18 250 × 20 mm column) 
using a MeOH-H2O gradient (35:65 to 100:0) over 60 minutes at a flow rate of 10 
mL/minute, with final purification being performed under varying gradient conditions 
by semi-preparative HPLC.  Purification resulted in the isolation of light-yellow 
amorphous solid (2 mg).  1H (400 MHz, CDCl3):  δ 3.71 (2H, s, H-7), 6.06 (1H, br s, N-
Ha-15), 6.61 (1H, s, H-5), 6.83  (2H, m, H-9/13), 7.05 (2H, m, H-2´/6´), 7.10 (2H, m, 
H-3´/5´), 7.21 (2H, m, H-10/12), 7.23 (1H, m, H-11), 8.49 (1H, s, H-2), 9.89 (1H, br s, 
N-Hb-15).  13C (100 MHz, CDCl3):  δ 39.74 (C-7), 116.9 (C-3´/5´), 117.7 (C-3), 121.9 
(C-5), 127.7 (C-11), 128.5 (C-9/13), 128.9 (C-10/12 and C-2´/6´), 134.8 (C-8), 146.9 
(C-2), 151.3 (C-6), 162.0 (C-1´), 164.1 (C-4́), 166.0 (C-14), 177.7 (C-4).  HRESIMS 
m/z 323.1192 [M + H]+ (calc. for C19H16FN2O2, 323.1196). 
5.3.8  Analysis of A. niger cultures for nygerone C under varying culture 
conditions with and without SAHA.  Cultures were grown following procedures 
outlined in 5.3.7.  Six different treatment conditions were utilized as outlined in Table 




control extracts were generated and processed for LC-ESIMS analysis by methods 
previously described in 5.3.6.     
5.3.9  3-Carbethoxy-6-phenyl-4-pyrone (50).  Synthesized and purified based 
on previous literature methods.129  The resulting product was a red crystalline solid.    
HRESIMS m/z 245.0816 [M + H]+ (calc. for C14H13O4, 245.0814). 
1H-NMR was in 
agreement with the literature.129  
5.3.10  3-Carbmethoxy-6-phenyl-4-pyrone (51).  Synthesized and purified 
based on previous literature methods129, with the use of methyl acetoacetate utilized in 
place of ethyl acetoacetate.  The resulting product was a red crystalline solid. 1H (500 
MHz, MeOH-d4): δ 3.86 (3H, s, H-15), 6.94 (1H, s, H-5), 7.53 (2H, m, H-9/11), 7.55 
(2H, m, H-10), 7.89 (2H, m, H-8/12).  13C (125 MHz, MeOH- d4):  δ 52.3 (C-15), 
112.4 (C-5), 118.3 (C-3), 126.2 (C-8/12), 129.6 (C-7), 130.8 (C-9/11 and C-10), 163.0 
(C-13), 164.1 (C-6), 166.0 (C-2), 175.6 (C-4). HRESIMS m/z 231.0659 [M + H]+ (calc. 
for 231.0657, C13H11O4). 
5.3.11  3-Carboxylic-6-phenyl-4-pyrone (52).  10 mg of 51 was reacted with 1 
N NaOH in distilled THF for three hours at room temperature then adjusted to pH 3 
with 1 N HCl.  The resulting solution was partitioned against ethyl acetate, and the 
resulting organic material was dried down.  Purification was performed on preparative 
HPLC using methods previously described, resulting in 6.2 mg of a yellow amporphous 
solid.   1H (500 MHz, (CD3)2CO:  δ 6.95 (1H, s, H-5), 7.60 (2H, m, H-9/11), 7.66 (1H, 
m, H-10), 8.04 (2H, m, H8/12), 9.88 (1H, s, H-2).   13C (125 MHz, (CD3)2CO):  δ 97.6 
(C-5), 100.6 (C-3), 126.7 (C-8/12), 129.2 (C-9/11), 130.4 (C-7), 132.8 (C-10), 161.7 




for 215.0350, C12H7O4). 
5.3.12  Pestalamide A (44).  HRESIMS m/z [M + Na]+ 366.0956 (calcd. for 
C18H17NO6Na 366.0954); 
1H- and 13C-NMR were in agreement with published    
values.123  
5.3.13 Antibacterial assay.  Frozen 20% glycerol stocks of 12 bacterial lines 
from ATCC (Table 5.4) were thawed and diluted into TSB media, 20 µL of stock into 
11 mL of media.  These stocks were plated to 96-well plates, 100uL per well.  Test 
compounds were diluted in DMSO and added to the wells; final DMSO concentration 
in the wells was 1%.  Plates were shaken orbitally for five seconds and an OD600 were 
taken.  Fungal strains were incubated for 24 hours in a humidified air incubator at 
37ºC.  Plates were removed, shaken again, and OD600 readings were obtained again.  
The final OD600 was subtracted from the initial OD600 to obtain the change in OD600. 
5.3.14 Antifungal assay.  Frozen 20% glycerol stocks of seven fungal lines 
from ATCC (Table 5.4) were thawed and diluted into YM media, 20 uL of stock into 
11 mL of media.  These stocks were plated to 96-well plates, 100 uL per well.  Test 
compounds were diluted in DMSO and added to the wells; final DMSO concentration 
in the wells was 1%.  Plates were shaken orbitally for five seconds and an OD600 were 
taken.  Fungal strains were incubated for 48 hours in a humidified air incubator at 37ºC 
degrees Celsius.  Plates were removed, shaken again, and OD600 readings were obtained 






Chapter 6. Reassessing the Ichthyotoxin Profile of Cultured 
Prymnesium parvum (Golden Algae) and Comparing it to Samples 
Collected from Recent Freshwater Bloom and Fish Kill Events in 
North America 
This chapter is adapted from a publication in Toxicon.140 
6.1  Introduction 
The marine haptophyte Prymnesium parvum (division Haptophyta, class 
Prymnesiophyceae),141 which is commonly referred to as ‘golden algae’, has played 
causal roles in scores of massive fish kills in coastal marine and high-to-moderate salinity 
inland waterways throughout the world.142-146  In the mid-1980s, the first reported cases 
documenting the entry of P. parvum into North America were marked by multiple large 
fish kill events in southern Texas, USA.147, 148  Even more troubling was the realization 
that P. parvum blooms were occurring in moderate-to-low salinity inland lakes, rivers, 
and reservoirs.  This marked a disturbing extension in the range of suitable P. parvum 
habitats149 causing considerable alarm regarding the ecological and potential human 
health risks associated with golden algae.  Adding to this concern has been the rapid rate 
of P. parvum’s dispersion across the southern United States, and its northerly     
spread.150, 151  
Despite its devastating biological effects, the identity of the toxic constituen (s) 
produced by P. parvum has not been definitively established.152-155  A combination of 
undefined proteolipids,156 ceramides,157 saponins,158 proteinaceous substances,159 plasma 




responsible for P. parvum’s toxicity.  In 1982, Kozaki and colleagues proposed that 
hemolysin I (a combination of galactoglycerolipids) was the P. parvum toxin, but no data 
substantiating the hypothesis were offered.160  Later in 1996161 and 1999,162 Igarashi and 
colleagues reported the structure determination of the high molecular weight cyclic 
polyethers prymnesin-1 (C107H154Cl3NO44) (62) and prymnesin-2 (C96H136Cl3NO35).  
Both of these compounds are potent ichthyotoxins against Tanichthys albonubes with 
LC50 values of 8 and 9 nM, respectively.
163  However, none of the prymnesiums have 
been directly linked to fish kill events and our ongoing LC-ESIMS and toxin isolation 
studies suggest that these compounds do not accumulate at lethal concentrations under 
laboratory or natural field conditions. 
 
 
This study used a bioassay-guided approach to identify some of the ichthyotoxic 
components in laboratory-grown P. parvum cultures.  These results were compared to 
LC-ESIMS and GC-EIMS data obtained for two recent fish kill and bloom events caused 




waters, extracts and pure compounds were also tested against a human cell line.  These 
data support an important toxic role for several polyunsaturated fatty acids in laboratory-
cultured P. parvum, but do not fully explain the organism’s significant ichthyotoxicity at 
natural bloom sites. 
6.2 Results and Discussions 
6.2.1 Bioassay-guided ichthyotoxin extraction and compound isolation.  We 
have approached the search for P. parvum toxins using an ichthyotoxicity-based 
bioassay-guided methodology.  The fathead minnow (Pimephales promelas) has served 
as a reporter organism for detecting biologically-relevant toxins in golden agae cultures 
and samples collected at two fish kill sites along the Oklahoma-Texas (Lake Texoma – 
February 2009) and Pennsylvania-West Virginia (Dunkard Creek – October 2009) 
borders.  Our initial studies applying a modified Kupchan-partitioning scheme to cultured 
P. parvum demonstrated that golden algae toxins accumulated in the organic layer 
following water-ethyl acetate partitioning.  Bioassays performed on the dried and then 
reconstituted aqueous layer (resolubilized at ×1, ×10 and ×100 its initial concentration) 
showed that it was devoid of biologically-relevant ichthyotoxic substances.  In contrast, 
the ×1, ×10 and ×100 reconstituted ethyl acetate layer retained the sample’s potent 
ichthyotoxic properties.  Notably, this extraction method varies significantly from the 
elaborate scheme reported for the isolation of intracellular prymnesins.162 
The ethyl acetate soluble material collected from 50 L of cultured P. parvum was 
subjected to MPLC (HP20SS resin, gradient elution from 30–100% methanol in water 
followed with a 100% acetone wash).  This afforded a single bioactive fraction (100% 




within ~20 min when the extract was reconstituted at ×1 its original concentration).  We 
have observed that fish placed in water taken from highly toxic blooms and lab-grown 
cultures exhibit similar toxicological symptoms that include excessive mucus production 
near the gills, hyperventilation, and an impaired righting reflex.  These symptoms usually 
appeared within 10-20 minutes of exposure to toxic water and fish typically ceased 
visible movement within 20-30 minutes.  A similar set of symptoms is reportedly brought 
on by eicosapentaenoic acid.164  The ichthyotoxic sample was subjected to preparative-
scale HPLC (reversed-phase octadecyl silica gel, gradient from 40-100% acetonitrile in 
H2O) yielding a single bioactive fraction.  The 
1H-NMR spectrum of the toxic fraction 
indicated that the sample was composed of several metabolites exhibiting spins span ing 
the region from δH 0.5–5.5, which were striking similarities to data reported for 
galactoglycerolipid and polyunsaturated lipid toxins previously isolated from certain 
unicellular marine organisms165-168 including P. parvum.160  Subsequent semi-preparative 
reversed-phase HPLC performed on a portion of the bioactive sample yielded a series of 
fractions that exhibited greatly diminished toxicity, which was spread across several 
consecutive fractions.  However, even after recombining the samples, the ichthyotoxic 
properties of the mixed fractions were substantially reduced (>10-fold loss of toxicity) 
and all samples were devoid of activity following brief storage (dried and held for < 24 h 
at 4 ºC).  Returning our attention to the parent preparative HPLC fraction, we found that 
it still retained toxicity and so we set about characterizing the sample’s thr e major 
components. 
Positive-ion HRESIMS of the purified metabolites provided quasi-molecular ions 




C45H68NaO10, 791.4710), and 793.4801 (calcd for C45H70NaO10, 793.4867) for 
metabolites 55 (GAT 512A), 56 (GAT 768A), and 57 (GAT 770A), respectively.  In 
order to provide a simple naming scheme for compounds 55, 56, and 57, we have 
proposed the use of the term “GATs” (golden algae toxins) rather than the more lengthy 
IUPAC nomenclature.  Each GAT is assigned a unique identifier number based on its 
molecular weight, which is followed by a letter code to distinguish isomers from each 
other.  Accordingly, compounds 55, 56, and 57 have been termed GAT 512A, GAT 
768A, and GAT 770A, respectively.  Further data obtained from 1D- (1H and 13C-NMR) 
and 2D- (COSY, HSQC, and HMBC) NMR (Supplementary Information, Table 1), 
controlled chemical and enzymatic degradation experiments, and optical rotation 
measurements of the metabolites and their respective hydrolysis products allowed us to 
confirm the structures of these compounds.  The identities of these compounds were also 
confirmed by comparisons of our data with values published in the literature for 55,169  
56,167 and 56.167 Surprisingly, 55-57 exhibited no ichthyotoxicity against P. promelas (up 
to 430 µM); however, we did observe modest cytotoxicity for 55 in a human (MDA-MB-
435) cancer cell line (IC50 24.2 ± 5.12 µM). 
6.2.2 Esterase mediated liberation of ichthyotoxic fatty acids.  Further 
consideration of structures 55-57, suggested that GATs might function as protoxins since 
the polyunsaturated O-alkyl esters moieties found within these metabolites could be 
readily hydrolyzed resulting in the release of their corresponding carboxylic acid 
derivatives.  Similar metabolites have been implicated as potent toxins against fish164 and 
isolated fish cell lines.170  We hypothesized that esterases, which are ubiquitous 




polyunsaturated fatty acids from the 55-57.  We tested this by incubating 55-57 with 
assorted esterases and this resulted in the liberation of a potent mixture of ichthyotoxins 
that included stearidonic acid (58) and its analog 59.  None of the controls utilizing heat 
denatured esterases showed any ichthyotoxic properties (Figure 6.1).  More importantly, 
tests performed using purified and commercially available 58 confirmed that the 
concentration of this fatty acid alone was sufficient to cause rapid-onset toxici y (LC50 
21.9 ± 6.3 µM; all fish dead in < 20 minutes at 40 µM) and other distinct pathological 




Figure 6.1 Assessment of the ichthyotoxicity and mammalian cell cytotoxicity of compounds obtained 
from the enzymatic hydrolysis of compound 55 Incubation of 55with a lipase/esterase mixture resulted in 
the liberation of D-isofloridoside and 58, which was ichthyotoxic. Conversion of 58 to its methyl ester 
derivative in the complete loss of ichthyotoxicity. Incubation of 2 with a heat denatured lipase/estera e 







6.2.3 Bioassay analysis of fatty acids.  We expanded our testing of 58 to include 
several of its derivatives (i.e., methyl steridonate, steridonoyl glycine, and stearic acid); 
however, none of these compounds were toxic to fish at concentrations of ≤ 40 µM 
(Figure 6.1).  An examination of 16 additional lipids led to the identification of several 
other fatty acids that displayed similar or increased potency against fish 
(docosahexanoeic acid: LC50 4.7 ± 1.3 µM; eicosapentaenoic acid: LC50 23.6 ± 9.0 µM, 
arachindonic acid: LC50 9.2 ± 0.8 µM, and pinolenic acid: LC50 18.2 ± 5.9 µM) (Figure 
6.1).  These results suggest that a combination of a carboxylic acid and ≥2 cis double 
bonds are necessary to confer ichthyotoxic properties to fatty acids.  Given the modest 
size of our lipid library, further speculation regarding the structural features required to 
impart ichthyotoxic properties to fatty acids is not possible at this time.  The cytotoxicity 
of the lipids was also tested against human cells (MDA-MB-435); however, none of the 
compounds inhibited cell proliferation at concentrations ≤ 10 µM. 
6.2.4  GC-EIMS assessment of cultured P. parvum lipids and comparisons to 
water from bloom and fish kill sites.  Tests performed by GC-EIMS on laboratory 
grown P. parvum enabled us to determine that this organism produces a complex suite of 
lipophilic metabolites.  A representative GC-EIMS trace of a lipid profile tak n from a 20 
day old P. parvum culture is provided in Figure A16.  The bulk of this mixture was 
found to consist of a combination of saturated and unsaturated C16, C18, C20, and C22 
compounds.  In view of the toxicity data obtained from tests performed with our lipid 
library (Figure 6.2), we conjecture that in addition to 58, some of the other 
polyunsaturated C20 and C22 metabolites might contribute to the ichthyotoxicity profile of 




We also assessed the quantity of 58 in cultured P. parvum since this compound 
represented one of the most prevalent (second only to myristic acid) substances in the 
mixture and we were able to secure authentic samples for analytical comparisons.  A 
seemingly positive correlation was observed between P. parvum cell numbers, the 
concentration of 58 in cultures, and toxicity of culture water against P. promelas (Table 
6.1).  Specifically, we noted that as the cell densities of P. parvum cultures approached 
106 cells/mL, the levels of 58 significantly exceeded the compound’s LC50 value (Table 
6.1).   
Next, we compared the 
results from cultured golden 
algae with data from field-
collected water samples 
obtained from recent fish 
kill/bloom sites.  We 
immediately discerned two 
substantial differences between 
laboratory-grown golden algae 
and field samples taken from 
recent blooms: 1) the cell 
density for wild P. parvum 
populations did not reach the 
same high levels achieved in 



































ot toxic at ≤ 40 µM
 
Figure 6.2  Library of lipids tested for ichthyotoxic 
properties.  Compounds are arranged based on their relative 




concentration of 58 was proportionally reduced.  While our analysis of field-collected 
samples did confirm the presence of 58 at bloom and fish kill events (Figure A18 and 
A16), its concentrations during these periods failed to reach toxic levels (< 0.5 µM) 
(Table 6.1).  Interestingly, we did not detect 58 at nearby non-bloom sites or in water 
gathered during non-bloom periods (Table 6.1 and Figure A19).  This suggests that 58 
may serve as a chemical marker for impeding or ongoing P. parvum blooms. 
 
Table 6.1 Determination of the cell density, stearidonic acid concentrations, and ichthyotoxicity of  
golden algae cultures and water samples collected at recent P. parvum associated fish kill and bloom 
events. 
Sample 
P. parvum cell density  
(X10
5






7 day old laboratory culture 8.2 ± 0.7 5.8 ± 1.8 No 
12 day old laboratory culture 13.0 ± 0.4 31.2 ± 7.7 Yes 
20 day old laboratory culture 24.0 ± 3.0 95.2 ± 23.7 Yes 
Bloom event in Lake Texoma, 
Lebanon Pool (Feb. 2009) 
1.2 ± 0.1 0.06 ± 0.02 Yes 
Post bloom in Lake Texoma, 
Lebanon Pool (June 2009) 
Not detected Not detected No 
Fish kill event in Dunkard Creek 
drainage, Wana Bridge (Oct. 
2009) 
5.9 ± 1.5 0.44 ± 0.16 Yes 
Non-fish kill area in Dunkard 
Creek drainage, Upper Beaver 
Dam (Oct. 2009) 
Not detected Not detected No 
6.2.5  Further Discussions.  Despite our many attempts using LC-ESIMS, direct 
injection ESIMS (positive and negative modes), and bioassay-guided approaches to 




that these cyclic polyethers meaningfully contribute to the ichthyotoxic properties of 
laboratory-grown or field samples P. parvum.  Instead, a suite of uncommon 
polyunsaturated fatty acids and their conjugated galactoglycerolipid progenitors have 
emerged as important chemical agents that appreciably contribute to the ichthyotoxic 
effects of cultured P. parvum.  This finding is supported by a substantial body of 
anecdotal evidence and extensive observations concerning the seemingly mixed 
lipophilic and amphiphilic properties of semipurified and purified P. parvum            
toxins.154, 156, 158, 172  Moreover, the labile nature of the P. parvum’s toxins can be partially 
explained based on numerous autooxidative degradation processes that polyunsaturated 
fatty acids can undergo.173, 174  Even if other ichthyotoxic compounds are biosynthesized 
by laboratory-grown P. parvum, the quantity of toxic fatty acids, alone, are sufficient to 
render the cultures lethal to fish.  Although we are unaware of considerable human ealth 
risks attributable to dermal contact, inhalation, or ingestion of galactoglycero ipids and 
polyunsaturated lipids such as 55-58, we recommend that caution be used while handling 
concentrated samples of these substances until further toxicological risk assesment 
studies have been conducted.   
We are confident that prymnesins are not this organism’s primary toxin.  This 
assertion is based on several key observations including: 1) prymnesins were not detected 
by LC-ESIMS in cultured or field-collected water samples where high P. parvum cell 
densities occurred, 2) bioassay-guided isolation methods have not provided any fractions 
in which 1H-NMR or ESIMS have yielded unequivocal evidence for prymnesins or 
prymnesin-degradation products, 3) the labile nature of the P. parvum toxin is an unlikely 




instabilities.  While preliminary FABMS data hint at the presence of high molecular 
weight (prymnesin-like) compounds in certain P. parvum samples (weak quasi-molecular 
ions have been observed between m/z 2,100 and 2,500; data not shown), we have not 
been able to link the occurrence of these substances with ichthyotoxic effects.  Moreover, 
the quantities of these putative high-molecular weight metabolites fall well below their 
reported LC50 values (e.g., the detection limits for FABMS are generally within the low 
nanogram to picogram range; the weak intensities of the peaks we have observed would 
put the concentrations of these compounds at levels that are ≥10–100-fold below their 
LC50 values).  Instead, our data support the idea that golden algae produce another, yet 
uncharacterized ichthyotoxin(s). 
The results are particularly significant in view of the increasing frequency with 
which people are becoming exposed to P. parvum infested waters and the current lack of 
concern regarding human contact with this organism.175, 176  Although our data provide 
convincing evidence for certain fatty acids serving as the predominant toxinsin 
laboratory-grown P. parvum cultures, we have not yet determined the identity of the 
ichthyotoxic compound(s) responsible for the growing number of fish kill events in the 
United States.  However, we cannot rule out the possibility that toxic fatty acids may 
exhibit ichthyotoxic effects when administered chronically to fish at low-d sages.  Given 
the different growth conditions experienced by P. parvum in the laboratory versus in 
nature, it is probable that golden algae produce different toxins under these different 
conditions.  We will continue to investigate methods for preserving the integrity of the 
labile P. parvum toxin (e.g., consideration of pH,177 free radicals,164 and possible metal 




6.3 Materials and Methods 
6.3.1  General instrumentation and experimental procedures.  HPLC was 
performed on a Shimadzu preparative instrument using a SCL-10A VP system controller, 
SPD-10AV VP UV-VIS detector, LC-6AD pumps, DGU-14A solvent degasser, and 
FRC-10A programmable fraction collector.  Samples were separated over a Phenomen x 
C18 Gemini column (5 µm, 110 Å, 250 × 21.2 mm).  Semi-preparative HPLC was 
performed on a similar system using LC-10AT VP pumps and a Phenomenex C18 
Gemini column (5 µm, 110 Å, 250 × 10 mm).  TOF-ESIMS data were acquired on a 
Waters LCT Premier instrument.  Corrections for exact mass determinations were made 
automatically with the lock mass feature in the MassLynx software.  Samples for mass 
determination were dissolved in methanol and introduced for ionization using an auto 
injector with a 20 µL loop.  Samples for LC-MS were analyzed by interfacing the HPLC 
with the ESIMS instrument.  GC-EIMS analyses were carried out on a HP 5890 Series II 
gas chromatograph and a HP 5971A MS detector using a HP-5 (30 m × 0.32 mm × 0.25 
µm) cross-linked 5% PH Me siloxane column.  Optical rotation measurements were 
performed on an Autopol III Automatic Polarmeter (Rudolph Research) at 589 nm and 
20º C in water.  NMR data were obtained on a Varian VNMR spectrometer at 400 and 
500 MHz (1H) and 100 and125 MHz (13C), respectively.  All solvents were of ACS grade 
or better. 
6.3.2  Biological material.  Prymnesium parvum (UTEX LB2927) was purchased 
from the University of Texas algal collection.  Cultures were grown in 1 L Erlenmeyer 
flasks containing sterilized COMBO media with added salts179 and adjusted to pH 7.8.  




Cultures were maintained under fluorescent grow lights (12 h light/12 h dark 
photoperiod) until cell densities reached approximately ~2×106 cells/mL as determined 
with a haemocytometer. 
6.3.3  Extraction and isolation.  Several sample preparation and extraction 
techniques were tested to identify the best method for extracting the toxic materials.  
These methods included extraction of freeze dried culture materials, liquid-li i  
partitioning of cultures, and extraction of filtered cells.  Ultimately, we det rmined that 
liquid-liquid partitioning of the whole cultures (medium plus cells) using ethyl acetate 
was the best method since the ichthyotoxicity profile of the resulting extract was identical 
to that of P. parvum water both in terms of its potency and rapid onset toxicity.  The ethyl 
acetate layers from partitioning against 50 L of P. parvum cultures were combined and 
the organic extract (~30 g) was subjected to gradient MPLC over HP20SS resin (30-
100% methanol in water with an acetone wash).  The fraction eluting with 100% 
methanol (680 mg) was found to retain all of the ichthyotoxic activity.  Preparative 
reversed phase HPLC (40-100% acetonitrile in water) yielded a fraction (310 mg) eluting 
between 75-100% acetonitrile that was ichthyotoxic.  1H-NMR and LC-ESIMS 
performed on this material showed it contained a variety of polyunsaturated lipids and 
galactoglycerolipids, but was devoid of any detectable prymnesiums.  Fractionation of 
this material by semi-preparative reversed phase HPLC consistently resu ted in sample 
sets that quickly lost their ichthyotoxic activities.  In addition, many of the 1H-NMR spins 
representing the presumed polyunsaturated lipid components showed diminished 
intensities.  After several failed attempts to stabilize the ichthyotoxic substances, we 




This resulted in the purification (semi-preparative HPLC eluted with 65-85% acetonitrile 
in water) of compounds 55 (75 mg), 56 (3 mg), and 57 (6 mg). 
6.3.4  Enzymatic hydrolysis.  For each experiment, a sample consisting of 2-3 
mg of galactoglycerolipid was dissolved by sonicating the compound in 2 mL of 
phosphate buffer (pH 7.0) and then adding a lipase/esterase mixture (Sigma lipase basic 
kit 62327).  The sample was incubated at 30 ºC for 36 h after which the reaction mixture 
was partitioned against dichloromethane.  After removal of the solvent from the organic 
layer in vacuo, the remaining residue was resuspended in methanol and immediately 
analyzed by HPLC for its fatty acid content by comparison of peak retention times to 
authentic standards.  For experiments in which the ichthyotoxicity of hydrolyzed samples 
were being evaluated, reaction mixtures were not extracted, but instead were directly
added to the bioassay vessels containing Pimephales promelas.  Controls for 
ichthyotoxicity testing consisted of heat denatured lipase/esterase mixtures. 
6.3.5  Alkaline hydrolysis.  Compounds (2 mg in 2 mL of methanol) were 
reacted with 2 mL of 4% (wt./vol.) sodium methoxide in methanol at room temperature 
for 30 min.  Reactions were neutralized by passing over acidic Dowex 50W X 8 ion-
exchange resin.  The eluents were partitioned between methanol and hexanes and the 
methanol-soluble phases were subjected to HPLC separation.  1H-NMR and optical 
rotation data ([α]20D -9.3 (c 0.02, water)) were identical to those reported for (2R)-3-O-[β-
D-galactopyranosyl]glycerol.180  The hexanes soluble material was analyzed by GC-
EIMS and the presence of methyl stearidonate was confirmed based on comparisons of 




6.3.6 GC-EIMS analysis of fatty acids.  The examination of lipids was 
performed using a method similar to a process described for the transesterification and 
GC analysis of lipid mixtures.181  Laboratory-grown cultures were prepared for fatty acid 
mixture analysis by lyophilization followed by methanol extraction.  After removal of the 
solvent in vacuo, 100 mg samples of the organic extracts were dissolved in 3 mL of 
methanol-benzene (4:1) and placed in 1 dram vials.  Acyl chloride (300 µL aliquots) was 
added to each vial and the vessels were capped.  The mixtures were held at 100 ºC for 1 h 
with constant stirring.  Samples were neutralized by adding 6 mL of 6% K2CO3 to each 
vial.  Samples were briefly sonicated and then centrifuged until phase separation 
occurred.  The upper benzene layers were removed and the samples directly submitted to 
GC-EIMS.  For the culture-derived samples, the following GC conditions were 
employed: oven temperature was 100 ºC, injection port and transfer lines were held at 
250 ºC and 280 ºC, respectively.  A thermal gradient was applied as follows: held at 100 
ºC for 3 minutes followed by a 20 ºC/min gradient to 180 ºC, a second gradient of 3 
ºC/min to 225 ºC, and a final gradient of 10 ºC/min to 250 ºC, which was then held for an 
additional 5 minutes at 250 ºC.  Due to the greater complexity of the field-collected 
samples, we further optimized the GC-EIMS conditions so that samples were held at 100 
ºC for 3 min followed by a 20 ºC/min gradient to a final temperature of 280 ºC, which 
was held for 6 min. 
6.3.7  Ichthyotoxicity assay.  Determination of the ichthyotoxic properties of P. 
parvum extracts and pure compounds were conducted in accordance with EPA-821-R-02-
012 182 (with the minor modifications noted below) and were approved by the University 




clear glass jars were loaded with 50 mL of filtered and aged tap water and 10-14 day old 
P. promelas fry (three per jar) were added and allowed to acclimatize for 1 h.  The jars 
were randomized and samples dissolved in 0.5 mL methanol were added to the jars.  
Controls consisting of vehicle-only were included in each experiment.  Fish were 
maintained under 12 h light/12 h dark photoperiods at 24 ºC.  Due to the rapid rate in 
which the toxin’s effects were observed, we monitored fish survivorship at 30 min, 1 h, 
24 h and 48 h.  We observed that the 1 h mortality counts were typically indistinguishable 
from observations made at 24 h and 48 h.  Each sample was tested in triplicate and the 
results were expressed as the LC50 (the concentration lethal to 50% of fish) ± standard 
deviation.  The LC50 values were determined in SigmaPlot v10 (Systat Software Inc) 
using sigmoidal dose-response regression analyses with variable slope parameters.  All 
fish were euthanized at the conclusion of each experiment. 
6.3.8.  Mammalian cytotoxicity assay.  Evaluations of mammalian cell 
cytotoxicity were performed as previously described.183, 184  Briefly, cells were plated in 
96-well plates and allowed to adhere and grow for 24 h.  Compounds were dissolved in 
ethanol and cells were incubated with compounds for 48 h. The cells were fixed with 
TCA and stained with sulforhodamine B.  The absorbance was read with a plate reader at 
560 nm.  Dose response curves were plotted and the IC50 values (the concentration 
required to inhibit cell proliferation by 50%) was calculated for each experiment.  Each 
sample was tested in triplicate in 3-5 independent experiments and results were expressed 





1. Cichewicz, R. H.; Henrikson, J. C.; Wang, X.; Branscum, K. M., Strategies for 
accessing microbial secondary metabolites from silent biosynthetic pathways. In 
Manual of Industrial Microbiology and Biotechnology 3rd Edition ed.; Baltz, R. 
H.; Davies, J. E.; Demain, A. L., Eds. American Society for Microbiology: 
Washington DC, 2009; pp 78-95. 
2. Newman, D. J.; Cragg, G. M., Natural products as sources of new drugs over the 
last 25 years. Journal of Natural Products 2007, 70, 461-477. 
3. Newman, D. J.; Cragg, G. M.; Snader, K. M., Natural products as sources of new 
drugs over the period 1981−2002. Journal of Natural Products 2003, 66, 1022-
1037. 
4. Cragg, G. M.; Newman, D. J.; Snader, K. M., Natural products in drug discovery 
and development. Journal of Natural Products 1997, 60, 52-60. 
5. Pelish, H. E.; Westwood, N. J.; Feng, Y.; Kirchhausen, T.; Shair, M. D., Use of 
biomimetic diversity-oriented synthesis to discover galanthamine-like molecules 
with biological properties beyond those of the natural product. Journal of the 
American Chemical Society 2001, 123, 6740-6741. 
6. Spring, D. R., Diversity-oriented synthesis; a challenge for synthetic chemists. 
Organic & Biomolecular Chemistry 2003, 1, 3867-3870. 
7. Gan, Z.; Reddy, P. T.; Quevillon, S.; Couve-Bonnaire, S.; Arya, P., 
Stereocontrolled solid-phase synthesis of a 90-membered library of indoline-
alkaloid-like polycycles from an enantioenriched aminoindoline scaffold. 




8. Baltz, R. H., Renaissance in antibacterial discovery from actinomycetes. Current 
Opinion in Pharmacology 2008, 8, 557-563. 
9. Bode, H. B.; Muller, R., The impact of bacterial genomics on natural product 
research. Angewandte Chemie-International Edition 2005, 44, 6828-6846. 
10. Brakhage, A. A.; Shuemann, S.; Bergmann, S.; Scherlach, K.; Schroeckh, V.; 
Hertweck, C., Activation of fungal silent gene clusters:  A new avenue to drug 
discovery. Progress in Drug Research 2008, 66, 3-12. 
11. Challis, G. L., Genome mining for novel natural product discovery. Journal of 
Medicinal Chemistry 2008, 51, 2618-2628. 
12. Challis, G. L., Mining microbial genomes for new natural products and 
biosynthetic pathways. Microbiology 2008, 154, 1555-1569. 
13. Fox, E. M.; Howlett, B. J., Secondary metabolism: regulation and role in fungal 
biology. Current Opinion in Microbiology 2008, 11, 481-487. 
14. Gross, H., Strategies to unravel the function of orphan biosynthesis pathways: 
recent examples and future prospects. Applied Microbiology and Biotechnology 
2007, 75, 267-277. 
15. Scherlach, K.; Hertweck, C., Triggering cryptic natural product biosynthesis in 
microorganisms. Organic & Biomolecular Chemistry 2009, 7, 1753-1760. 
16. Schneider, P.; Misiek, M.; Hoffmeister, D., In vivo and in vitro production 





17. Schumann, J.; Hertweck, C., Advances in cloning, functional analysis and 
heterologous expression of fungal polyketide synthase genes. Journal of 
Biotechnology 2006, 124, 690-703. 
18. Singh, S. B.; Pelaez, F., Biodiversity, chemical diversity and drug discovery. In 
Natural compounds as Drugs, Vol. I.  Birkhauser: Basel, Switzerland, 2008; pp 
141-147. 
19. Van Lanen, S. G.; Shen, B., Microbial genomics for the improvement of natural 
product discovery. Current Opinion in Microbiology 2006, 9, 252-260. 
20. Wilkinson, B.; Micklefield, J., Mining and engineering natural-product 
biosynthetic pathways. Nature Chemical Biology 2007, 3, 379-386. 
21. Zerikly, M.; Challis, G. L., Strategies for the discovery of new natural products by 
genome mining. ChemBioChem 2009, 10, 625-633. 
22. Lee, B. N.; Kroken, S.; Chou, D. Y. T.; Robbertse, B.; Yoder, O. C.; Turgeon, B. 
G., Functional analysis of all nonribosomal peptide synthetases in Cochliobolus 
heterostrophus reveals a factor, NPS6, involved in virulence and resistance to 
oxidative stress. Eukaryotic Cell 2005, 4, 545-555. 
23. Fisch, K. M.; Gillaspy, A. F.; Gipson, M.; Henrikson, J. C.; Hoover, A. R.; 
Jackson, L.; Najar, F. Z.; Wagele, H.; Cichewicz, R. H., Chemical induction of 
silent biosynthetic pathway transcription in Aspergillus niger. Journal of 
Industrial Microbiology & Biotechnology 2009, 36, 1199-1213. 
24. Galagan, J. E.; Calvo, S. E.; Cuomo, C.; Ma, L. J.; Wortman, J. R.; Batzoglou, S.; 
Lee, S. I.; Basturkmen, M.; Spevak, C. C.; Clutterbuck, J.; Kapitonov, V.; Jurka, 




Draht, O.; Busch, S.; D'Enfert, C.; Bouchier, C.; Goldman, G. H.; Bell-Pedersen, 
D.; Griffiths-Jones, S.; Doonan, J. H.; Yu, J.; Vienken, K.; Pain, A.; Freitag, M.; 
Selker, E. U.; Archer, D. B.; Penalva, M. A.; Oakley, B. R.; Momany, M.; 
Tanaka, T.; Kumagai, T.; Asai, K.; Machida, M.; Nierman, W. C.; Denning, D. 
W.; Caddick, M.; Hynes, M.; Paoletti, M.; Fischer, R.; Miller, B.; Dyer, P.; Sachs, 
M. S.; Osmani, S. A.; Birren, B. W., Sequencing of Aspergillus nidulans and 
comparative analysis with A. fumigatus and A. oryzae. Nature 2005, 438, 1105-
1115. 
25. Dean, R. A.; Talbot, N. J.; Ebbole, D. J.; Farman, M. L.; Mitchell, T. K.; Orbach, 
M. J.; Thon, M.; Kulkarni, R.; Xu, J. R.; Pan, H. Q.; Read, N. D.; Lee, Y. H.; 
Carbone, I.; Brown, D.; Oh, Y. Y.; Donofrio, N.; Jeong, J. S.; Soanes, D. M.; 
Djonovic, S.; Kolomiets, E.; Rehmeyer, C.; Li, W. X.; Harding, M.; Kim, S.; 
Lebrun, M. H.; Bohnert, H.; Coughlan, S.; Butler, J.; Calvo, S.; Ma, L. J.; Nicol, 
R.; Purcell, S.; Nusbaum, C.; Galagan, J. E.; Birren, B. W., The genome sequence 
of the rice blast fungus Magnaporthe grisea. Nature 2005, 434, 980-986. 
26. Pel, H. J.; de Winde, J. H.; Archer, D. B.; Dyer, P. S.; Hofmann, G.; Schaap, P. J.; 
Turner, G.; de Vries, R. P.; Albang, R.; Albermann, K.; Andersen, M. R.; 
Bendtsen, J. D.; Benen, J. A. E.; van den Berg, M.; Breestraat, S.; Caddick, M. 
X.; Contreras, R.; Cornell, M.; Coutinho, P. M.; Danchin, E. G. J.; Debets, A. J. 
M.; Dekker, P.; van Dijck, P. W. M.; van Dijk, A.; Dijkhuizen, L.; Driessen, A. J. 
M.; d'Enfert, C.; Geysens, S.; Goosen, C.; Groot, G. S. P.; de Groot, P. W. J.; 
Guillemette, T.; Henrissat, B.; Herweijer, M.; van den Hombergh, J. P. T. W.; van 




Klis, F. M.; Kools, H. J.; Kubicek, C. P.; van Kuyk, P. A.; Lauber, J.; Lu, X.; van 
der Maarel, M. J. E. C.; Meulenberg, R.; Menke, H.; Mortimer, M. A.; Nielsen, J.; 
Oliver, S. G.; Olsthoorn, M.; Pal, K.; van Peij, N. N. M. E.; Ram, A. F. J.; Rinas, 
U.; Roubos, J. A.; Sagt, C. M. J.; Schmoll, M.; Sun, J. B.; Ussery, D.; Varga, J.; 
Vervecken, W.; de Vondervoort, P. J. J. V.; Wedler, H.; Wosten, H. A. B.; Zeng, 
A. P.; van Ooyen, A. J. J.; Visser, J.; Stam, H., Genome sequencing and analysis 
of the versatile cell factory Aspergillus niger CBS 513.88. Nature Biotechnology 
2007, 25, 221-231. 
27. Machida, M.; Asai, K.; Sano, M.; Tanaka, T.; Kumagai, T.; Terai, G.; Kusumoto, 
K. I.; Arima, T.; Akita, O.; Kashiwagi, Y.; Abe, K.; Gomi, K.; Horiuchi, H.; 
Kitamoto, K.; Kobayashi, T.; Takeuchi, M.; Denning, D. W.; Galagan, J. E.; 
Nierman, W. C.; Yu, J. J.; Archer, D. B.; Bennett, J. W.; Bhatnagar, D.; 
Cleveland, T. E.; Fedorova, N. D.; Gotoh, O.; Horikawa, H.; Hosoyama, A.; 
Ichinomiya, M.; Igarashi, R.; Iwashita, K.; Juvvadi, P. R.; Kato, M.; Kato, Y.; 
Kin, T.; Kokubun, A.; Maeda, H.; Maeyama, N.; Maruyama, J.; Nagasaki, H.; 
Nakajima, T.; Oda, K.; Okada, K.; Paulsen, I.; Sakamoto, K.; Sawano, T.; 
Takahashi, M.; Takase, K.; Terabayashi, Y.; Wortman, J. R.; Yamada, O.; 
Yamagata, Y.; Anazawa, H.; Hata, Y.; Koide, Y.; Komori, T.; Koyama, Y.; 
Minetoki, T.; Suharnan, S.; Tanaka, A.; Isono, K.; Kuhara, S.; Ogasawara, N.; 
Kikuchi, H., Genome sequencing and analysis of Aspergillus oryzae. Nature 
2005, 438, 1157-1161. 
28. Udwary, D. W.; Zeigler, L.; Asolkar, R. N.; Singan, V.; Lapidus, A.; Fenical, W.; 




metabolome in the marine actinomycete Salinispora tropica. Proceedings of the 
National Academy of Sciences of the United States of America 2007, 104, 10376-
10381. 
29. Galagan, J. E.; Calvo, S. E.; Borkovich, K. A.; Selker, E. U.; Read, N. D.; Jaffe, 
D.; FitzHugh, W.; Ma, L. J.; Smirnov, S.; Purcell, S.; Rehman, B.; Elkins, T.; 
Engels, R.; Wang, S. G.; Nielsen, C. B.; Butler, J.; Endrizzi, M.; Qui, D. Y.; 
Ianakiev, P.; Pedersen, D. B.; Nelson, M. A.; Werner-Washburne, M.; 
Selitrennikoff, C. P.; Kinsey, J. A.; Braun, E. L.; Zelter, A.; Schulte, U.; Kothe, 
G. O.; Jedd, G.; Mewes, W.; Staben, C.; Marcotte, E.; Greenberg, D.; Roy, A.; 
Foley, K.; Naylor, J.; Stabge-Thomann, N.; Barrett, R.; Gnerre, S.; Kamal, M.; 
Kamvysselis, M.; Mauceli, E.; Bielke, C.; Rudd, S.; Frishman, D.; Krystofova, S.; 
Rasmussen, C.; Metzenberg, R. L.; Perkins, D. D.; Kroken, S.; Cogoni, C.; 
Macino, G.; Catcheside, D.; Li, W. X.; Pratt, R. J.; Osmani, S. A.; DeSouza, C. P. 
C.; Glass, L.; Orbach, M. J.; Berglund, J. A.; Voelker, R.; Yarden, O.; Plamann, 
M.; Seiler, S.; Dunlap, J.; Radford, A.; Aramayo, R.; Natvig, D. O.; Alex, L. A.; 
Mannhaupt, G.; Ebbole, D. J.; Freitag, M.; Paulsen, I.; Sachs, M. S.; Lander, E. 
S.; Nusbaum, C.; Birren, B., The genome sequence of the filamentous fungus 
Neurospora crassa. Nature 2003, 422, 859-868. 
30. van den Berg, M. A.; Albang, R.; Albermann, K.; Badger, J. H.; Daran, J. M.; 
Driessen, A. J. M.; Garcia-Estrada, C.; Fedorova, N. D.; Harris, D. M.; Heijne, W. 
H. M.; Joardar, V.; Kiel, J. A. K. W.; Kovalchuk, A.; Martin, J. F.; Nierman, W. 
C.; Nijland, J. G.; Pronk, J. T.; Roubos, J. A.; van der Klei, I. J.; van Peij, N. N. 




A. L., Genome sequencing and analysis of the filamentous fungus Penicillium 
chrysogenum. Nature Biotechnology 2008, 26, 1161-1168. 
31. Ikeda, H.; Ishikawa, J.; Hanamoto, A.; Shinose, M.; Kikuchi, H.; Shiba, T.; 
Sakaki, Y.; Hattori, M.; Omura, S., Complete genome sequence and comparative 
analysis of the industrial microorganism Streptomyces avermitilis. Nature 
Biotechnology 2003, 21, 526-531. 
32. Omura, S.; Ikeda, H.; Ishikawa, J.; Hanamoto, A.; Takahashi, C.; Shinose, M.; 
Takahashi, Y.; Horikawa, H.; Nakazawa, H.; Osonoe, T.; Kikuchi, H.; Shiba, T.; 
Sakaki, Y.; Hattori, M., Genome sequence of an industrial microorganism 
Streptomyces avermitilis: Deducing the ability of producing secondary 
metabolites. Proceedings of the National Academy of Sciences of the United 
States of America 2001, 98, 12215-12220. 
33. Bentley, S. D.; Chater, K. F.; Cerdeno-Tarraga, A. M.; Challis, G. L.; Thomson, 
N. R.; James, K. D.; Harris, D. E.; Quail, M. A.; Kieser, H.; Harper, D.; Bateman, 
A.; Brown, S.; Chandra, G.; Chen, C. W.; Collins, M.; Cronin, A.; Fraser, A.; 
Goble, A.; Hidalgo, J.; Hornsby, T.; Howarth, S.; Huang, C. H.; Kieser, T.; Larke, 
L.; Murphy, L.; Oliver, K.; O'Neil, S.; Rabbinowitsch, E.; Rajandream, M. A.; 
Rutherford, K.; Rutter, S.; Seeger, K.; Saunders, D.; Sharp, S.; Squares, R.; 
Squares, S.; Taylor, K.; Warren, T.; Wietzorrek, A.; Woodward, J.; Barrell, B. G.; 
Parkhill, J.; Hopwood, D. A., Complete genome sequence of the model 
actinomycete Streptomyces coelicolor A3(2). Nature 2002, 417, 141-147. 
34. Bölker, M.; Basse, C. W.; Schirawski, J., Ustilago maydis secondary metabolism-




35. Kamper, J.; Kahmann, R.; Bolker, M.; Ma, L. J.; Brefort, T.; Saville, B. J.; 
Banuett, F.; Kronstad, J. W.; Gold, S. E.; Muller, O.; Perlin, M. H.; Wosten, H. A. 
B.; de Vries, R.; Ruiz-Herrera, J.; Reynaga-Pena, C. G.; Snetselaar, K.; McCann, 
M.; Perez-Martin, J.; Feldbrugge, M.; Basse, C. W.; Steinberg, G.; Ibeas, J. I.; 
Holloman, W.; Guzman, P.; Farman, M.; Stajich, J. E.; Sentandreu, R.; Gonzalez-
Prieto, J. M.; Kennell, J. C.; Molina, L.; Schirawski, J.; Mendoza-Mendoza, A.; 
Greilinger, D.; Munch, K.; Rossel, N.; Scherer, M.; Vranes, M.; Ladendorf, O.; 
Vincon, V.; Fuchs, U.; Sandrock, B.; Meng, S.; Ho, E. C. H.; Cahill, M. J.; 
Boyce, K. J.; Klose, J.; Klosterman, S. J.; Deelstra, H. J.; Ortiz-Castellanos, L.; 
Li, W. X.; Sanchez-Alonso, P.; Schreier, P. H.; Hauser-Hahn, I.; Vaupel, M.; 
Koopmann, E.; Friedrich, G.; Voss, H.; Schluter, T.; Margolis, J.; Platt, D.; 
Swimmer, C.; Gnirke, A.; Chen, F.; Vysotskaia, V.; Mannhaupt, G.; Guldener, 
U.; Munsterkotter, M.; Haase, D.; Oesterheld, M.; Mewes, H. W.; Mauceli, E. W.; 
DeCaprio, D.; Wade, C. M.; Butler, J.; Young, S.; Jaffe, D. B.; Calvo, S.; 
Nusbaum, C.; Galagan, J.; Birren, B. W., Insights from the genome of the 
biotrophic fungal plant pathogen Ustilago maydis. Nature 2006, 444, 97-101. 
36. Steinberg, R. A., A study of some factors in the chemical stimulation of the 
growth of Aspergillus niger. American Journal of Botany 1919, 6, 357-372. 
37. Steinberg, R. A., A study of some factors in the chemical stimulation of the 
growth of Aspergillus niger. American Journal of Botany 1919, 6, 330-356. 
38. Porges, N., Chemical composition of Aspergillus niger as modified by zinc 




39. Waksman, S. A.; Horning, E. S.; Spencer, E. L., Two antagonistic fungi, 
Aspergillus fumigatus and Aspergillus clavatus, and their antibiotic substances. 
Journal of Bacteriology 1943, 45, 233-248. 
40. Ashley, J. N.; Hobbs, B. C.; Raistrick, H., Studies in the biochemistry of micro-
organisms LIII. The crystalline colouring matters of Fusarium culmorum (W. G. 
Smith) sacc. and related forms. Biochemical Journal 1937, 31, 385-397. 
41. Curtin, T.; Fitzgerald, G.; Reilly, J., Production of phoenicine on synthetic media-  
1. Penicillium phoeniceum van beyma - 2. Penicillium rubrum gras berger-stoll. 
Biochemical Journal 1940, 34, 1605-1610. 
42. Calam, C. T.; Hockenhull, D. J. D., The production of penicillin in surface 
culture, using chemically defined media. Journal of General Microbiology 1949, 
3, 19-31. 
43. Davey, V. F.; Johnson, M. J., Penicillin production in corn steep media with 
continuous carbohydrate addition. Applied Microbiology 1953, 1, 208-211. 
44. Jarvis, F. G.; Johnson, M. J., The role of the constituents of synthetic media for 
penicillin production. Journal of the American Chemical Society 1947, 69, 3010-
3017. 
45. Pirt, S. J.; Righelat.R.C., Effect of growth rate on synthesis of penicillin by 
Penicillium chrysogenum in batch and chemostat cultures. Applied Microbiology 1967, 
15, 1284. 
46. Shwartzman, G., Enhanced production of penicillin in fluid medium containing 




47. Stone, R. W.; Farrell, M. A., Synthetic media for penicillin production. Science 
1946, 104, 445-446. 
48. Bode, H. B.; Bethe, B.; Hofs, R.; Zeeck, A., Big effects from small changes: 
Possible ways to explore nature's chemical diversity. Chembiochem 2002, 3, 619-
627. 
49. Lin, Z. J.; Zhu, T. J.; Wei, H. J.; Zhang, G. J.; Wang, H.; Gu, Q. Q., Spicochalasin 
A and new aspochalasins from the marine-derived fungus Spicaria elegans. 
European Journal of Organic Chemistry 2009, 3045-3051. 
50. Christian, O. E.; Compton, J.; Christian, K. R.; Mooberry, S. L.; Valeriote, F. A.; 
Crews, P., Using jasplakinolide to turn on pathways that enable the isolation of 
new chaetoglobosins from Phomospis asparagi. Journal of Natural Products 
2005, 68, 1592-1597. 
51. Shao, H. J.; Qin, X. D.; Dong, Z. J.; Zhang, H. B.; Liu, J. K., Induced daldinin A, 
B, C with a new skeleton from cultures of the ascomycete Daidinia concentrica. 
Journal of Antibiotics 2008, 61, 115-119. 
52. Seibert, S. F.; Krick, A.; Eguereva, E.; Kehraus, S.; Konig, G. M., 
Ascospiroketals A and B, unprecedented cycloethers from the marine-derived 
fungus Ascochyta salicorniae. Organic Letters 2007, 9, 239-242. 
53. Bode, Helge B.; Walker, M.; Zeeck, A., Cladospirones B to I from 
Sphaeropsidales p. F-24′707 by variation of culture conditions. European 




54. Gloer, J. B., Applications of fungal ecology in the search for new bioactive 
natural products. In C. P. Kubicek and I. S. Druzhinina (ed.), The Mycota. 
Springer: Berlin, Germany, 2007; pp 257-283. 
55. Burgess, J. G.; Jordan, E. M.; Bregu, M.; Mearns-Spragg, A.; Boyd, K. G., 
Microbial antagonism: A neglected avenue of natural products research. Journal 
of Biotechnology 1999, 70, 27-32. 
56. Degenkolb, T.; Heinze, S.; Schlegel, B.; Strobel, G.; Grafe, U., Formation of new 
lipoaminopeptides, acremostatins A, B, and C, by co-cultivation of Acremonium 
sp. Tbp-5 and Mycogone rosea DSM 12973. Bioscience Biotechnology 
Biochemistry 2002, 66, 883-886. 
57. Slattery, M.; Rajbhandari, I.; Wesson, K., Competition-mediated antibiotic 
induction in the marine bacterium Streptomyces tenjimariensis. Microbial 
Ecology 2001, 41, 90-96. 
58. Sonnenbichler, J.; Dietrich, J.; Peipp, H., Secondary fungal metabolites and their 
biological-activities.  Investigations concerning the induction of the biosynthesis 
of toxic secondary metabolites in basidiomycetes. Biol Chem 1994, 375, 71-79. 
59. Yakovleva, E. P.; Sokolova, E. N., Dissociation of Candida tropicalis and its 
capacity for stimulation of levorin synthesis on cultivation with Actinomyces 
levoris. Antibiot Med Biotek 1978, 23, 199-203. 
60. Shin, C. S.; Kim, H. J.; Kim, M. J.; Ju, J. Y., Morphological change and enhanced 
pigment production of monascus when cocultured with Saccharomyces cerevisiae 




61. Cueto, M.; Jensen, P. R.; Kauffman, C.; Fenical, W.; Lobkovsky, E.; Clardy, J., 
Pestalone, a new antibiotic produced by a marine fungus in response to bacterial 
challenge. Journal of Natural Products 2001, 64, 1444-1446. 
62. Oh, D. C.; Kauffman, C. A.; Jensen, P. R.; Fenical, W., Induced production of 
emericellamides A and B from the marine-derived fungus Emericella sp. in 
competing co-culture. Journal of Natural Products 2007, 70, 515-520. 
63. Park, H. B.; Kwon, H. C.; Lee, C. H.; Yang, H. O., Glionitrin A, an Antibiotic-
antitumor metabolite derived from competitive interaction between abandoned 
mine microbes. Journal of Natural Products 2009, 72, 248-252. 
64. Zhu, F.; Lin, Y., Marinamide, a novel alkaloid and its methyl ester produced by 
the application of mixed fermentation technique to two mangrove endophytic 
fungi from the South China Sea. Chinese Sci Bull 2006, 51, 1426-1430. 
65. Oh, D. C.; Jensen, P. R.; Kauffman, C. A.; Fenical, W., Libertellenones A-D: 
Induction of cytotoxic diterpenoid biosynthesis by marine microbial competition. 
Bioorgan Med Chem 2005, 13, 5267-5273. 
66. Gross, F.; Luniak, N.; Perlova, O.; Gaitatzis, N.; Jenke-Kodama, H.; Gerth, K.; 
Gottschalk, D.; Dittmann, E.; Muller, R., Bacterial type III polyketide synthases: 
Phylogenetic analysis and potential for the production of novel secondary 
metabolites by heterologous expression in pseudomonads. Archives of 
Microbiology 2006, 185, 28-38. 
67. Amagata, T.; Tanaka, M.; Yamada, T.; Doi, M.; Minoura, K.; Ohishi, H.; Yamori, 




Gymnascella dankaliensis by manipulating the carbon source. Journal of Natural 
Products 2007, 70, 1731-1740. 
68. Lin, X.; Hopson, R.; Cane, D. E., Genome mining in Streptomyces coelicolor: 
Molecular cloning and characterization of a new sesquiterpene synthase. Journal 
of the American Chemical Society 2006, 128), 6022-6023. 
69. Palmu, K.; Ishida, K.; Mantsala, P.; Hertweck, C.; Metsa-Ketela, M., Artificial 
reconstruction of two cryptic anglucycline antibiotic biosynthetic pathways. 
Chembiochem 2007, 8, 1577-1584. 
70. Bok, J. W.; Keller, N. P., LaeA, a regulator of secondary metabolism in 
Aspergillus spp. Eukaryotic Cell 2004, 3, 527-535. 
71. Keller, N. P.; Turner, G.; Bennett, J. W., Fungal secondary metabolism - from 
biochemistry to genomics. Nature Reviews Microbiology 2005, 3, 937-947. 
72. Perrin, R. M.; Fedorova, N. D.; Bok, J. W.; Cramer, R. A.; Wortman, J. R.; Kim, 
H. S.; Nierman, W. C.; Keller, N. P., Transcriptional regulation of chemical 
diversity in Aspergillus fumigatus by LaeA. PLoS Pathogens 2007, 3, 508-517. 
73. Williams, R. B.; Henrikson, J. C.; Hoover, A. R.; Lee, A. E.; Cichewicz, R. H., 
Epigenetic remodeling of the fungal secondary metabolome. Organic & 
Biomolecular Chemistry 2008, 6, 1895-1897. 
74. Bergmann, S.; Schumann, J.; Scherlach, K.; Lange, C.; Brakhage, A. A.; 
Hertweck, C., Genomics-driven discovery of PKS-NRPS hybrid metabolites from 
Aspergillus nidulans. Nat. Chem. Biol. 2007, 3, 213-217. 
75. Nierman, W. C.; Pain, A.; Anderson, M. J.; Wortman, J. R.; Kim, H. S.; Arroyo, 




Chen, D.; Collins, M.; Coulsen, R.; Davies, R.; Dyer, P. S.; Farman, M.; 
Fedorova, N.; Fedorova, N.; Feldblyum, T. V.; Fischer, R.; Fosker, N.; Fraser, A.; 
Garcia, J. L.; Garcia, M. J.; Goble, A.; Goldman, G. H.; Gomi, K.; Griffith-Jones, 
S.; Gwilliam, R.; Haas, B.; Haas, H.; Harris, D.; Horiuchi, H.; Huang, J.; 
Humphray, S.; Jimenez, J.; Keller, N.; Khouri, H.; Kitamoto, K.; Kobayashi, T.; 
Konzack, S.; Kulkarni, R.; Kumagai, T.; Lafton, A.; Latge, J. P.; Li, W. X.; Lord, 
A.; Majoros, W. H.; May, G. S.; Miller, B. L.; Mohamoud, Y.; Molina, M.; 
Monod, M.; Mouyna, I.; Mulligan, S.; Murphy, L.; O'Neil, S.; Paulsen, I.; 
Penalva, M. A.; Pertea, M.; Price, C.; Pritchard, B. L.; Quail, M. A.; 
Rabbinowitsch, E.; Rawlins, N.; Rajandream, M. A.; Reichard, U.; Renauld, H.; 
Robson, G. D.; de Cordoba, S. R.; Rodriguez-Pena, J. M.; Ronning, C. M.; Rutter, 
S.; Salzberg, S. L.; Sanchez, M.; Sanchez-Ferrero, J. C.; Saunders, D.; Seeger, K.; 
Squares, R.; Squares, S.; Takeuchi, M.; Tekaia, F.; Turner, G.; de Aldana, C. R. 
V.; Weidman, J.; White, O.; Woodward, J.; Yu, J. H.; Fraser, C.; Galagan, J. E.; 
Asai, K.; Machida, M.; Hall, N.; Barrell, B.; Denning, D. W., Genomic sequence 
of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. 
Nature 2005, 438, 1151-1156. 
76. Paranagama, P. A.; Wijeratne, E. M. K.; Gunatilaka, A. A. L., Uncovering 
biosynthetic potential of plant-associated fungi: Effect of culture conditi s on 
metabolite production by Paraphaeosphaeria quadriseptata and Chaetomium 




77. Shwab, E. K.; Bok, J. W.; Tribus, M.; Galehr, J.; Graessle, S.; Keller, N. P., 
Histone deacetylase activity regulates chemical diversity in Aspergillus sp. 
Eukaryotic Cell 2007, 6, 1656-1664. 
78. Kamper, J.; Kahmann, R.; Bolker, M.; Ma, L.-J.; Brefort, T.; Saville, B. J.; 
Banuett, F.; Kronstad, J. W.; Gold, S. E.; Muller, O.; Perlin, M. H.; Wosten, H. A. 
B.; de Vries, R.; Ruiz-Herrera, J.; Reynaga-Pena, C. G.; Snetselaar, K.; McCann, 
M.; Perez-Martin, J.; Feldbrugge, M.; Basse, C. W.; Steinberg, G.; Ibeas, J. I.; 
Holloman, W.; Guzman, P.; Farman, M.; Stajich, J. E.; Sentandreu, R.; Gonzalez-
Prieto, J. M.; Kennell, J. C.; Molina, L.; Schirawski, J.; Mendoza-Mendoza, A.; 
Greilinger, D.; Munch, K.; Rossel, N.; Scherer, M.; Vranes, M.; Ladendorf, O.; 
Vincon, V.; Fuchs, U.; Sandrock, B.; Meng, S.; Ho, E. C. H.; Cahill, M. J.; 
Boyce, K. J.; Klose, J.; Klosterman, S. J.; Deelstra, H. J.; Ortiz-Castellanos, L.; 
Li, W.; Sanchez-Alonso, P.; Schreier, P. H.; Hauser-Hahn, I.; Vaupel, M.; 
Koopmann, E.; Friedrich, G.; Voss, H.; Schluter, T.; Margolis, J.; Platt, D.; 
Swimmer, C.; Gnirke, A.; Chen, F.; Vysotskaia, V.; Mannhaupt, G.; Guldener, 
U.; Munsterkotter, M.; Haase, D.; Oesterheld, M.; Mewes, H.-W.; Mauceli, E. 
W.; DeCaprio, D.; Wade, C. M.; Butler, J.; Young, S.; Jaffe, D. B.; Calvo, S.; 
Nusbaum, C.; Galagan, J.; Birren, B. W., Insights from the genome of the 
biotrophic fungal plant pathogen Ustilago maydis. Nature 2006, 444, 97-101. 
79. Bölker, M.; Basse, C. W.; Schirawski, J., Ustilago maydis secondary metabolism 





80. Galagan, J. E.; Calvo, S. E.; Borkovich, K. A.; Selker, E. U.; Read, N. D.; Jaffe, 
D.; FitzHugh, W.; Ma, L.-J.; Smirnov, S.; Purcell, S.; Rehman, B.; Elkins, T.; 
Engels, R.; Wang, S.; Nielsen, C. B.; Butler, J.; Endrizzi, M.; Qui, D.; Ianakiev, 
P.; Bell-Pedersen, D.; Nelson, M. A.; Werner-Washburne, M.; Selitrennikoff, C. 
P.; Kinsey, J. A.; Braun, E. L.; Zelter, A.; Schulte, U.; Kothe, G. O.; Jedd, G.; 
Mewes, W.; Staben, C.; Marcotte, E.; Greenberg, D.; Roy, A.; Foley, K.; Naylor, 
J.; Stange-Thomann, N.; Barrett, R.; Gnerre, S.; Kamal, M.; Kamvysselis, M.; 
Mauceli, E.; Bielke, C.; Rudd, S.; Frishman, D.; Krystofova, S.; Rasmussen, C.; 
Metzenberg, R. L.; Perkins, D. D.; Kroken, S.; Cogoni, C.; Macino, G.; 
Catcheside, D.; Li, W.; Pratt, R. J.; Osmani, S. A.; DeSouza, C. P. C.; Glass, L.; 
Orbach, M. J.; Berglund, J. A.; Voelker, R.; Yarden, O.; Plamann, M.; Seiler, S.; 
Dunlap, J.; Radford, A.; Aramayo, R.; Natvig, D. O.; Alex, L. A.; Mannhaupt, G.; 
Ebbole, D. J.; Freitag, M.; Paulsen, I.; Sachs, M. S.; Lander, E. S.; Nusbaum, C.; 
Birren, B., The genome sequence of the filamentous fungus Ne rospora crassa. 
Nature 2003, 422, 859-868. 
81. Galagan, J. E.; Calvo, S. E.; Cuomo, C.; Ma, L.-J.; Wortman, J. R.; Batzoglou, S.; 
Lee, S.-I.; Basturkmen, M.; Spevak, C. C.; Clutterbuck, J.; Kapitonov, V.; Jurka, 
J.; Scazzocchio, C.; Farman, M.; Butler, J.; Purcell, S.; Harris, S.; Braus, G. H.; 
Draht, O.; Busch, S.; D'Enfert, C.; Bouchier, C.; Goldman, G. H.; Bell-Pedersen, 
D.; Griffiths-Jones, S.; Doonan, J. H.; Yu, J.; Vienken, K.; Pain, A.; Freitag, M.; 
Selker, E. U.; Archer, D. B.; Penalva, M. A.; Oakley, B. R.; Momany, M.; 
Tanaka, T.; Kumagai, T.; Asai, K.; Machida, M.; Nierman, W. C.; Denning, D. 




M. S.; Osmani, S. A.; Birren, B. W., Sequencing of Aspergillus nidulans and 
comparative analysis with A. fumigatus and A. oryzae. Nature 2005, 438, 1105-
1115. 
82. Nierman, W. C.; Pain, A.; Anderson, M. J.; Wortman, J. R.; Kim, H. S.; Arroyo, 
J.; Berriman, M.; Abe, K.; Archer, D. B.; Bermejo, C.; Bennett, J.; Bowyer, P.; 
Chen, D.; Collins, M.; Coulsen, R.; Davies, R.; Dyer, P. S.; Farman, M.; 
Fedorova, N.; Fedorova, N.; Feldblyum, T. V.; Fischer, R.; Fosker, N.; Fraser, A.; 
Garcia, J. L.; Garcia, M. J.; Goble, A.; Goldman, G. H.; Gomi, K.; Griffith-Jones, 
S.; Gwilliam, R.; Haas, B.; Haas, H.; Harris, D.; Horiuchi, H.; Huang, J.; 
Humphray, S.; Jimenez, J.; Keller, N.; Khouri, H.; Kitamoto, K.; Kobayashi, T.; 
Konzack, S.; Kulkarni, R.; Kumagai, T.; Lafton, A.; Latge, J.-P.; Li, W.; Lord, A.; 
Lu, C.; Majoros, W. H.; May, G. S.; Miller, B. L.; Mohamoud, Y.; Molina, M.; 
Monod, M.; Mouyna, I.; Mulligan, S.; Murphy, L.; O'Neil, S.; Paulsen, I.; 
Penalva, M. A.; Pertea, M.; Price, C.; Pritchard, B. L.; Quail, M. A.; 
Rabbinowitsch, E.; Rawlins, N.; Rajandream, M.-A.; Reichard, U.; Renauld, H.; 
Robson, G. D.; de Cordoba, S. R.; Rodriguez-Pena, J. M.; Ronning, C. M.; Rutter, 
S.; Salzberg, S. L.; Sanchez, M.; Sanchez-Ferrero, J. C.; Saunders, D.; Seeger, K.; 
Squares, R.; Squares, S.; Takeuchi, M.; Tekaia, F.; Turner, G.; de Aldana, C. R. 
V.; Weidman, J.; White, O.; Woodward, J.; Yu, J.-H.; Fraser, C.; Galagan, J. E.; 
Asai, K.; Machida, M.; Hall, N.; Barrell, B.; Denning, D. W., Genomic sequence 
of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. 




83. Pel, H. J.; de Winde, J. H.; Archer, D. B.; Dyer, P. S.; Hofmann, G.; Schaap, P. J.; 
Turner, G.; de Vries, R. P.; Albang, R.; Albermann, K.; Andersen, M. R.; 
Bendtsen, J. D.; Benen, J. A. E.; van den Berg, M.; Breestraat, S.; Caddick, M. 
X.; Contreras, R.; Cornell, M.; Coutinho, P. M.; Danchin, E. G. J.; Debets, A. J. 
M.; Dekker, P.; van Dijck, P. W. M.; van Dijk, A.; Dijkhuizen, L.; Driessen, A. J. 
M.; d'Enfert, C.; Geysens, S.; Goosen, C.; Groot, G. S. P.; de Groot, P. W. J.; 
Guillemette, T.; Henrissat, B.; Herweijer, M.; van den Hombergh, J. P. T. W.; van 
den Hondel, C. A. M. J. J.; van der Heijden, R. T. J. M.; van der Kaaij, R. M.; 
Klis, F. M.; Kools, H. J.; Kubicek, C. P.; van Kuyk, P. A.; Lauber, J.; Lu, X.; van 
der Maarel, M. J. E. C.; Meulenberg, R.; Menke, H.; Mortimer, M. A.; Nielsen, J.; 
Oliver, S. G.; Olsthoorn, M.; Pal, K.; van Peij, N. N. M. E.; Ram, A. F. J.; Rinas, 
U.; Roubos, J. A.; Sagt, C. M. J.; Schmoll, M.; Sun, J.; Ussery, D.; Varga, J.; 
Vervecken, W.; van de Vondervoort, P. J. J.; Wedler, H.; Wosten, H. A. B.; Zeng, 
A.-P.; van Ooyen, A. J. J.; Visser, J.; Stam, H., Genome sequencing and analysis 
of the versatile cell factory Aspergillus niger CBS 513.88. Nature Biotechnology 
2007, 25, 221-231. 
84. Dean, R. A.; Talbot, N. J.; Ebbole, D. J.; Farman, M. L.; Mitchell, T. K.; Orbach, 
M. J.; Thon, M.; Kulkarni, R.; Xu, J.-R.; Pan, H.; Read, N. D.; Lee, Y.-H.; 
Carbone, I.; Brown, D.; Oh, Y. Y.; Donofrio, N.; Jeong, J. S.; Soanes, D. M.; 
Djonovic, S.; Kolomiets, E.; Rehmeyer, C.; Li, W.; Harding, M.; Kim, S.; Lebrun, 
M.-H.; Bohnert, H.; Coughlan, S.; Butler, J.; Calvo, S.; Ma, L.-J.; Nicol, R.; 
Purcell, S.; Nusbaum, C.; Galagan, J. E.; Birren, B. W., The genome sequence of 




85. Machida, M.; Asai, K.; Sano, M.; Tanaka, T.; Kumagai, T.; Terai, G.; Kusumoto, 
K.-I.; Arima, T.; Akita, O.; Kashiwagi, Y.; Abe, K.; Gomi, K.; Horiuchi, H.; 
Kitamoto, K.; Kobayashi, T.; Takeuchi, M.; Denning, D. W.; Galagan, J. E.; 
Nierman, W. C.; Yu, J.; Archer, D. B.; Bennett, J. W.; Bhatnagar, D.; Cleveland, 
T. E.; Fedorova, N. D.; Gotoh, O.; Horikawa, H.; Hosoyama, A.; Ichinomiya, M.; 
Igarashi, R.; Iwashita, K.; Juvvadi, P. R.; Kato, M.; Kato, Y.; Kin, T.; Kokubun, 
A.; Maeda, H.; Maeyama, N.; Maruyama, J.-i.; Nagasaki, H.; Nakajima, T.; Oda, 
K.; Okada, K.; Paulsen, I.; Sakamoto, K.; Sawano, T.; Takahashi, M.; Takase, K.; 
Terabayashi, Y.; Wortman, J. R.; Yamada, O.; Yamagata, Y.; Anazawa, H.; Hata, 
Y.; Koide, Y.; Komori, T.; Koyama, Y.; Minetoki, T.; Suharnan, S.; Tanaka, A.; 
Isono, K.; Kuhara, S.; Ogasawara, N.; Kikuchi, H., Genome sequencing and 
analysis of Aspergillus oryzae. Nature 2005, 438, 1157-1161. 
86. Henrikson, J. C.; Hoover, A. R.; Joyner, P. M.; Cichewicz, R. H., A chemical 
epigenetics approach for engineering the in situ biosynthesis of a cryptic natural 
product from Aspergillus niger. Organic & Biomolecular Chemistry 2009, 7, 435-
438. 
87. Grewal, S. I. S.; Bonaduce, M. J.; Klar, A. J. S., Histone deacetylase homologs 
regulate epigenetic inheritance of transcriptional silencing and chromosome 
segregation in fission yeast. Genetics 1998, 150, 563-576. 
88. Bernstein, B. E.; Tong, J. K.; Schreiber, S. L., Genomewide studies of histone 
deacetylase function in yeast. Proceedings of the National Academy of Sciences of 




89. Graessle, S.; Dangl, M.; Haas, H.; Mair, K.; Trojer, P.; Brandtner, E.-M.; Walton, 
J. D.; Loidl, P.; Brosch, G., Characterization of two putative histone deacetylase 
genes from Aspergillus nidulans. Biochimica et Biophysica Acta 2000, 1492, 120-
126. 
90. Peng, W.; Togawa, C.; Zhang, K.; Kurdistani, S. K., Regulators of cellular levels 
of histone acetylation in Saccharomyces cerevisiae. Genetics 2008, 179, 277-289. 
91. Tamaru, H.; Selker, E. U., A histone H3 methyltransferase controls DNA 
methylation in Neurospora crassa. Nature 2001, 414, 277-283. 
92. Trojer, P.; Brandtner, E. M.; Brosch, G.; Loidl, P.; Galehr, J.; Linzmaier, R.; 
Haas, H.; Mair, K.; Tribus, M.; Graessle, S., Histone deacetylases in fungi:Novel 
members, new facts. Nucleic Acids Research 2003, 31, 3971-3981. 
93. Van West, P.; Shepherd, S. J.; Walker, C. A.; Li, S.; Appiah, A. A.; Grenville-
Briggs, L. J.; Govers, F.; Gow, N. A. R., Internuclear gene silencing in 
Phytophthora infestans i  established through chromatin remodelling. 
Microbiology 2008, 154, 1482-1490. 
94. Brosch, G.; Loidl, P.; Graessle, S., Histone modifications and chromatin 
dynamics: a focus on filamentous fungi. FEMS Microbiology Reviews 2008, 32, 
409-439. 
95. Biel, M.; Wascholowski, V.; Giannis, A., Epigenetics - an epicenter of gene 
regulation: Histones and histone-modifying enzymes. Angewandte Chemie 
International Edition 2005, 44, 3186-3216. 
96. Cole, P. A., Chemical probes for histone-modifying enzymes. Nature Chemical 




97. Goffin, J.; Eisenhauer, E., DNA methyltransferase inhibitors - state of theart. 
Annals of Oncology 2002, 13, 1699-1716. 
98. Zhou, Y.; Cambareri, E. B.; Kinsey, J. A., DNA methylation inhibits expression 
and transposition of the Neurospora Tad retrotransposon. M lecular Genetics and 
Genomics 2001, 265, 748-754. 
99. Lee, D. W.; Freitag, M.; Selker, E. U.; Aramayo, R., A cytosine methyltransfer se 
homologue is essential for sexual development in Aspergillus nidulans. PLoS 
ONE 2008, 3, e2531. 
100. Wada, H.; Kagoshima, M.; Ito, K.; Barnes, P. J.; Adcock, I. M., 5-Azacytidine 
suppresses RNA polymerase II recruitment to the SLPI gene. Biochemical and 
Biophysical Research Communications 2005, 331, 93-99. 
101. Wozniak, R. J.; Klimecki, W. T.; Lau, S. S.; Feinstein, Y.; Futscher, B. W., 5-
Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and 
histone H3 K9 di-methylation levels are linked to tumor suppressor gene 
reactivation. Oncogene 2006, 26, 77-90. 
102. Andersen, M. R.; Nielsen, J., Current status of systems biology in aspergilli. 
Fungal Genetics and Biology 2009, 46, S180-S190. 
103. Baker, S. E., Aspergillus niger genomics: past, present and into the future. 
Medical Mycology 2006, 44, 17-21. 
104. Baker, S. E., Aspergillus niger genomics: Past, present and into the future. 




105. Semova, N.; Storms, R.; John, T.; Gaudet, P.; Ulycznyj, P.; Min, X. J.; Sun, J.; 
Butler, G.; Tsang, A., Generation, annotation, and analysis of an extensive 
Aspergillus niger EST collection. BMC Microbiol. 2006, 6. 
106. James, T. Y.; Kauff, F.; Schoch, C. L.; Matheny, P. B.; Hofstetter, V.; Cox, C. J.; 
Celio, G.; Gueidan, C.; Fraker, E.; Miadlikowska, J.; Lumbsch, H. T.; Rauhut, A.; 
Reeb, V.; Arnold, A. E.; Amtoft, A.; Stajich, J. E.; Hosaka, K.; Sung, G.-H.; 
Johnson, D.; O/'Rourke, B.; Crockett, M.; Binder, M.; Curtis, J. M.; Slot, J. C.; 
Wang, Z.; Wilson, A. W.; Schuszler, A.; Longcore, J. E.; O/'Donnell, K.; Mozley-
Standridge, S.; Porter, D.; Letcher, P. M.; Powell, M. J.; Taylor, J. W.; White, M. 
M.; Griffith, G. W.; Davies, D. R.; Humber, R. A.; Morton, J. B.; Sugiyama, J.; 
Rossman, A. Y.; Rogers, J. D.; Pfister, D. H.; Hewitt, D.; Hansen, K.; Hambleton, 
S.; Shoemaker, R. A.; Kohlmeyer, J.; Volkmann-Kohlmeyer, B.; Spotts, R. A.; 
Serdani, M.; Crous, P. W.; Hughes, K. W.; Matsuura, K.; Langer, E.; Langer, G.; 
Untereiner, W. A.; Lucking, R.; Budel, B.; Geiser, D. M.; Aptroot, A.; Diederich, 
P.; Schmitt, I.; Schultz, M.; Yahr, R.; Hibbett, D. S.; Lutzoni, F.; McLaughlin, D. 
J.; Spatafora, J. W.; Vilgalys, R., Reconstructing the early evolution of fungi 
using a six-gene phylogeny. Nature 2006, 443, 818-822. 
107. Scherlach, K.; Hertweck, C., Triggering cryptic natural product biosynthesis in 
microorganisms. Organic & Biomolecular Chemistry 2009, 7, 1753-1760. 
108. Gross, H., Strategies to unravel the function of orphan biosynthesis pathways:  
recent examples and future prospects. Applied Microbiology and Biotechnology 




109. Henrikson, J. C.; Hoover, A. R.; Joyner, P. M.; Cichewicz, R. H., A chemical 
epigenetics approach for engineering the in situ biosynthesis of a cryptic natural 
product from Aspergillus niger. Organic & Biomolecular Chemistry 2009, 7, 435-
438. 
110. Williams, R. B.; Henrikson, J. C.; Hoover, A. R.; Lee, A. E.; Cichewicz, R. H., 
Epigenetic remodeling of the fungal secondary metabolome. Organic & 
Biomolecular Chemistry 2008, 6, 1895-1897. 
111. Bok, J. W.; Noordermeer, D.; Kale, S. P.; Keller, N. P., Secondary metabolic gene 
cluster silencing in Aspergillus nidulans. Molecular Microbiology 2006, 61, 1636-
1645. 
112. Katan-Khaykovich, Y.; Struhl, K., Heterochromatin formation involves changes 
in histone modifications over multiple cell generations. The EMBO Journal 2005, 
24, 2138-2149. 
113. Lam, K. S., New aspects of natural products in drug discovery. Trends in 
Microbiology 2007, 15, 279-289. 
114. Koehn, F. E.; Carter, G. T., The evolving role of natural products in drug 
discovery. Nature Reviews Drug Discovery 2005, 4, 206-220. 
115. Paterson, I.; Anderson, E. A., The renaissance of natural products as drug 
candidates. Science 2005, 310, 451-453. 
116. Baker, D. D.; Chu, M.; Oza, U.; Rajgarhia, V., The value of natural products to 




117. Nielsen, K. F.; Mogensen, J. M.; Johansen, M.; Larsen, T. O.; Frisvad, J. C., 
Review of secondary metabolites and mycotoxins from the Aspergillus niger 
group. Analytical and Bioanalytical Chemistry 2009, 395, 1225-1242. 
118. Clark, B.; Capon, R. J.; Lacey, E.; Tennant, S.; Gill, J. H., Quinolactacins 
revisited: From lactams to imide and beyond. Organic & Biomolecular Chemistry 
2006, 4, 1512-1519. 
119. Fukuda, T.; Hasegawa, Y.; Hagimori, K.; Yamaguchi, Y.; Masuma, R.; Tomoda, 
H.; Omura, S., Tensidols, new potentiators of antifungal miconazole activity, 
produced by Aspergillus niger FKI-2342. Journal of Antibiotics 2006, 59, 480-
485. 
120. Zhang, Y. P.; Zhu, T. J.; Fang, Y. C.; Liu, H. B.; Gu, Q. Q.; Zhu, W. M., 
Carbonarones A and B, new bioactive gamma-pyrone and alpha-pyridone 
derivatives from the marine-derived fungus A pergillus carbonarius. Journal of 
Antibiotics 2007, 60, 153-157. 
121. Takagi, M.; Motohashi, K.; Hwang, J.-H.; Nagai, A.; Shin-ya, K., New tensidols, 
JBIR-86 and JBIR-87, isolated from Aspergillus sp. fJ80. Journal of Antibiotics 
2010, 63, 371-373. 
122. Ye, Y. H.; Zhu, H. L.; Song, Y. C.; Liu, J. Y.; Tan, R. X., Structural revision of 
aspernigrin A, reisolated from Cladosporium herbarum IFB-E002. Journal of 
Natural Products 2005, 68, 1106-1108. 
123. Ding, G.; Jiang, L. H.; Guo, L. D.; Chen, X. L.; Zhang, H.; Che, Y. S., 
Pestalazines and pestalamides, bioactive metabolites from the plant pathogenic 




124. The chemical shift published for the 13C-NMR of pestalamide B was found to be 
incorrectly listed in Ding et. al.'s article.  A revision of this data, with corrected 
chemical shifts, is published in a table found in the supplemental materials. 
125. Hiort, J.; Maksimenka, K.; Reichert, M.; PeroviÄ‡-Ottstadt, S.; Lin, W. H.; Wray, 
V.; Steube, K.; Schaumann, K.; Weber, H.; Proksch, P.; Ebel, R.; Mäller, W. E. 
G.; Bringmann, G., New natural products from the sponge-derived fungus 
Aspergillus niger. Journal of Natural Products 2004, 67, 1532-1543. 
126. Rychnovsky, S., 2006-2007 ACS Division of Organic Chemistry Graduate 
Fellowship Awards. Org Lett 2006, 8, 5679-5683. 
127. White, K. N.; Amagata, T.; Oliver, A. G.; Tenney, K.; Wenzel, P. J.; Crews, P., 
Structure revision of spiroleucettadine, a sponge alkaloid with a bicyclic ore 
meager in H-atoms. Journal of Organic Chemistry 2008, 73, 8719-8722. 
128. Wipf, P.; Kerekes, A. D., Structure reassignment of the fungal metabolite 
TAEMC161 as the phytotoxin viridiol. Journal of Natural Products 2003, 66, 
716-718. 
129. McCombie, S. W.; Metz, W. A.; Nazareno, D.; Shankar, B. B.; Tagat, J., 
Generation and in situ acylation of enaminone anions: a convenient synthesis of 
3-carbethoxy-4(1H)-pyridinones and -4-pyrones and related compounds. The 
Journal of Organic Chemistry 1991, 56, 4963-4967. 
130. Zhang, L. X.; Yan, K. Z.; Zhang, Y.; Huang, R.; Bian, J.; Zheng, C. S.; Sun, H. 
X.; Chen, Z. H.; Sun, N.; An, R.; Min, F. G.; Zhao, W. B.; Zhuo, Y.; You, J. L.; 
Song, Y. J.; Yu, Z. Y.; Liu, Z. H.; Yang, K. Q.; Gao, H.; Dai, H. Q.; Zhang, X. L.; 




Kuai, J.; Zhou, G. C.; Chen, X. P., High-throughput synergy screening identifies 
microbial metabolites as combination agents for the treatment of fungal 
infections. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 4606-4611. 
131. Yamazaki, H.; Omura, S.; Tomoda, H., 6 '-Hydroxy-3 '-methoxy-mitorubrin, a 
new potentiator of antifungal miconazole activity, produced by Penicillium 
radicum FKI-3765-2. Chem. Pharm. Bull. 58, 829-832. 
132. Varga, J.; Kocsube, S.; Toth, B.; Frisvad, J. C.; Perrone, G.; Susca, A.; Meijer, 
M.; Samson, R. A., Aspergillus brasiliensis p nov., a biseriate black Aspergillus 
sp. with world-wide distribution. Int. J. Syst. Evol. Microbiol. 2007, 57, 1925-
1932. 
133. Sorensen, L. M.; Lametsch, R.; Andersen, M. R.; Nielsen, P. V.; Frisvad, J. C., 
Proteome analysis of Aspergillus niger: Lactate added in starch-containing 
medium can increase production of the mycotoxin fumonisin B-2 by modifying 
acetyl-CoA metabolism. BMC Microbiol. 2009, 9, 20. 
134. Iwatsuki, M.; Uchida, R.; Yoshijima, H.; Ui, H.; Shiomi, K.; Matsumoto, A.; 
Takahashi, Y.; Abe, A.; Tomoda, H.; Omura, S., Guadinomines, Type III 
secretion system inhibitors, produced by Streptomyces sp K01-0509. Journal of 
Antibiotics 2008, 61, 222-229. 
135. Hasegawa, Y.; Fukuda, T.; Hagimori, K.; Tomoda, H.; Omura, S., Tensyuic acids, 
new antibiotics produced by Aspergillus niger FKI-2342. Chem. Pharm. Bull. 




136. Fukuda, T.; Hasegawa, Y.; Sakabe, Y.; Tomoda, H.; Omura, S., Citrinamides, 
new potentiators of antifungal miconazole activity, produced by Penicillium sp, 
FKI-1938. Journal of Antibiotics 2008, 61 (9), 550-555. 
137. Bowers, A. A.; Walsh, C. T.; Acker, M. G., Genetic interception and structural 
characterization of thiopeptide cyclization precursors from Bacillus cereus. 
Journal of the American Chemical Society 2010, 132, 12182-12184. 
138. Compound 13 was generated in order to ensure the literature method would 
produce one of the previously synthesized compounds.  This compounds was then 
submitted to the bioassays along with other compound discussed in this paper. 
139. Hiort, J.; Maksimenka, K.; Reichert, M.; Perovic-Ottstadt, S.; Lin, W. H.; Wray, 
V.; Steube, K.; Schaumann, K.; Weber, H.; Proksch, P.; Ebel, R.; Muller, W. E. 
G.; Bringmann, G., New natural products from the sponge-derived fungus 
Aspergillus niger. (vol 67, pg 1532, 2004). Journal of Natural Products 2005, 68, 
1821-1821. 
140. Henrikson, J. C.; Gharfeh, M. S.; Easton, A. C.; Easton, J. D.; Glenn, K. L.; 
Shadfan, M.; Mooberry, S. L.; Hambright, K. D.; Cichewicz, R. H., Reassessing 
the ichthyotoxin profile of cultured Prymnesium parvum (golden algae) and 
comparing it to samples collected from recent freshwater bloom and fish kill 
events in North America. Toxicon 2010, 55, 1396-1404. 
141. Andersen, R. A., Biology and systematics of heterokont and haptophyte algae. 




142. Edvardsen, B.; Imai, I., The ecology of harmful flagellates within 
prymnesiophyceae and raphidophyceae. In Ecology of Harmful Algae, Graneli, 
E.; Turner, J. T., Eds. Springer-Verlag: New York, 2006; pp 67-79. 
143. Guo, M. X.; Harrison, P. J.; Taylor, F. J. R., Fish kills related to Prymnesium 
parvum N Carter (Haptophyta) in the People's Republic of China. Journal of 
Applied Phycology 1996, 8, 111-117. 
144. Kaartvedt, S.; Johnsen, T. M.; Asksnes, D. L.; Lie, U.; Svendsen, H., Occurrence 
of the toxic phytoflagellate Prymnesium parvum and associated fish mortality in a 
Norwegian fjord system. Can. J. Fish. Aquat. Sci. 1991, 48, 2316-2323. 
145. Reich, K.; Aschner, M., Mass development and control of the phytoflagellate 
Prymnesium parvum in fish ponds in Palestine. Pales. J. Bot. 1947, 4, 14-23. 
146. Sabour, B.; Loudiki, M.; Oudra, B.; Oubraim, S.; Fawzi, B.; Fadlaoui, S.; 
Chlaida, M., First report on the occurrence of ichthyotoxic yellow tides of 
Prymnesium parvum Carter (Haptophyceae) in Oued Mellah hypertrophic lake 
(Morocco). Revue des science de l'Eau (J. Water Sci.) 2002, 15, 327-342. 
147. Lopez, C. B.; Jewett, E. B.; Dortch, Q.; Walton, B. T.; Hudnell, H. K., Scientific 
assessment of freshwater harmful algal blooms. Interagency working group on 
harmful algal blooms. In Hypoxia/Human Health of the Joint Subcommittee on 
Ocean Science and Technology, Ed. Washington, D.C., 2008. 
148. Sager, D.; Fries, L.; Singhurst, L.; Southard, G., Guidelines for golden alga 
Prymnesium parvum anagement options for ponds and small reserviors (public 
waters) in Texas. Inland Fishers, Texas Parks and Wildlife Department - PWD RP 




149. Baker, J. W.; Grover, J. P.; Ramachandrannair, R.; Black, C.; Valenti, T. W.; 
Brooks, B. W.; Roelke, D. L., Growth at the edge of the niche: An experimental 
study of the harmful alga Prymnesium parvum. Limnology and Oceanography 
2009, 54, 1679-1687. 
150. Aguiar, R.; Kugens, P., New and rare chrysophytes from Wyoming and Colorado 
lakes. J. Phycology 2000, 26, 1-2. 
151. Hargraves, P. E.; Maranda, L., Potentially toxic or harmful microalgae from the 
northeast coast. Northeastern Naturalist 2002, 9, 81-120. 
152. Kim, Y. S.; Padilla, G. M., Hemolytically active components from P. parvum and 
G. breve toxins. Life Sciences 1977, 21, 1287-1292. 
153. Mariussen, E.; Nelson, G. N.; Fonnum, F., A toxic extract of the marine 
phytoflagellate Prymnesium parvum induces calcium-dependent release of 
glutamate from rat brain synaptosomes. Journal of Toxicology and Environmental 
Health-Part A-Current Issues 2005, 68, 67-79. 
154. Ulitzur, S., Amphiphatic nature of Prymnesium parvum hemolysin. Biochimica Et 
Biophysica Acta 1973, 298, 673-679. 
155. Ulitzur, S.; Shilo, M., Mode of action of Prymnesium parvum ichthyotoxin. 
Journal of Protozoology 1966, 13, 332-336. 
156. Ulitzur, S.; Shilo, M., Procedure for purification and separation of Prymnesium 
parvum toxins. Biochimica Et Biophysica Acta 1970, 201, 350-363. 
157. Wright, J. L. C.; Tomas, C.; Satake, M.; Alam, N.; Schuster, T., Structures of 




fish ponds in North Carolina. In 3rd Symposium on Harmful Algae in the US., 
Pacific Grove, CA, 2005. 
158. Yariv, J.; Hestrin, S., Toxicity of extracellular phase of Prymnesium parvum 
cultures. Journal of General Microbiology 1961, 24, 165-175. 
159. Watson, S., Texas Parks and Wildlife Department - Literature review of the
microalga Prymnesium parvum and its associated toxicity. Texas Parks and 
Wildlife Department (http://www.tpwd.state.tx.us/landwater/water/ 
environconcners/hab/ga/literature/index.phtml accessed October 18, 2001. 
160. Kozakai, H.; Oshima, Y.; Yasumoto, T., Isolation and structural elucidation of 
hemolysin from the phytoflagellate Prymnesium parvum. Agricultural and 
Biological Chemistry 1982, 46, 233-236. 
161. Igarashi, T.; Satake, M.; Yasumoto, T., Prymnesin-2: A potent ichthyotoxic and 
hemolytic glycoside isolated from the red tide alga Prymnesium parvum. Journal 
of the American Chemical Society 1996, 118, 479-480. 
162. Igarashi, T.; Satake, M.; Yasumoto, T., Structures and partial stereochemical 
assignments for prymnesin-1 and prymnesin-2: Potent hemolytic and ichthyotoxic 
glycosides isolated from the red tide alga Prymnesium parvum. Journal of the 
American Chemical Society 1999, 121, 8499-8511. 
163. Igarashi, T.; Aritake, S.; Yasumoto, T., Biological activities of prymnesin-2 
isolated from a red tide alga Prymnesium parvum. Nat. Toxins 1998, 6, 35-41. 
164. Marshall, J. A.; Nichlols, P. D.; Hamilton, B.; Lewis, R. J.; Hallegraeff, G. M., 




(Acanthochromis polycanthus): The synergisitic role of reactive oxygen species 
and free fatty acids. Harmful Algae. 2003, 2, 273-281. 
165. Fu, M.; Koulman, A.; van Rijssel, M.; Lutzen, A.; de Boer, M. K.; Tyl, M. R.; 
Liebezeit, G., Chemical characterisation of three haemolytic compounds from the 
microalgal species Fibrocapsa japonica (Raphidophyceae). Toxicon 2004, 43, 
355-363. 
166. Hiraga, Y.; Kaku, K.; Omoda, D.; Sugihara, K.; Hosoya, H.; Hino, M., A new 
digalactosyl diacylglycerol from a cultured marine dinoflagellate Heterocapsa 
circularisquama. Journal of Natural Products 2002, 65, 1494-1496. 
167. Kobayashi, M.; Hayashi, K.; Kawazoe, K.; Kitagawa, I., Marine natural-products 
heterosigma-glycolipid-I, heterosigma-glycolipid-II, heterosigma-glycolipid-III, 
and heterosigma-glycolipid-IV, 4 diacylglyceroglycolipids possessing omega-3-
polyunsaturated fatty-acid residues, from the raphidophycean dinoflagellate 
Heterosigma akashiwo. Chemical & Pharmaceutical Bulletin 1992, 40, 1404-
1410. 
168. Stabell, O. B.; Pedersen, K.; Aune, T., Detection and separation of toxins 
accumulated by mussels during the 1988 bloom of Chrysochromulina polylepis in 
Norwegian coastal waters. Marine Environmental Research 1993, 36, 185-196. 
169. Hiraga, Y.; Shikano, T.; Widianti, T.; Ohkata, K., Three new glycolipids with 
cytolytic activity from cultured marine dinoflagellate Heterocapsa 
circularisquama. Natural Product Research 2008, 22, 649-657. 
170. Fossat, B.; Porthe-Nibelle, J.; Sola, P.; Masoni, A.; Gentien, P.; Bodennec, G., 




pH and KC uptake in isolated trout hepatocytes. Journal of Applied Toxicology 
1999, 19, 275-278. 
171. Mudryk, Z. J.; Skorczewski, P., Enzymatic activity and degradation of organic 
macromolecules by neustonic and planktonic bacteria in an estuarine lake. Polish 
Journal of Ecology 2006, 54, 3-14. 
172. Shilo, M., Toxins of Chrysophyceae. In Microbial Toxins, vol. VII., Kadis, S.; 
Ciegler, A.; Ajl, S. J., Eds. Academic Press: New York, 1971; pp 67-102. 
173. Schauenstein, E., Autoxidation of polyunsaturated esters in water - chemical 
structure and biological activity of products. Journal of Lipid Research 1967, 8, 
417-428. 
174. Vanrollins, M.; Murphy, R. C., Autooxidation of docosahexaenoic acid - analysis 
of 10 isomers of hydroxydocosahexaenoate. Journal of Lipid Research 1984, 25, 
507-517. 
175. TPWD, Golden Algae in Texas (document GI-378, 9/07). (Texas Parks and 
Wildlife Department), accessed October 1, 2009. 
176. AGFD, Golden Alga Frequently Asked Questions, http://www.azgfd.gov/ 
temp/golden_alga_faqs.shtml#2, Arizona Game and Fish Department accessed 
October 1, 2009. 
177. Valenti, T. W.; James, S. V.; Lahousse, M. J.; Schug, K. A.; Roelke, D. L.; 
Grover, J. P.; Brooks, B. W., A mechanistic explanation for pH-dependent 





178. Moeller, P. D. R.; Beauchesne, K. R.; Huncik, K. M.; Davis, W. C.; Christopher, 
S. J.; Riggs-Gelasco, P.; Gelasco, A. K., Metal complexes and free radical tox ns 
produced by Pfiesteria piscicida. Environmental Science & Technology 2007, 41, 
1166-1172. 
179. Kilham, S. S.; Kreeger, D. A.; Lynn, S. G.; Goulden, C. E.; Herrera, L., COMBO: 
a defined freshwater culture medium for algae and zooplankton. Hydrobiologia 
1998, 377, 147-159. 
180. Oshima, Y.; Yamada, S.-h.; Matsunaga, K.; Moriya, T.; Ohizumi, Y., A 
monogalactosyl diacylglycerol from a cultured marine dinoflagellate, Scrippsidla 
trochoidea. Journal of Natural Products 1994, 57, 534-536. 
181. Lepage, G.; Roy, C. C., Direct transesterification of all classes of lipids in a one-
step reaction. Journal of Lipid Research 1986, 27, 114-120. 
182. U.S.E.P.A., EPA-821-R-02-012 - Methods for Measuring the ACute Toxicity of 
Effluents and Receiving Waters to Freswater and marine Organisms, 5th edition. 
Agency, U.S. Environmental Protection Agency. Washington D.C., 2002. 
183. Mooberry, S. L.; Weiderhold, K. N.; Dakshanamurthy, S.; Hamel, E.; Banner, E. 
J.; Kharlamova, A.; Hempel, J.; Gupton, J. T.; Brown, M. L., Identification and 
characterization of a new tubulin-binding tetrasubstituted brominated pyrrole. 
Molecular Pharmacology 2007, 72, 132-140. 
184. Tinley, T. L.; Randall-Hlubek, D. A.; Leal, R. M.; Jackson, E. M.; Cessac, J. W.; 
Quada, J. C.; Hemscheidt, T. K.; Mooberry, S. L., Taccalonolides E and A: Plant-






Appendix Table of Contents 
Table A1  Screening of epigenetic modifiers 121 
Figure A1  Real time qRT PCR determination of the fold changes in expression 
 of PKS, NRPS, and HPN gene clusters in A. niger ATCC 1015 122  
Synthesis of p-fluoro SAHA 123 
Table A2  Results from LC-ESI-MS analysis from 12 different species  
of aspergilli 124 
Table A3  GIAO based calculations of 13C-NMR chemical shifts for 48 and 41 125 
Table A4 1H- and 13C-NMR data tables for various γ-pyrones and γ-pyridinones  
from natural and synthetic sources 126 
Figure A2  Antibacterial activity of 44 130 
Figure A3  Antifungal activity of 44 130 
Figure A4  Antibacterial activity of 37 131 
Figure A5  Antifungal activity of 37 131 
Figure A6  Antibacterial activity of 49 132 
Figure A7  Antifungal activity of 49 132  
Figure A8  Antibacterial activity of 48 133 
Figure A9  Antifungal activity of 48 133 
Figure A10  Antibacterial activity of 50 134 
Figure A11  Antifungal activity of 50 134 
Figure A12  Antifungal activity of 51 135 
Figure A13  Antifungal activity of 52 135 





Figure A15  Effects of compounds 50, 51, and 52 on K. pneumonia 136 
Figure A16  Representative GC-EIMS trace showing the lipid profile obtained   
from a 20 day old P. parvum culture 137 
Figure A17  Representative GC-EIMS trace showing the lipid profile obtained  
from water collect at a large P. parvum bloom event in Lake Texoma, Lebanon  
Pool (Oklahoma, USA, Feb. 2009) 138 
Figure A18  Representative GC-EIMS trace showing the lipid profile obtained  
from water collect at a large P. parvum fish kill event in the Dunkard Creek 
drainage, Wana Bridge (Pennsylvania, USA, Oct. 2009) 139 
Figure A19 Representative GC-EIMS trace showing the lipid profile obtained  
from water collect near, but not part of a large P. parvum fish kill (control) in the 
Dunkard Creek drainage, Upper Beaver Dam (Pennsylvania, USA, Oct. 2009) 140 
 
Table A5  NMR data used for the structure determination of compounds 63,  
64, and 65 141 
 
Lunalide A NMR spectra 142 
Lunalide B NMR spectra 146 
Suberoylanilide hydroxamic acid (SAHA) NMR spectra 154 
Nygerone A NMR spectra 155 
Nygerone B NMR spectra 160 
Methyl succinate NMR spectra 163 
Nygerone C NMR spectra 164 
Pestalamide A/Tensidol B NMR spectra 167 
 
Pestalamide B NMR spectra 170 
 
Carbonarone A NMR spectra 175 
 
Compound 48 NMR spectra 178 
 
Compound 50 NMR spectra 182 
 





Compound 52 NMR spectra 188 
 
GAT 512A NMR spectra 192 
 
GAT 768A NMR spectra 202 
 





























































































Figure A1  Real-time qRT PCR determination of the fold changes in expression of PKS, NRPS, and HPN 
gene clusters in A. niger ATCC 1015.  All data are presented relative to the expression of actin.  PKSs 12 
and 38 are not included since no transcripts were dt cted for these gene clusters.  RQ values were 
determined using the using the 2-∆∆CT method.  Fold changes of <1 were expressed as their corresponding 





Synthesis of p-fluoro-SAHA.  The preparation of the fluorine containing SAHA 
derivative was accomplished by coupling the commercially available suberic acid 
monomethyl ester with p-fluoroanaline under standard conditions utilizing 
hydroxybenzotriazole (HOBt) and dicyclohexylcarbodiimide (DCC) in DMF.  This 
reaction was quenched by diluting the reaction mixture with water (1:20 DMF:water) 
after allowing the reaction to progress for 3 hours at room temperature.  The resulting 
precipitate was purified via flash silica gel chromatography utilizing a hexane, ethyl 
acetate gradient, providing the suber-p-fluoroanilic acid methyl ester in 82% yield.  The 
oxime moiety was introduced via the treatment of the suber-p-fluoroanilic acid methyl 
ester with hydroxylamine hydrochloride in methanol and an excess of potassium 
hydroxide at 50o C.  This mixture was allowed to react for 12 hours before the reaction 
mixture was diluted with water and neutralized with acetic acid.  The resulting precipitate 
was filtered, washed with water, and dried affording the p-fluoro-SAHA derivative in 
61% overall yield.  Analysis of the product with NMR revealed that the product was 
obtained in high chemical purity without need for further purification. 
 
 







Table A2  Results from LC-ESI-MS analysis from 12 different species of aspergilli, — indicates that the presence of the compounds was not at levels detectable 
by ESI-MS.  + indicates that the presence of the compound at detectable levels by ESI-MS. 
Organism Treatment Tensidol A/ Carbonarone A 
Tensidol B/ 
Pestalamide A Aspernigrin A Pestalamide B Nygerone A Nygerone B 
A.aculeatus ATCC 5094 Control — — — + — — 
 5-Aza — — — + — — 
 SAHA — + — + — — 
A. japonicas ATCC 2053 Control — — — + — — 
 5-Aza — — — — — — 
 SAHA — — — + — — 
A.brasiliensis ATCC 35542 Control — + — + — — 
 5-Aza — — — + — — 
 SAHA — — — + — — 
A.carbonarius ATCC 346 Control — — — + — — 
 5-Aza — — — + — — 
 SAHA + + — + — — 
A.ibericus ATCC 35644 Control — — — + — — 
 5-Aza — — — + — — 
 SAHA — — — + — — 
A.tubingensis ATCC 4875 Control — + — + — — 
 5-Aza — + — + — — 
 SAHA — + — + — — 
A. carbonarius ATCC 369 Control — — + + — — 
 5-Aza — — + + — — 
 SAHA — — — — — — 
A.parasiticus ATCC 465 Control + — + + — — 
 5-Aza + — + + — — 
 SAHA + — + + — — 
A.ellipticus ATCC 5120 Control — — — + — — 
 5-Aza + — — + — — 
 SAHA — — — — — — 
A.niger ATCC 1956 Control — — — — — — 
 5-Aza — — — — — — 
 SAHA — — — + — — 
A.niger ATCC 326 Control + + — + — — 
 5-Aza + + — + — — 
 SAHA — — — — — — 
A. niger ATCC 1015* Control — + — + — — 
 5-Aza — + — + — — 









Table A3  GIAO based Calculations of 13C-NMR chemical shifts for 48 and 41 compared to the reported 13C-NMR chemical shifts 











|δC Calc -   δC 
Exp| Position 
2 155.92 161.70 5.78  115.24 161.70 46.46 
3 161.65 163.90 2.25  143.94 163.90 19.96 
3a 126.39 119.80 6.59  92.79 119.80 27.01 
4 167.86 175.00 7.14  133.87 175.00 41.13 
5 115.63 117.30 1.67  96.74 117.30 20.56 
6a 164.94 167.60 2.66  141.80 167.60 25.80 
7 44.24 40.00 4.24  50.25 40.00 10.25 
8 133.12 134.10 0.98  137.00 134.10 2.90 
9 124.81 129.40 4.59  123.30 129.40 6.10 
10 125.46 129.30 3.84  124.07 129.30 5.23 
11 124.52 128.00 3.48  123.23 128.00 4.77 
12 124.77 129.30 4.53  125.68 129.30 3.62 
13 127.15 129.40 2.25  123.31 129.40 6.09 
OMe 55.50 52.80 2.70  56.21 52.80 3.41 













Table A4 1H- and 13C-NMR data tables for various γ-pyrones and γ-pyridinones from natural and synthetic sources 
 Carbonarone A (52)/ 
Tensidol A (46) 
Pestalamide A (50)/ 




Proposed Compound 61 
Positiona δH
 (J in Hz) δC, mult. δH
 (J in Hz) δC, mult. δH
 (J in Hz) δC, mult. δH
 (J in Hz) δC, mult. 
2 (2) 8.73, s 162.0 8.88, s 164.4 8.45, s 161.8 8.80, s 165.3 
3 (3a)  119.3  119.2  119.7  119.5 
4 (4)  178.1  178.8  175.2  179.7 
5 (5) 6.25, s 116.0 6.44, s 116.5 6.22, s 117.2 6.38, s 116.5 
6 (6a)  168.8  170.7  167.7  171.9 
7 (7) 3.90, s 39.6 4.06, s 39.6 3.84, s 39.8 4.06, s 40.0 
8 (8)  133.7  135.8  134.0  135.9 
9,13 (9,13) 7.29, m 129.1 7.38, m 129.7 7.34, m 129.4 7.34, m 130.3 
10,12 (10,12) 7.25, m 129.1 7.25, m 130.1 7.23, m 129.3 7.36, m 130.0 
11 (11) 7.29, m 127.8 7.29, m 128.3 7.34, m 128.0 7.32, m 128.7 
14 (3)  164.0  162.1  163.9  162.7 
16 (1́ )    173.7    174.4 
17 (2́ )   2.96, m 
3.29, dd (8.0, 18.0) 
42.5   2.90, dd (4.8, 17.9) 
3.16, dd (8.4, 17.9) 
42.6 
18 (3́ )   2.90, m 39.4   2.98, m 36.3 
19 (4́ )    178.1    177.8 
20 (5́ )   1.24, d (7.0) 17.4   1.22, d (7.2) 17.4 
NH-15 
(3-OH) 
  11.74, br s    11.72  
14-NH2  
(3-OH, 4-OH) 
5.94, br s 
9.07, br s 
       
14-OCH3 
(3-OCH3) 
    3.88, s 52.83   
4´-OCH3       3.66, s 52.4 











Table A4 Continued 
 Pestalamide Ba Nygerone A (51) Nygerone B (53) Nygerone C (57) 
Position δH
 (J in Hz) δC, mult. δH
 (J in Hz) δC, mult. δH
 (J in Hz) δC, mult. δH
 (J in Hz) δC, mult. 
2 8.52, s 145.3 8.43, s 148.2 8.42, s 146.9 8.49, s 146.9 
3  117.5  117.2  118.1  117.7 
4  178.0  177.6  177.8  177.7 
5 6.36, s 120.2 6.55, s 122.3 6.48, s 121.8 6.61, s 121.9 
6  154.2  152.0  150.9  151.3 
7 4.06, s 39.6 3.67, s 39.4 3.66, s 39.2 3.71, s 39.4 
8  137.2  134.8  134.7  134.8 
9,13 7.34, m 130.2 6.77, m 128.9 6.80, m 128.7 6.83, m 128.5 
10,12 7.37, m 130.2 7.18, m 129.0 7.17, m 128.7 7.21, m 128.9 
11  7.20, m 128.7 7.18, m 127.7 7.18, m 127.5 7.23, m 127.7 
14   164.8  163.2  166.0  166.0 
16     173.2     
17  2.96 dd (5.0, 18.0) 
3.29 dd (8.0, 18.0) 
 2.86, dd (5.1, 17.2) 
3.20, dd (8.2, 17.2) 
42.0     
18  2.90 ddd (5.0, 7.0, 8.0) 43.0 3.05, m 35.1     
19   175.0  178.9     
20  1.12, d (7.0) 17.8 1.27, d (7.0) 17.2     
1´    140.4  140.4  162.0 
2´/6´   7.06, t (7.6) 127.0 7.05, d (7.6) 126.9 7.05 128.9 
3´/5´   7.42, t (7.6) 130.2 7.40, d (7.6) 129.7 7.10 116.9 
4´   7.49, t (7.6) 130.5 7.47, d (7.6) 130.0  164.1 
NH-15   12.83, br s      
14-NH2     5.70, br s 
9.90, br s 
 6.06, br s 
9.89, br s 
 
4´-F       -112.6b  
a 13C-NMR Published values for Pestalamide B were incorrectly published, these have been corrected based on the isolation of this compound during the A. niger work discussed in 
Chapter 5. 












Table A4 Continued 
 Compound 59 Compound 60 
Position δH
 (J in Hz) δC, mult. δH
 (J in Hz) δC, mult. 
2 8.82, s 166.0 9.88, s 193.9 
3  118.3  100.6 
4  175.6  178.5 
5 6.94, s 112.4 7.95, s 97.6 
6  164.1  167.1 
7  129.6  130.4 
8,12 7.89, m  126.2 8.04, m 126.7 
9,11 7.53, m 130.8 7.60, m 129.2 
10 7.55, m  130.8 7.66, m 132.8 
13   163.0  161.7 
























Antibacterial Activity of Tensidol B/
Pestalamide A (44)






























Antifungal Activity of Tensidol B/
Pestalamide A (44)



























Figure A2  Antibacterial activity of 44 














Antibacterial Activity of Nygerone A






























Antifungal Activity of Nygerone A



























Figure A4  Antibacterial activity of 37 














Antibacterial Activity of Nygerone C




























Antifungal Activity of Nygerone C


























Figure A6  Antibacterial activity of 49 














Antibacterial Activity of Compound 48






























Antifungal Acitivity of Compound 48


























Figure A8  Antibacterial activity of 48 





     
  







Antibacterial Activity of Compound 50





























Antifungal Activity of Compound 50


























Figure A10  Antibacterial activity of 50 






                
 





Antifungal Activity of Compound 51



























Antifungal Activity of Compound 52
























Figure A12  Antifungal activity of 51 





             
                       
 













































































































































































































































































Figure A14  Effects of compounds 50, 51, and 52 on C. alibicans 


















Figure A17 Representative GC-EIMS trace showing the lipid profile obtained from water collect at a large 












Figure A18  Representative GC-EIMS trace showing the lipid profile obtained from water collect at a large 











Figure A19 Representative GC
not part of a large P. parvum fish kill (control) in the Dunkard Creek drainage, Upper Beaver Dam 

















Table A10  NMR data used for the structure determination of comp unds 63, 64, and 65.  Data were obtained at 500 MHz and 125 MHz for 1H and 13 NMR, 
respectively.  Samples were prepared in methanol-d4. 
 Compound 63  Compound 65  Compound 64 
Position δC δH HMBC  δC δH HMBC  δC δH HMBC 
1 66.7 
4.15 bd (4.5, 
5.9) 
2, 3, 1'  61.0 
4.20 dd (6.9, 
12.1) 
4.44 dd (3.1, 
12.0) 
2, 3, 1'  63.0 
4.24 dd (6.7, 
12.0) 
4.44 dd (3.0, 
12.1) 
2, 3, 1' 
2 68.8 3.99 m 1  70.4 5.29 m   70.4 5.29 m  
3 72.0 
3.65 dd (4.6,  
10.4) 
3.92 dd (5.1, 
10.4) 
1, 2, 1'''  67.4 
3.74 m 
3.99 dd (5.2, 
10.7) 
1, 2, 1'''  67.2 
3.76 m 
4.00 dd (5.2, 
10.8) 
1, 2, 1''' 
1' 175.5    173.6    171.6   
2' 34.9 2.38 t (7.5) 1', 3', 4'  35.5 2.34 t (7.1) 1', 3', 4'  32.3 3.14 bd (4.8) 1', 3', 4'' 
3' 25.8 1.66 p (7.4) 3', 4', 5'  25.5 1.63 m   121.0 5.58 m 2' 
4' 30.3 1.41 p (7.8) 3', 4', 5'  29.7 1.41 m   131.0 5.58 m 2' 
5' 28.0 2.08 m 3', 4'  28.4 2.11 m 4'  25.2 2.84 m 3', 4' 
6', 7', 9', 10', 
12', 13', 15', 
16' 
129.2-132.9 5.36 m   127.8-129.2 5.33-5.38   127.8-129.2 5.25-5.35 m  
8', 11', 14' 26.6-26.7 2.83 m   25.2 2.84 m   25.2 m 2.84 m  
17' 21.7 2.06 m 16', 18'  20.2 2.08 m 18'  20.3 m 2.09 m 18' 
18' 14.8 0.93 t (7.6) 16', 17'  13.2 0.98 t (7.6) 17'  13.7 0.98 t (7.7) 17' 
1''     173.6    173.3   
2''     35.5 2.34 t (7.1) 1'', 3'', 4''  33.5 2.34 t (7.5) 1'', 3'', 4'' 
3''     25.5 1.63 m   24.3 1.63 m 1'', 2', 4'', 5'' 
4''     29.7 1.41 m   29.1 1.41 m 2'', 3'' 
5''     28.4 2.11 m 4''  26.5 2.12 m 3'', 4' 
6'', 7'', 9'', 
10'', 12'', 13'', 
15'', 16'', 
    127.8-129.2 5.33-5.38 m   127.8-129.2 5.25-5.35 m  
8'', 11'', 14'''     25.2 2.84 m   25.2 2.84 m  
17''     20.2 2.08 m 18''  20.3 2.09 m 18'' 
18''     13.2 0.98 t (7.6) 17''  13.7 0.98 t (7.7) 17'' 
1''' 103.9 4.22 d (7.6) 3, 3'''  103.8 4.21 d (7.6)   104.0 4.21 d (7.5) 3, 2''' 
2''' 72.3 3.54 m 3'''  71.1 3.48 m 1'''  71.0 3.51 m 1''', 3''' 
3''' 74.8 3.47 m 1''', 2''', 4'''  73.4 
3.45 dd (3.3, 
9.8) 
2'''  73.4 
3.45 dd (3.1, 
9.8) 
2''' 
4''' 70.4 3.81 bd (2.9) 3''', 2'''  68.8 3.82 m 3''', 5'''  68.8 3.82 m 3''', 5''' 
5''' 76.6 3.51 m 4''', 6'''  75.2 3.51 m 4''', 6'''  75.1 3.51 m 4''', 6''' 







































































































































































































































































































































































































































































































































































































GAT 770A  1H-13C HMBC in CD3OD. 
